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1 Abstract 
 
Human Rhinoviruses (HRVs) constitute the most frequent causative agents of common 
cold infections. Roughly 100 serotypes are differentiated, which are divided into two 
classes according to receptor specificity upon cell infection. Major group viruses bind to 
intercellular adhesion molecule 1 (ICAM-1), minor group viruses to members of the low-
density-lipoprotein receptor (LDLR) family. We demonstrated previously that chip 
electrophoresis allows for analysis of fluorescence labeled virus and its bioaffinity 
reactions, for instance binding of minor group HRV2 to receptor fragments derived from 
the Very-Low-Density-Lipoprotein Receptor (VLDLR) [Weiss et al. (2007): Virus analysis 
by electrophoresis on a microfluidic chip, J. Chromatogr. B 860, 173 – 179 and Kolivoška 
et al. (2007): Electrophoresis on a microfluidic chip for analysis of fluorescence-labeled 
human rhinovirus, Electrophoresis 28, 4734 – 4740].  
 
In continuation of our previous work this thesis will be dedicated to the specific, receptor 
mediated attachment of HRV2 to cells via chip electrophoresis. However, instead of 
working with living cells, receptor decorated unilamellar vesicles (liposomes) were 
employed. Such, binding experiments between model membranes and virions could be 
carried out under well defined conditions.  
 
In addition to binding experiments of HRV2 to liposomes, the transfer of the HRV2 
genome into the aqueous lumen of model vesicles was investigated. In vivo, HRVs are 
internalized into cells via receptor mediated endocytosis. Endosomes undergo acidification 
which induces conformational changes in encapsulated HRVs. Through these changes 
virions are able to transfer their RNA genome through the plasma membrane into the 
cytosol of the infected cell. Therefore, I took interest in membrane disrupting abilities of 
viral proteins as well as of complete virions. Furthermore, experiments were carried out 
setting the stage for monitoring of the RNA transfer itself via so-called molecular beacons, 
fluorescence labeled oligonucleotide probes that bind specifically to corresponding 
nucleotide sequences. Binding to target sequences renders beacons fluorescent, which can 
be followed by chip electrophoresis.  
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2 Introduction 
 
2.1 Biological Background  
 
2.1.1 Human Rhinoviruses [3] 
 
Human Rhinoviruses (HRVs) from the picornavirus family are non-enveloped, acid labile 
viruses of icosahedral symmetry with about 30 nm diameter. 60 copies each of the four 
viral proteins VP1 - VP4 form the viral capsid and encapsulate a single stranded, positive 
sense RNA of about 7100 nucleotides (figure 1). VP4 lies on the inner side of the virus 
capsid and is externalized upon virus conversion during the infection process together with 
the N-terminus of VP1. Other areas of VP1 together with VP2 and VP3 form the outer 
virus surface. According to their receptor specificity the roughly 100 different HRV 
serotypes are classified into a major and a minor group [4, 5]. Major group HRVs bind 
ICAM-1 for cell entry, whereas the minor group binds members of the LDL receptor 
family – LDL receptor (LDLR), very-LDL receptor (VLDLR) and LDLR related protein 
(LRP) [6]. This thesis concentrates on HRV2, the best studied minor group HRV member. 
Recombinant soluble receptor fragments derived from VLDLR were shown to bind in a 
circular way around the fivefold axis on the HRV2 capsid surface. According to the 
number of available binding modules per receptor fragment even multi-module binding 
was experienced [7 – 11]. Another classification of the several HRV serotypes is based on 
their sensitivity against a number of antiviral drugs, termed WIN compounds after the 
synthesizing company [12]. 
 
 
Fig. 1: Human Rhinoviruses are particles of icosahedral symmetry formed of four viral proteins: 
VP1 – blue , VP2 – green, VP3 – red, VP4 lies at the inside of the capsid and is not visible. Image 
taken from http://www.mediresource.com/CPNews/images/x021226A_2009.jpg 
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Binding of virions to plasma membrane receptors is defined as the first step in the HRV 
infection cycle. Following steps include (figure 2):   
 
 
(i) Endocytosis of receptor bound virions to early endosomes [13] 
 
(ii) Dissociation of the virus / receptor complex as well as changes in the virus 
conformation (uncoating) upon further transport along the endosomal route 
 
(iii) Release of the viral RNA from the inside of the capsid through the 
encapsulating membrane into the cytosol of the infected cell 
 
(iv) Synthesis of new infectious viral particles from internalized RNA 
 
 
HRV2 enters target cells mainly via clathrin dependent pathways. Internalized virions 
cumulate in early endosomes (within 5 min), membrane enclosed organelles of a mildly 
acidic pH value (pH 6.0 to 6.5). Under these conditions bound virus particles dissociate 
from respective plasma membrane receptors. Virions are then transported via endosomal 
carrier vesicles (ECV) to late endosomes (within 15 min). Both cell compartments exhibit 
pH values below 5.6, the pH threshold for HRV2 uncoating. In the course of virus 
uncoating the structure of the virus capsid is altered – VP4 is expelled from the virion and 
the N-termini of VP1, which lay previously at the inner side of the virus shell, are 
externalized. In a second step the viral RNA is expelled from the inside of the virus capsid. 
Viral and subviral particles can be differentiated via their sedimentation upon 
centrifugation. Native virions sediment at 150S, whereas viral particles still including the 
RNA but already without VP4 sediment at 135S. Subviral particles, that have expelled the 
RNA as well, sediment at 80S. Conversely to major group HRVs, uncoating of HRV2 in 
vivo is solely pH dependant, whereas in vitro HRV conversion can also be induced via 
heating to temperatures of 56°C or more. pH triggered RNA release could be visualized via 
dynamic force microscopy [14]. 
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Fig. 2: Endocytosis, as shown in overview (A), a typical cellular 
internalization route, is employed by HRV2 for cell infection. Upon 
virus binding to cell surface receptors, clathrin coated vesicles are 
formed (B) that allow for transport of virions to early endosomes (C). 
In early endosomes the virus / receptor complex dissociates after 
acidification of organelles to pH values of 6.0 to 6.5. Virions are 
further transported along the endosomal route to endosomal carrier 
vesicles (ECV) and late endosomes (D). The pH value of these 
organelles measures less than 5.6, hence virions uncoat and shuttle 
their RNA content into the cytosol of the infected cell via 
conformational changes of the virus capsid. Empty virus shells are 
degraded in lysosomes. Images taken from [15].  
 
A 
B 
C 
D 
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De novo virus synthesis takes place after viral RNA has reached the cytosol of an infected 
cell. Therefore, HRVs have to shuttle their RNA through the endosomal plasma 
membrane. In principal two mechanisms are possible – (i) rupture of the endosomal 
membrane or (ii) formation of pores in the membrane that allow for passing of the virus 
RNA over the lipid barrier. For HRV2 co-uptake of fluid phase markers has demonstrated 
the latter case. Only fluorescence labeled dextrans of small size were found to enter the 
cytosol of infected cells, whereas larger molecules were retained in late endosomes. 
Moreover the acidic pH of ECVs and late endosomes was maintained during HRV 
infection which also argues against endosomal rupture. Such, formation of a rougly 10Å 
wide pore via the N-terminus of VP1 as well as via VP4 was suggested [16, 17]. 
Externalized N-termini of VP1 are thought to insert into the endosomal lipid bilayer during 
HRV2 uncoating to arrange the direction of RNA expulsion. After release of the viral 
genome to the cytoplasm, subviral 80S particles are degraded in lysosomes at pH values of 
4.0 to 4.5. 
 
Ribosomal translation of the viral RNA is error prone, thus accounting for the large 
number of different HRV serotypes [18]. Small changes in the amino acid sequence lead to 
serological completely different rhinoviruses. For the pharmaceutical industry this variety 
of serotypes hinders the development of vaccines and antiviral drugs against HRVs. 
Therefore, rhinoviruses present the most frequent causative agents of common cold 
infections, reaching from annoying but else harmless mild infections of the upper 
respiratory tract to more serious lower respiratory tract infections like pneumonia and 
exacerbations of other diseases like bronchial asthma. HRVs are typically transmitted via 
self-infection (contact of hands contaminated with virus containing secretions with eyes or 
the nasal mucosa) or via aerosols. After initial contact, virions are transported to target 
cells in the posterior nasal areas, where binding to respective receptors occurs [19 – 22].  
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2.1.2 From Plasma Membranes to Liposomes [23] 
 
Cells are confined from their extracellular environment via plasma membranes. Also in the 
cytosol of a respective cell, are membranes needed for the confinement of different 
intracellular compartments to maintain specific organelle characteristics, for instance pH 
values. Plasma membranes are bilayers formed from phospholipids (figure 3).  
 
 
 
Fig. 3: Electron microscope image of a plasma membrane cross section (A), a two dimensional 
plasma membrane view (B) and a three dimensional model (C). Phospholipids are depicted in red, 
membrane proteins in green. Image taken from [23]. 
 
Phospholipids are amphipathic molecules – they consist of a polar headgroup and two 
hydrophobic fatty acid chains. When introduced to aqueous solutions, amphipathic 
molecules spontaneously form aggregates to minimize their impact on the three 
dimensional structure of the aqueous medium (figure 4), thus minimizing the resulting 
increase in free energy (similia similibus solvuntur). 
 
 
 
Fig. 4: Impact of hydrophilic and hydrophobic molecules on the three dimensional structure of an 
aqueous solution. Polar molecules, for instance acetone (A), form electrostatic interactions with 
water and are therefore incorporated in the three dimensional structure of the solution. Isobutane 
(B) on the other hand is not able to form electrostatic interactions with water molecules thus 
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forcing the aqueous solution to reorganize into ice like cages. This entropy reduction leads to an 
increase of the free energy of the solution. In order to keep this increase as small as possible 
hydrophobic molecules form clusters, e.g. oil droplets in water. Image taken from [23]. 
 
Clustering of phospholipids in aqueous media leads to energetically favorable spherical 
structures formed of lipid bilayers. Lipid bilayers are in fact fluids themselves, where 
individual phospholipids are able to diffuse laterally, to flex or to rotate. Crossovers of 
phospholipids from one leaflet of the bilayer to the other only seldom occur. Proteins are 
inserted into the bilayer either via hydrophobic anchors or transmembrane domains. 
Together with heterogeneity in membrane composition, attached proteins yield cellular 
lipid bilayers their biological functionality. For membrane research experiments living 
cells are often replaced by liposomes, i.e. artificial, spherical lipid bilayers that encapsulate 
an aqueous core. Such liposomes offer the possibility to concentrate on basic traits related 
to the plasma membrane itself. 
 
Liposomes are distinguished according to their size and lamellarity (figure 5 A and [24, 
25]).  
 
(i) MLVs – multilamellar vesicles of 0.15 - 1 µm diameter 
 
(ii) SUVs – small unilamellar vesicles of 25 - 50 nm diameter 
 
(iii) LUVs – large unilamellar vesicles of 100 nm - 1 µm diameter 
 
(iv) GUVs – giant unilamellar vesicles of 1 - 200 µm diameter 
 
(v) MVVs – multivesicular vesicles of 1.6 - 10.5 µm diameter 
 
Liposomes are thermodynamical stable structures, formed spontaneously upon hydration of 
a lipid film. Modification of liposome size and lamellarity can be achieved upon 
processing of the initially formed material via e.g. sonication or extrusion through filters of 
a well defined pore size [24, 25]. Functionalization of liposomes can be achieved through 
several means (figure 5B and [24, 25]). 
 
(i) Encapsulation of water soluble molecules 
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(ii) Entrapment of hydrophobic molecules in the lipid bilayer  
 
(iii) Interaction of the lipid bilayer with amphipathic molecules 
 
(iv) Anchoring molecules on the liposome surface (NB, we opted in previous work 
(refer to 2.3.3) for this approach to decorate liposomes with recombinant 
receptor fragments: a Ni
2+
 chelating  lipid, DOGS-NTA – 1,2-dioleoyl-sn-
glycero-3-[N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (nickel 
salt) – was incorporated into the liposomal bilayer. Free coordinative sites on 
Ni
2+
 could be targeted by recombinant receptor fragments expressing a His6-tag 
– six histidines in tandem – at their C-terminus.) 
 
 
Fig. 5: Difference in liposome size and lamellarity (A) MLV: multilamellar vesicles, SUV: small 
unilamellar vesicles, LUV: large unilamellar vesicles, GUV: giant unilamellar vesicles, MVV: 
multivesicular vesicles. Liposomes can be functionalized via various methods (B) – e.g. 
encapsulation of hydrophilic molecules into their aqueous core or interaction of hydrophobic or 
amphipathic molecules with the lipid bilayer.  
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2.2 Technical Background 
 
2.2.1 Capillary Electrophoresis [26 – 30] 
 
2.2.1.1 Migration of Analytes 
Capillary electrophoresis (CE) allows for separation of analytes in open tubes, i.e. 
capillaries, filled with a background electrolyte (BGE) upon application of an electric field. 
Figure 6A shows a schematic drawing of a typical CE setup: A capillary is placed between 
two buffer reservoirs that are additionally connected via electrodes and a high voltage 
power supply. Sample injection is carried out on one end, analyte zones are detected at the 
opposite end of the capillary after analyte separation in an electric field. Figure 6B 
demonstrates a typical CE instrument as found in our laboratory. 
 
 
Fig. 6: Schematic drawing of a capillary electrophoresis setup (A). Image of a commercially 
available Agilent CE instrument (B). Image 6B was taken from 
http://www.spectralabsci.com/images/HP-3D-CE-G1600AX.jpg 
 
Analytes subjected to CE are separated according to their migration velocity in the applied 
electric field.  
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The velocity of migration  is directly proportional the applied field  times an analyte 
specific factor. This factor can be expressed as  and is termed , or absolute 
mobility of a substance. It is a result of two counterdirected forces working in steady state 
on a particle during electrophoresis: (i) an accelerating term  reflecting the electric 
force being proportional to the charge of the respective analyte and (ii) a retarding term  
considering hydrodynamic friction according to Stokes law (described by the frictional 
coefficient). The frictional coefficient itself is defined as  reflecting the 
particle geometry as well as the dynamic viscosity η of the BGE. Via the viscosity 
dependence temperature as well as solvent effects are taken into account. The absolute 
mobility can therefore be described as: 
 
 
 
However, the term  defines an idealized, rigid and non changing sphere. 
Furthermore, the absolute mobility describes the electrophoretic behaviour of an analyte in 
the absence of any ions, i.e. a BGE diluted to an infinitely low concentration. Both these 
facts illustrate that the concept of an absolute electrophoretic mobility can only be 
understood as a first approximation in describing the migrational behaviour of an analyte 
in CE. 
 
According to the Debye-Hückel-Onsager theory the absolute mobility is modified through 
solvent dependant parameters to consider the finite ionic strength of the BGE.  is 
corrected for the relaxation (A) and the electrophoretic (B) effect as well as for the ionic 
strength (I) of the employed solvent, thus yielding the concept of an actual mobility .  
 
 
 
 
Both, relaxation (A) and electrophoretic effect (B) decelerate analytes in CE. The 
relaxation effect describes the retardation of molecules by displacement of charged 
particles out of the centre of a sphere of counter ions and the time needed thereafter for 
formation of such a sphere anew. The electrophoretic effect on the other hand describes the 
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retardation due to solvent molecules transported by counter-moving counter-charged ions. 
Both effects are shown schematically in figure 7. 
 
 
Fig. 7: Retarding effects in CE: relaxation effect (A) and electrophoretic effect (B) 
 
Furthermore all kinds of equilibria, such as ion pair formation, conjugation or complex 
formation have to be considered upon description of the migrational behaviour of analytes 
in CE. For weak acids or bases the effective mobility  accounts for the pH value of the 
BGE, since proteolysis of analytes is of course affected by the pH. For a monovalent acid 
thus the following expression is obtained: 
 
 
 
For fused silica capillaries also the electroosmotic flow (EOF) has to be considered in 
dependence of the pH value of the BGE. Silanol groups (pKa = 4-6) are ionized upon 
application of BGEs with intermediate or high pH, thus attracting cationic species from the 
buffer to the capillary surface. Hence an electric bilayer is formed from deprotonized 
silanol groups and cationic species from the solution. Upon application of an electric field 
the cationic species of the electric bilayer migrate in the direction of the cathode inducing 
movement of the whole electrolyte bulk inside the capillary in the same direction. This 
effect is termed EOF and induces an additional electroosmotic mobility . Effective 
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and EOF mobility are combined to form the apparent mobility  of an analyte in CE. 
The apparent mobility can be visualized as vectorial sum of its two constituents (figure 8).  
 
 
 
 
 
Direction and value of 
effective mobility 
Direction and value of EOF 
mobility 
Direction and value of 
resulting apparent mobility 
 
 
 
 
 
 
 
 
 
 
No EOF mobility, i.e. in PVA 
capillaries or at low pH 
 
No effective mobility, i.e. 
analytes are not charged 
 
 
 
 
 
 
 
  
 
 
 Effective and EOF mobility 
are equivalent but counter 
directed, no migration 
 
 
 
  
 
Fig. 8: Effective and EOF mobility are visualized as vectors for calculation of the apparent 
mobility of an analyte. 
 
The electroosmotic mobility  is dependent on the zeta-potential ζ of the BGE as well 
as on its viscosity η;  describes the relative permittivity and  the permittivity of 
vacuum. 
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2.2.1.2 Peak Dispersion [31 – 33] 
Even if the analyte zone forms a Dirac function upon injection to the capillary, at analyte 
detection the peak shape resembles a Gauss function. The width of this function can be 
expressed via the peak variance  after analyte migration for a distance z. z, the standard 
deviation of the Gaussian distribution expressed in the space domain, is half of the distance 
between the inflection points of the curve (at approximately 0.6 of the peak height). The 
peak variance  and the migrational distance z can be related via a proportional factor H, 
which is according to Martin and Synge termed plate height and which indicates peak 
broadening after migration for the distance z. 
 
 
 
 
In CE the position of the detector is normally fixed, which implies that not the peak 
variance in dependence on the migrational distance of the analyte peak from the point of 
injection is of importance but the time needed for the analyte zone to pass the detection 
window. Nevertheless the plate model of Martin and Synge can also be employed for CE 
since  and , the peak variances in the space and time domain, respectively, can be 
related via the analyte velocity vi.  
 
 
 
A number of individual effects contribute to the total peak broadening in CE. The resulting 
total peak variance as well as the total plate height can be understood as sum of those 
individual effects. 
 
 
 
Effects influencing the total plate height in CE include: 
 
(i) Extracolumn effects – Sample injection as well as detection influence the peak 
variance due to finite zone width independent of the migrational process itself. 
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(ii) Longitudinal diffusion – Longitudinal diffusion results from a respective 
concentration gradient across the zonal boundary. It depends on the diffusional 
coefficient of the analyte Di in a direct proportional and from the velocity of the 
analyte  in an indirect proportional way. 
 
(iii) Radial temperature gradient – Joule heat is generated by the passing of an 
electric current through the capillary. High capillary surface-to-volume ratios 
(narrow capillaries) allow for efficient heat dissipation. Narrow capillary 
diameters on the other hand increase the current density inside the capillary. 
Therefore, to reduce the amount of generated Joule heat, the current itself has to 
be reduced, either by application of lower field strengths or by reduction of the 
ionic strength of the BGE. 
 
(iv) Wall adsorption – Wall adsorption especially in conjunction with slow kinetics 
of analyte sorption from the capillary wall contributes to peak broadening in CE 
as well. Irreversible adsorption to the capillary wall can even lead to loss of the 
analyte peak. On the other hand, however, adsorption of molecules to the 
capillary wall can be employed for coating procedures. 
 
(v) Electromigration dispersion – In capillary zone electrophoresis the same current 
is applied across the capillary. However, the presence of analyte ions in the 
sample zone influences the conductivity in that particular capillary volume. 
Thus, the field strength in the sample zone is lower (for zones of higher 
conductivity) than in adjacent capillary sections. Analyte ions therefore exhibit 
different migration velocities according to their relative position in the 
capillary. Analytes after the terminating front of the sample zone exhibit higher 
velocities (because of higher field strength) in the direction of overall migration 
than analytes in the sample zone itself. As soon as the analyte reaches the 
sample zone again it is confronted with its lower field strength and is slowed 
down. This effect results in peak sharpening at the terminating front of the 
sample zone. However, the same effect at the leading front of the sample zone 
leads to peak broadening since the direction of longitudinal diffusion and 
analyte acceleration due to a higher field strength point at the same direction. 
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(vi) Minor effects – Capillary bending results in different path lengths for analyte 
ions passing the capillary and thus as well to peak broadening. Also the 
presence of EOF causes peak broadening as do laminar flows inside the 
capillary or even the cut of the capillary. In overall, for short capillaries and 
even more so on electrophoretic microchips, peak broadening effects resulting 
from channel geometry as well as from extracolumn effects gain more influence 
on the total peak variance than for longer separation distances. 
 
The plate number N relates the effective length of the capillary to the plate height H. 
 
 
 
The plate number N in CE is analyte specific and is accessible from the resulting peak 
variance after analyte migration. For  it can be further reasoned: 
 
 
 
 
 
 corresponds to the average mobility of two solutes. Likewise the separation of two 
analytes is described via the resolution R as ratio between the difference in peak migration 
distance  and peak width. For Gauss peaks baseline separation is obtained at  which 
leads to: 
 
 
 
 
Comparison of equations for N and R finally relates the resolution between two peaks to a 
selectivity (comparison of mobilities) and an efficiency term (related to peak dispersion via 
the square root of the plate number N). Therefore baseline separation between two peaks in 
CE depends on both factors, migration and dispersion. However, since the plate number is 
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considered only as square root, the resolution between two analytes is more easily adjusted 
via the selectivity term.  
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2.2.2 Chip Electrophoresis on the Agilent 2100 Bioanalyzer 
System 
 
The Agilent 2100 Bioanalyzer system (figure 9) was developed for chip electrophoretic 
separation of proteins, DNA and RNA as well as for cell flow-cytometry. Protein 
separation is described in literature in detail [34 – 36]; other applications work similarly.  
 
 
Fig. 9: Agilent 2100 Bioanalyzer workstation; image taken from http://www.chem.agilent.com/  
  
Agilent 2100 Bioanalyzer chips (figure 10) are single-use products manufactured from 
Caliper Technologies Corp. (Mountain View, CA) and fabricated from soda lime glass. 
Channels are etched photolithographically to 13 µm depth and 36 µm width on square 
chips of 17.5 mm edge length. In the case of the protein application up to 10 samples can 
be analyzed per chip, DNA and RNA chips even allow analysis of up to 12 samples. Upon 
purchase, chips are supplied with background electrolyte, dye and standard solutions to 
allow for quick lab-on-a-chip sample analysis. 
 
 
 
Fig. 10: Chips for Agilent 2100 Bioanalyzer – blue for DNA, green for RNA and violet for 
protein analysis. Yellow chips are employed for cell flow-cytometry. Image taken from 
http://www.bcm.edu/cms_web/110/biolabchips.jpg  
 
Channels of protein chips are filled on the supplied chip priming station via pressurization 
(12.0 µL for 60 sec from well A4) with a polymer containing BGE as sieving matrix 
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(120 mM Tricine, 42 mM Tris, pH 7.6, 8.7 mM SDS, 3.25 % polydimethylacrylamide, 
4 µM FL dye with λex / em = 650 / 680nm). Remaining BGE is removed from well A4 
before 12.0 µL of BGE are pipetted to wells A4, B4, C4 and D3, respectively. Well D4 is 
filled with 12.0 µL BGE not including SDS or dye, hence termed destaining solution. Well 
D2 is used for application of a protein size standard solution. All other wells are filled with 
6.0 µL of denatured protein samples. Notation of wells as described above is according to 
literature [34] and shown below (figure 11). 
 
  
 
Fig. 11: Protein chip for Agilent 2100 Bioanalyzer (A); the scheme (B) reflects the chip geometry. 
 
All processes during analysis of samples on Agilent 2100 Bioanalyzer chips are controlled 
via a computer script, which is embedded in the assay surface of the instrument and hence 
usually not accessible to the user. The script allows individual targeting of 16 high voltage 
power supplies. Thus, samples are injected electrophoretically to the separation channel on 
the chip via a two step process as shown in figure 12. This two step process allows for 
injection of a sharp sample zone into the separation channel; the volume of the respective 
sample plug was calculated to 25 pL [34]. 
 
 
 
Fig. 12: Electrophoretic sample injection to the chip separation channel (A). An example for 
sample injection from a well of the lower chip part is detailed. In a first step, molecules are 
1   2   3   4 
A 
B 
C 
D 
A      B
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electrophoresed to well D3 (B), in a second step across the separation channel to well B4 (C). A 
short sample plug of approximately 25 pL is then analyzed in the separation channel (D). Samples 
from the upper chip part are injected upon electrophoresis to according wells. 
 
The instrument is equipped for FL detection at two wavelengths; a red laser allows for 
detection at a maximum λex = 630 nm, a blue LED for detection at a maximum λex = 
470 nm. Upon migration in the separation channel proteins are separated in the polymer 
sieving matrix according to their respective size. Furthermore, proteins are FL labeled via a 
dye included in the BGE to allow for detection with the red laser of the instrument. Dye 
molecules interact with SDS/protein complexes and SDS micelles likewise, rendering both 
fluorescent. However, interaction of the FL dye with detergent micelles greatly diminishes 
the sensitivity of the analytical system. Therefore, Agilent developed a so called virtual 
destain (figure 13), that dilutes the SDS concentration in the BGE after analyte separation 
below the detergent CMC value with destaining solution (BGE not including dye or SDS). 
Dye molecules are reported not to interact with SDS monomers but attach to the 
proteinaceous analytes instead, rendering them even more fluorescent and thus increasing 
the sensitivity of protein detection. 
 
 
 
Fig. 13: Online virtual destain in the course of protein analysis on Agilent 2100 Bioanalyzer 
chips: Chip geometry (A) and direction of flows (B). The SDS concentration of the BGE is 
diluted below the CMC of the detergent after separation of analytes via a destaining solution, thus 
greatly improving the sensitivity of the instrument for FL labeled protein detection. 
 
Results of protein analysis can either be read out in the form of electropherograms or can 
be converted to simulate SDS-PAGE gels. An electropherogram obtained after analysis of 
a protein ladder size standard can be found in figure 14. Peaks for 7 marker proteins and 
for the dye as lower marker (sizing from 4.5 - 240 kDa) are baseline separated. The second 
peak of the electropherogram is described as system peak [37]. 
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Fig. 14: Electropherogram of a ladder sample analyzed on a protein chip of Agilent 2100 
Bioanalyzer. Peaks correspond to seven marker proteins, a peak for the FL dye as lower marker 
and a system peak (second peak).  
 
DNA analysis is carried out presumably in a likewise fashion although the exact 
composition of the BGE has not been published so far. The most striking difference 
between protein and DNA chips is the chip geometry itself. Whereas protein chips include 
a destaining cycle, this cycle is omitted with DNA chips. Thus up to twelve DNA samples 
can be analyzed per chip (figure 15 and [38]). 
 
  
 
Fig. 15: DNA chip for Agilent 2100 Bioanalyzer (A); the scheme on the right side demonstrates 
the chip geometry (B). 
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2.3 Analytical Background 
 
2.3.1 Capillary Electrophoresis of HRVs 
 
After initial capillary electrophoresis experiments with tobacco mosaic virus by Hjertén et 
al. [39] during the late 1980s, CE has more and more evolved as a powerful tool for the 
analysis of viruses. Electrophoresis in the capillary format offers the great advantage over 
other analysis methods that virions can be followed in free solution, therefore allowing for 
tracking of virions in the fluid phase. In such a way, for instance binding of virus particles 
to receptor molecules or antibodies can be monitored. CE has thus been successfully 
employed for the study of several virus families, like togaviridae [40] comoviridae [41], 
adenoviridae [42] and picornaviridae [43 – 45].  
 
Human rhinoviruses, belonging to the latter virus family, have been extensively 
characterized via CE in a series of papers [46, 47] (for reviews refer to [43, 44, 48, 49]). As 
has been stated (refer to 2.1.1) HRVs consist of a proteinaceous capsid of 60 copies each of 
the four viral proteins VP1 - 4 encapsulating a viral RNA genome. The pI of such a protein 
capsid assembly – that of HRV serotype 2 – was found to be 6.8 via capillary isoelectric 
focussing (CIEF, [50]). Therefore, HRV2 particles are negatively charged at pH 8.3, the 
pH of the BGE normally employed for rhinovirus analysis in CE. The basic pH value of 
the BGE was chosen to allow for electrophoresis with reasonable virus mobility – the BGE 
pH should value at least ± 1 pH units of the analyte pI. However, virus uncoating at acidic 
pH values anticipates application of BGEs with pH values lower than 5.8. Thus sodium 
borate at pH 8.3 was introduced as BGE for CE of HRVs. 
 
Furthermore, it was found that virions tend to yield aggregates upon subjection to CE in 
plain sodium borate. Therefore, to reduce virus aggregation and to suppress spike 
formation, detergents like sodium dodecyl sulphate (SDS), sodium deoxycholate, Triton X-
100R or dodecylpolyethyleneglycol ether (Thesit) were introduced to the BGE. Surfactants 
had to be applied above their respective critical micellar concentration (CMC) to show the 
desired effect on virus electrophoresis [51]. Depending on the choice of the detergent 
applied to the BGE, native virions as well as subviral 80S particles or even viral proteins 
and the virus RNA genome were accessible for CE. Figure 16, A displays an 
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electropherogram of native 150S viral particles in CE obtained after application of 10 mM 
SDS to the BGE. DMSO was included in samples as EOF marker. The peak obtained for 
native 150S particles shows an UV absorption maximum at 260 nm because of 
encapsulated RNA within the virion (figure 16, B). Under such BGE conditions (100 mM 
boric acid, adjusted to pH 8.3 including 10 mM SDS) determination of concentration and 
purity of virus preparations via comparison to a standard electropherogram is possible and 
carried out routinely in our laboratory.  
 
 
 
 
Fig. 16: Virus analysis on an Agilent 3D CE (A). The HRV2 stock solution valued 4.7 mg/mL; 
Sample preparation: 1:20 dilution of virus and 1:4 x 10
3
 dilution of DMSO in BGE; BGE: 
100 mM sodium borate, pH 8.3, 10 mM SDS; CE at + 25 kV, 20°C, injection at 50 mbar x 9 sec, 
detection at 200/205/260 nm, BW 10 nm; Capillary: fused silica, 50 µm inner diameter, 375 µm 
outer diameter, Ltot / Leff = 60.0 / 51.5 cm. Native 150S particles exhibit an UV absorption 
maximum at 260 nm (B) 
 
 
 
Heat denaturation of such virus samples (10 min heating to 56°C in SDS containing BGE) 
leads to disintegration of viral capsids. Instead of one peak for 150S particles four peaks 
corresponding to viral proteins and one peak corresponding to the viral RNA (again UV 
absorption maximum at 260 nm) are obtained. Figure 17 displays a respective 
electropherogram. 
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Fig. 17: CE as with figure 16; Sample was heated for 10 min to 56°C prior to analysis. 
 
Substitution of SDS with Thesit no longer permits electrophoretic separation of native 
virions and a contaminant of the virus preparation (figure 18). However, heat denaturation 
and CE of corresponding virus samples now allow for analysis of subviral B particles 
sedimenting at 80S instead of VPs (figure 19). Therefore, the choice of detergents and 
sample pre-treatment allows for specific targeting of several species of the virus uncoating 
process. Subviral A particles sedimenting at 135S were only reported once in CE so far 
[52] and could until now not be reproducibly targeted.  
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Fig. 18: Virus analysis on an Agilent 3D CE. HRV2 stock solution as with figure 16; Sample 
preparation: 1:20 dilution of virus and 1:4 x 10
3
 dilution of DMSO in BGE not including any 
detergents; BGE: 100 mM sodium borate, pH 8.3, 10 mM Thesit; CE as with figure 16; Capillary: 
fused silica, 50 µm inner diameter, 375 µm outer diameter, Ltot / Leff = 60.2 / 51.8 cm 
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Fig. 19: CE as with figure 18; Sample was heated for 10 min to 56°C prior to analysis. 
 
Upon application of the described CE conditions reaction of viral as well as subviral 
particles to recombinant soluble receptors, antibodies and antibody fragments was reported 
[53 – 58]. Also the kinetics of thermal denaturation in the presence or absence of antiviral 
compounds (WIN) was accessible for analysis [52]. Postcolumn infectivity assays enabled 
the differentiation of HRV serotypes [59]. To allow for more sensitive virus detection, also 
FL labeling was introduced. In principle two possible approaches of FL labeling of virions 
exist: (i) FL modification of the proteinaceous capsid or (ii) labeling of the encapsulated 
viral RNA genome [60 – 62]. Although labeling of the encapsulated genome promised to 
offer the great advantage of unmodified capsids yet still FL viral particles and thus to allow 
for sterical unhindered reactions of virions with receptor molecules upon cell infection 
experiments, only few dye molecules could be attached to the RNA. Therefore, only low 
FL signals were obtained. Furthermore, dye molecules did not covalently attach to the 
RNA but probably intercalated to double stranded regions of the virus genome. Upon RNA 
release and unfolding, FL dye molecules therefore detached from their target, no longer 
allowing for FL tracking of the viral genome. Thus, for most experiments FL modification 
of the viral capsid was chosen instead to enhance virus detectability in CE. A 
corresponding electropherogram for FITC (λex / λem at 488 / 518 nm) modified HRV2 is 
presented in figure 20. A contaminant of the virus preparation was as well heavily labeled 
with the amine reactive dye, yielding a FL peak even larger than that of the labeled virus 
particle. Also, unreacted dye molecules could not be completely removed from samples by 
application of column size exclusion chromatography (SEC) as demonstrated below. 
Furthermore, SEC led to quite high sample dilution. Finally, covalent modification of 
29 
 
primary amines of the proteinaceous virus capsid (mainly of VP1) limited the ability of 
modified virions for receptor attachment (modified amines of VP1 lay most probably at the 
starshaped dome of the capsid where receptor binding takes place). Nevertheless, some of 
the virus receptor binding properties were maintained. Therefore, virions still exhibited 
infectivity albeit at much lower levels than unmodified viruses. Despite all these 
drawbacks, FL modification of HRV capsids is widely employed for improvement of virus 
detectability in CE. 
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Fig. 20: CE of FITC labeled HRV2 after SEC. Sample was applied undiluted after SEC with 
50 mM sodium borate, pH 8.3 as elution buffer; BGE: 100 mM sodium borate, pH 8.3, 10 mM 
SDS; Capillary: fused silica, 75 µm inner diameter, Ltot = 73.0 cm, LUV = 23.5 cm, LFL = 58.0 cm; 
CE at 20°C, + 20 kV (~27 kV/m), 200/260 nm UV detection, FL detection with external FL 
detector from Picometrics (Ramonville, France) equipped with a red argon laser (λex = 488 nm) 
from Spectra-Physics (Mountain View, USA), 25 mbar x 10 sec injection 
 
Lately, FL modification of the viral capsid via the amine reactive probe Cy5 (λex / λem at 
649 / 670 nm) was reported [1, 2] to allow for chip electrophoresis of virus samples 
employing the commercially available Agilent Bioanalyzer system. 
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2.3.2 Electrophoresis of HRV2 on the Agilent 2100 Bioanalyzer 
System 
 
In the course of our previous research we extended the applicability of Agilent 2100 
Bioanalyzer to another type of analytes – viruses and subviral particles [1, 2].  In order to 
do so, the script of the instrument, originally intended for DNA analysis, was adapted to 
our needs. The following changes were implemented: 
 
 
(i) Change in polarity: According to CE data (refer to 2.3.1), we decided to opt for 
100 mM boric acid adjusted to pH 8.3 via sodium hydroxide and including the 
detergent SDS as BGE. Under these conditions, we experienced EOF values 
comparable to CE. However, since chip DNA analysis was developed with a 
polymer containing sieving matrix with highly reduced EOF we had to change 
the polarity of all electrophoretic steps on the chip, i.e. sample injection to the 
separation channel and electrophoretic sample analysis. In the end, we opted for 
1300 V potential for sample injection and 800 V (approx. 19 kV/m) potential 
for electrophoretic sample analysis, both applied in positive polarity, i.e. lower 
potentials were set for the respective outlet than for the respective inlet wells. 
 
(ii) Setup of the instrument optics: Changing the BGE to sodium borate, pH 8.3, 
including SDS as surfactant had also a significant impact on the optical 
adjustment of the instrument. Normal polymer containing BGE for DNA 
analysis includes a FL dye as well, in order to stain DNA in the course of 
electrophoresis on the chip. Under these conditions adjustment of the 
instrument optics to the detection window of the separation channel filled with 
a FL BGE is possible. Omitting the FL dye in the BGE causes severe problems 
in the system setup process. Therefore, we included some modifications in our 
script allowing for flushing of the separation channel with Cy5 containing BGE 
prior to setup of the instrument optics. After setup of the optics was complete, 
we again removed the dye electrophoretically from the separation channel. 
With this setup we could sustain the high detection sensitivity upon chip 
electrophoresis and could greatly improve the baseline stability during analyses. 
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(iii) Further changes affected chip handling and sample preparation: DNA chips 
were filled with 12.0 µL BGE on the Priming Station (20 s, upper syringe clip 
position, position C of the base plate) from the BGE outlet well. Twelve µL of 
Cy5 containing sample buffer (62.5 nM dye concentration) were applied to the 
ladder well for adjustment of the instrument optics and 12.0 µL BGE to the 
remaining two wells marked 'G'. Six µL of the samples were applied to the 
remaining wells. After the run, electrodes were cleaned with the Electrode 
Cleaning Chip (filled with 380 µL doubly distilled water). Samples consisted of 
prestained FL analytes. Cy5 (λex / λem at 649 / 670 nm) was employed for 
analyte modifications. 
 
 
After implementation of our modifications we were able to run Cy5-labeled virus samples 
on DNA chips. Modification of the SDS content of the BGE allowed for separation of all 
sample constituents: labeled HRV2, free dye molecules, which had not been completely 
removed from samples via SEC and a contaminant of the virus preparation which was as 
well heavily modified by the amine reactive probe Cy5. Resulting electropherograms taken 
from [2] are depicted in figure 21.  
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Fig. 21: Electropherograms of Cy5-labeled HRV2 containing samples. BGE was 100 mM sodium 
borate (pH 8.3) containing SDS at indicated concentrations between 2.0 and 5.0 mM. Samples 
were analyzed after SEC purification and 1:15 dilution in BGE. Intentionally, a SEC fraction that 
still contained free dye molecules was employed for analysis. Separations were carried out at 
800 V (approx. 19 kV/m), the FL signal was recorded at λex/λem 630/680 nm. c, contaminant. 
Image taken from [2]. 
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Plotting of the selectivity coefficient between the three sample constituents against the 
SDS concentration of the BGE (figure 22, taken from [2]) demonstrates that at 3.1 mM 
SDS concentration baseline separation of the analytes was achieved. A resulting 
electrophrogram can be found in figure 23. 
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Fig. 22: Selectivity coefficients, i.e. ratio of the total electrophoretic mobilities µ between labeled 
HRV2, Cy5 and the contaminant, c, respectively, as a function of the SDS content of the BGE. 
Image taken from [2] 
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Fig. 23: Electropherogram of Cy5-labeled HRV2, an equally labeled contaminant of the virus 
preparation and free dye molecules. At 3.1 mM SDS concentration in the BGE, baseline 
separation of all sample constituents was accomplished. Other chip electrophoresis conditions as 
with figure 21.  
 
Upon application of our adapted script and with 100 mM sodium borate, pH 8.3 including 
3.1 mM SDS as BGE, we were able to assess several analytical questions via chip 
electrophoresis – peak identification reactions via virus degradation to proteins and RNA 
followed by proteolytic digestion of proteins, receptor binding experiments with several 
soluble recombinant receptor fragments derived from the VLDLR as well as temperature 
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dependant time curves of virus denaturation. However, most interesting for our further 
scheduled analyses was the fact, that electrophoresis in the chip format allowed for virus 
analysis in the complete absence of detergents. CE of viruses or subviral particles only 
yielded reproducible results upon application of surfactants above their critical micellar 
concentration (CMC) in the capillary format (refer to 2.3.1). Therefore, we were surprised 
by our chip electrophoretic finding, which we related to the short migration distance of 
virions on chips when compared to the capillary format. A corresponding 
electropherogram obtained via chip electrophoresis in the absence of detergents can be 
found in figure 24 (taken from [1]).  
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Fig. 24: Electropherogram of Cy5-labeled HRV2, an equally labeled contaminant of the virus 
preparation and free dye molecules. Upon application of BGE without any detergents labeled 
HRV2 and the contaminant were comigrating. However, although no baseline separation between 
sample constituents was accomplished, still electrophoresis in the absence of any surfactants was 
possible, a very important prerequisite for the analysis of liposomes in our chip electrophoretic 
system. Other chip electrophoresis conditions as with figure 21. Image taken from [1]. 
 
Although no separation between labeled virus and the equally modified contaminant was 
possible without application of detergents, absence of detergents was a very important 
prerequisite for the extension of our electrophoretic system to questions concerning virus 
binding to membranes in the course of cell infection. However, instead of working with 
living cells, we opted for liposomes as model membranes to mimic the in vivo situation. 
Liposomes are not stable in the presence of detergents. Therefore, receptor mediated 
attachment of virions to model membranes could previously only be investigated indirectly 
in CE, i.e. via the disappearance of corresponding peaks (refer to 2.3.3). We suggested that 
electrophoresis in the chip format would allow for tracing of all constituents of such 
binding experiments. 
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2.3.3 Capillary Electrophoresis of Liposomes [63, 64] 
 
Liposomes in electrically driven capillary separation methods are mostly employed as part 
of the separation system itself. Application of liposomes as pseudostationary phase in CE 
(liposome electrokinetic chromatography, LEKC) constituted an advancement of micellar 
electrokinetic chromatography (MEKC) introduced by Terabe et al. [65, 66] employing 
detergents. In LEKC, liposomes are dispersed in the BGE to assess interactions of analytes 
with membranes mimicking the interaction with living cells. This allowed for instance the 
development of a model for human drug absorption via the transcellular passive transport 
route. A variant of LEKC employed only partial filling of a coated capillary with a 
liposome containing solution [67]. Due to low EOF values and application of uncharged 
lipids for liposome preparation a non-moving, liposome containing plug was generated 
through which analytes had to pass in the course of their migration. Alteration of analyte 
mobility was a result of interaction with lipid vesicles.  
 
In capillary electrochromatography (CEC), liposomes are immobilized as coating on the 
capillary silica surface and thus employed as stationary phase comparable to LC. Again 
separation of analytes is based on different partition between the liquid bulk and the 
stationary liposome phase. Capillary coatings with phospholipids are described as semi-
permanent, which implies that, although no liposomes have to be present in the BGE 
during a run, often coatings have to be regenerated after analysis.  
 
A series of papers also concentrated on liposomes as analytes in CE. The main interest lay 
in the stability of liposomes and leakage of encapsulated drugs as well as in the 
homogeneity of liposome formulations concerning their size and mobility. Bilek et al. [68, 
69] employed liposomes functionalized for protein binding via implantation of an anchor 
lipid containing a nitrilotriacetate acid group for complexation of Ni
2+
. His6-tagged 
proteins were employed for attachment to Ni
2+
 on the liposome surface. Such, binding of 
HRV2 to receptor decorated liposomes could be followed. However, since analysis of 
HRV2 in the capillary format requires the application of detergents in the BGE (refer to 
2.3.1) but since liposome analysis in CE on the other hand also precludes the application of 
surfactants, resulting adducts were not resolved as CE peak but deduced from the 
appearance of spikes upon complex formation. Nevertheless, these publications 
demonstrate the basic principles underlying the work presented in the course of this thesis. 
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3 Results and Discussion 
 
Interaction of human Rhinovirus with cells during early virus infection can be structured 
into several steps reaching from the receptor mediated endocytosis of virions into host cells 
to the transfer of viral RNA from the inside of late endosomes through the endosomal 
membrane to the cytosol of the respective cell (see chapter 2.1). Part of the research in our 
laboratory concentrates on the development of an in vitro system allowing for the discrete 
targeting of each of these early infection steps employing serotype 2 of HRV as 
representative. Instead of working with cells, we opted for liposomes as vesicles since they 
offer the possibility of a well characterized model membrane in terms of lipid composition 
as well as particle size. For similar reasons we replaced native receptor molecules with 
recombinant receptor fragments bound via His6-tags to Ni
2+
-ions embedded on the 
liposome surface. In continuation of previous work (see chapter 2.3) I opted for 
electrophoresis, both in the capillary as well as in the chip format, to target our analytical 
questions. My electrophoretic results were further supported by transmission electron 
microscopy (TEM).  
 
Figure 25 outlines the early steps of the infection pathway of HRV2. Electrophoresis of 
viral 150S (i in figure 25) as well as subviral 80S particles has already been published 
extensively (see chapters 2.3.1 – 2.3.2), however, electrophoresis of subviral 135S particles 
has only been seldomly described. Therefore, the first part of this chapter will be dedicated 
to findings concerning this latter subviral particle. Receptor mediated attachment of virions 
to cell surfaces (ii in figure 25) compromises the first key step in virus infection and 
respective results will be discussed thereafter.  Receptor bound virions are then 
internalized into cells via endocytosis (iii – iv in figure 25). Upon maturation, endosomes 
undergo changes in the pH of their aqueous interior from neutral to acidic values around 
pH 5.6. This acidification triggers a series of changes in internalized virions termed virus 
uncoating (v – vi in figure 25). In the course of this process, the viral RNA is shuttled from 
the inside of the virus capsid through assumed size selective pores in the endosomal 
membrane to the cytosol of the infected cell (see chapter 2.1). To investigate the process of 
pore formation an electrophoresis based leakage assay was developed that will be 
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described alongside its application in the evaluation of membrane disrupting abilities of 
HRV2 virions and viral proteins. Finally, viral RNA has entered the cytosol of the infected 
cell (vii in figure 25) and is ready for viral replication. To monitor the viral RNA transfer 
across a membrane, the employment of molecular beacons – short single stranded 
oligonucleotides, which bind specifically to corresponding nucleotide sequences of the 
viral RNA, thus yielding a fluorescence signal, was suggested. Upon encapsulation of 
beacons in liposomes inverse endosomes were created, which were intended to follow the 
viral genome transfer from a position outside of a membrane to the aqueous lumen of a 
liposomal vesicle. Initial experiments demonstrated comparability of this inverse direction 
of RNA transfer to the in vivo situation. First results in method development for the setup 
of such inverse endosomes will be presented at the end of this chapter. 
 
Fig. 25: Interaction of HRV2 virions with cells: free HRV2 (i); HRV2 bound to receptor 
molecules of the VLDL receptor family on the cell surface (ii); internalization of receptor bound 
virions (iii); HRV2 in early endosomes (iv); acidification of endosomes triggers virus uncoating 
(v) which finally leads to the transfer of viral RNA through the plasma membrane (vi) into the 
cytosol of the infected cell (vii). 
 
Some data presented below, especially resulting publications, were obtained in close 
cooperation with other authors. Therefore, at the beginning of each subchapter the state of 
publication as well as the amount of experimental contribution of respective authors to the 
corresponding publication will be detailed. 
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3.1 Capillary Electrophoresis of Subviral 135S Particles 
 
Publication: Capillary Electrophoresis of 135S Particles of Human Rhinovirus Serotype 2 
State of publication: under preparation 
Experimental contributing authors:   Victor U. Weiss – 55% 
      Gerhard Bilek – 15% 
      Angela Pickl-Herk – 25% 
      Irene Goesler – 5% 
 
Virions from human Rhinovirus serotype 2 (HRV2) convert in the course of their cell 
infection from particles sedimenting at 150S to particles sedimenting at 80S (subviral B-
particles). 80S particles lack viral protein number 4 (VP4), the innermost capsid protein, 
and the viral RNA genome. An intermediate of this conversion, a particle including the 
viral RNA but already lacking VP4 and sedimenting at 135S is also known and termed 
subviral A-particle. CE of 135S particles was so far only reported once [52]. We report 
here: (i) A reproducible way of 135S particle preparation; moreover, we could demonstrate 
the dependence of 135S particle formation on the dilution of the virus stock solution. (ii) 
We were also able to estimate the stability of 135S particles in free solution. (iii) We 
confirmed the identity of our obtained subviral species by several means: Electrophoretic 
mobility, UV-absorption spectra, sucrose density gradient centrifugation, immunaffinity 
reaction and size exclusion chromatography (SEC). Transmission electron microscopy 
(TEM) imaging of virions at different stages of virus conversion additionally confirms our 
CE findings. In such a way, we could clearly distinguish between viral 150S and subviral 
135S and 80S particles. (iv) We were able to trace the conversion of 135S to 80S particles 
after application of additional triggers of virus conversion. Therefore, we could 
demonstrate that subviral 135S particles are no end points or aborted particles of virus 
infection but intermediates of the virus uncoating process. The accessibility of subviral 
135S particles offers the possibility to target this intermediate of virus uncoating 
specifically. Thus it is of great importance for further understanding of the viral infection 
pathway and for elucidating structural intermediates of virus uncoating. 
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Analysis of viral 150S and subviral 80S particles 
Virus analysis via CE in Thesit containing buffer is known to yield just one peak from two 
unresolved sample constituents – a contaminant from the virus preparation and the virus 
itself (see chapter 2.3.1). After heating of such a sample for 10 min to 56.0°C, viral 150S 
particles are completely converted to subviral 80S particles, lacking VP4 as well as the 
viral RNA genome [47]. Both species, the intact viral 150S and the subviral 80S particle, 
migrate similarly in CE, however, they can be sufficiently distinguished via their 
electrophoretic mobility. For viral 150S particles the electrophoretic net mobility values 
5.7 x 10
-9
 m
2
/Vs, for 80S particles 8.5 x 10
-9
 m
2
/Vs [51]. In contrast to 80S particles, intact 
virions show UV absorption at 260 nm resulting from still encapsulated viral RNA [52].  
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Fig. 26: Analysis of viral 150S and subviral 80S particles. (A): CE of HRV2 150S (i) and 80S (iii) 
particles and electropherograms obtained upon mixing of virions with monoclonal antibody 2G2 
(mAb 2G2) (ii 150S + 2G2; iv 80S + 2G2). Subviral 80S particles react with the antibody in 
contrast to 150S particles. Additionally, 150S and 80S particles can be differentiated visually as 
seen from TEM image of 150S particles (B) and TEM image of 80S particles (C). Native virions 
appear as bright dots, 80S particles as dark areas of uniform density surrounded by bright coronas. 
Due to pores in the viral capsid (80S particles lack viral protein 4) and the missing viral RNA 
genome, subviral 80S particles allow readily for negative stain penetration. For CE, the applied 
field strength valued approx. 42 kV/m at 20.0°C with sodium borate (100 mM boric acid, pH 8.3) 
containing 10 mM Thesit as BGE. The sample buffer (SB) did not contain any detergents. 
Capillary: fused silica, 50 µm inner diameter, Ltot / Leff = 60.0 / 51.5 cm. TEM images were 
B
C
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obtained with phospho-tungsten acid pH 7.3 as contrast medium on glow discharged carbon 
coated copper grids. Images were taken at a 8.9 x 10
4
 fold magnification. 
 
Figure 26 A depicts electropherograms for an HRV2 sample run in Thesit containing BGE. 
Before heating, virus and contaminant are comigrating (i). However, after thermal 
denaturation the peak for the subviral 80S particle is partially resolved from the 
contaminant peak as described above (iii). Viral 150S particles do not react with mAb 2G2 
([57]and ii), whereas subviral 80S particles do (iv). The appearance of spikes after 
monoclonal antibody addition, demonstrates the precipitating ability of mAb 2G2 for 
empty viral capsids. We further visualized viral 150S and subviral 80S particles via TEM. 
Viral 150S particles (figure 26 B) appear as bright dots upon TEM imaging since negative 
stain cannot penetrate the proteinaceous viral capsid. Subviral 80S particles (figure 26 C), 
however, have lost VP4 as well as the RNA genome. Upon viral uncoating, pores open at 
fivefold axes on the capsid surface that allow for negative stain penetration. Therefore, 
subviral 80S particles show a core of high density surrounded by a bright circle. Cloud 
shaped particles upon imaging of viral 150S and subviral 80S particles most probably 
result from denatured virions during the staining process.  
 
The release of RNA from inside of the viral capsid constitutes the critical step of cell 
infection. Subviral 135S particles are therefore an important intermediate of HRV2 
uncoating. Although virions have already started to convert by release of VP4, they still 
include the viral genome. Therefore, 135S particles allow for investigation of direct 
mechanisms of RNA release. Subviral 135S particles have been recorded once during CE 
analysis [52]. However, we could greatly improve the reproducibility of the described 
formation protocol. We found the formation of 135S particles of HRV2 depending on the 
dilution of the virus stock solution prior to heat denaturation (10 min heating of virus 
solution to 56.0°C). We opted for heat denaturation instead of sample acidification in order 
to minimize matrix effects and additional sample dilution during virus uncoating. First 
experiments with sample acidification yielded comparable results to the heat denaturation 
setup (data not shown). Low diluted virus stock solutions mainly yielded 135S particles, 
whereas higher dilution mainly led to the formation of 80S particles upon virus uncoating. 
In such a way, conversion of native 150S particles could be directed to either of the two 
subviral species. 
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Fig. 27: Electropherograms obtained for HRV2 samples upon heat denaturation (10 min at 
56.0°C) at different virus concentrations. At 2.0 mg/mL (1:2 dilution of virus stock) favourably 
80S particles are formed (i), whereas at 3.0 mg/mL (3:4 dilution of virus stock) mostly subviral 
135S particles can be found (ii). HRV2 was diluted to indicated concentration values in SB prior 
to heat denaturation. After heating the sample volume was adjusted with SB and intermediate 
DMSO solution to a final dilution of 1 : 10 for HRV2 and 1 : 4 x 10
3
 for DMSO. CE conditions as 
with figure 26. 
 
Figure 27 shows two sample electropherograms obtained for heat denaturation at different 
virus concentrations. Whereas heat denaturation of a 2.0 mg/mL HRV2 sample (1:2 
dilution of virus stock) preferentially yielded subviral 80S particles migrating with 8.5 x 
10
-9
 m
2
/Vs (i), at 3.0 mg/mL HRV2 concentration (3:4 dilution of virus stock) a peak with 
a migration time of about 4.8 min corresponding to a net mobility of 17.8 x 10
-9
 m
2
/Vs 
prevailed (ii). A peak with the latter mobility neither corresponds to viral 150S nor subviral 
80S particles and was thus suggested to be related to subviral 135S particles. Furthermore, 
an UV absorption maximum at 260 nm (data not shown) supports our peak identification. 
Such maxima are only obtained for RNA containing viral species [52]. Spikes recorded at 
approximately 4.6 min migration time probably result from aggregating hydrophobic 
subviral particles and / or VP4 molecules in free solution. In a next step we evaluated the 
applicability of our findings to other HRV2 preparations. 
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Fig. 28: Concentration dependence of subviral particle formation upon heat denaturation (10 min 
at 56.0°C) of viral 150S particles for three virus preparations. At low virus concentrations (up to 
approx. 1.0 mg/mL) mostly 80S particles are formed upon virus conversion, whereas high 135S 
particle concentrations are obtained for undiluted virus solutions (circled data points). 
Measurements were at least in duplicate. Data points were obtained by calculating area ratios of 
the 135S peak : (80S + contaminant) peak bundle. The value obtained for the highest virus 
concentration for each stock solution was set to 100%, all other ratios were related to respective 
maximum values.  
 
Figure 28 depicts the dependence of subviral particle formation on the dilution of the virus 
stock upon heat denaturation. Three preparations with 1.9, 4.0 and 5.2 mg/mL virus 
concentration were investigated. For calculation of data points, the ratio of the area of the 
135S peak to the area of the peak bundle (contaminant and subviral 80S particles) 
migrating at approximately 4 min runtime was calculated. The ratio obtained for the 
highest virus concentration for each of the three virus preparations was set to 100%. Ratios 
obtained for diluted incubation solutions during heat denaturation were then related to the 
100% value. Measurements were carried out at least in duplicate for each data point.  
 
It was observed that heat denaturation of undiluted HRV2 solutions always yielded highest 
amounts of subviral 135S particles. After slight dilution of virus stocks with SB prior to 
heat denaturation, a reduction of the obtained 135S particle peak was observed and more 
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80S particles were detected. Yet both subviral species were still found in parallel. 
However, after dilution of HRV2 stocks to approximately 1.0 mg/mL almost exclusively 
80S particles were observed. Influence of the ionic strength of employed buffers on the 
preferential formation of subviral 80S particles upon heat denaturation of diluted virus 
stock solutions was negligible (data not shown). For other picornaviridae stabilization of 
virions is known after interaction with short fatty acids such as myristic acid, which is in 
fact also covalently bound to VP4 [70 – 72] or after interaction with other proteins, for 
example, albumin [73]. In the case of HRV2 initial experiments neither showed 
stabilization of subviral 135S particles upon virus pre-incubation with fatty acid 
suspensions – myristic, palmitic and stearic acid as most abundant fatty acids described as 
pocket factors with bovine enterovirus (BEV) [74] were tested – nor did the addition of 
bovine serum albumin (BSA) during heat denaturation increase the amount of obtained 
subviral 135S particles (data not shown). In fact, preincubation of virions with fatty acid 
suspensions prior to heat denaturation rather decreased the amount of obtained subviral 
135S particles (figure 29).  
0 2 4 6 8 10 12 14
-2
0
2
4
6
8
10
12
14
16
RNA
no fatty acid
135S
Cont. / 80S
DMSO
+ stearic acid
+ palmitic acid
+ myristic acid
U
V
 a
b
s
o
rb
a
n
c
e
 (
2
0
5
n
m
)
time [min]
 
Fig. 29: Decrease in the amount of obtained 135S particles upon heat denaturation (10 min at 
56.0°C) of virus solutions pre-incubated with fatty acid suspensions. All three fatty acids tested – 
myristic, palmitic and stearic acid – lead to a significant lower number of obtained subviral 135S 
particles than the control diluted in plain SB. HRV2 was diluted 1:2 in SB or SB / fatty acid 
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suspension and incubated for 1 hour on ice prior to heat denaturation. After virus conversion 
samples were further diluted with SB and DMSO to a final dilution of 1:15 for virus and 1 : 4 x 
10
3
 for DMSO. CE conditions as with figure 26. 
 
We therefore suggest that addition of fatty acids to virus solutions during heat denaturation 
hinders the interaction of viral capsids with other components of the incubation solution. In 
fact, we found that the contaminant of the virus preparation or rather the area ratio VP1 / 
contaminant, when analyzing samples in SDS containing BGE, was significant for the 
amount of obtained subviral 135S particles during heat denaturation. The lower the ratio 
VP1 / contaminant, the higher was the amount of obtained subviral 135S particles. The 
contaminant from virus preparations thus seems to stabilize 135S particles but could so far 
not be identified.  
 
After conversion of native virions, subviral 135S particles remain stable after dilution to 
lower analyte concentrations for CE analysis in Thesit containing BGE. Even after one 
week storage of diluted samples at 4.0°C still approximately 80 % of the initial amount of 
135S particles were found in solution (data not shown). This slow conversion of subviral 
135S to 80S particles might be explained by accessibility of the viral RNA genome to 
RNases through pores in the 135S particle (missing VP4 capsid protein) or by simple RNA 
diffusion through such pores. However, our findings allow for preparation of subviral 135S 
particles of HRV2 at fairly high concentrations and stability, both criteria being important 
prerequisites for investigation of this virus uncoating intermediate via TEM, cryo TEM and 
X-Ray cristallography. 
 
Identification of subviral 135S particles 
Several characteristics of subviral 135S particles besides their electrophoretic mobility and 
UV absorption can be employed for their identification: 
 
(i) Originally, subviral 135S particles were defined via their sedimentation characteristic. 
Therefore, we subjected a sample containing viral as well as subviral particles to 
sedimentation in a 10 - 40 w/w% sucrose gradient. After collection of 20 fractions we 
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subjected samples to CE employing a Thesit containing BGE. Indeed, when we plotted the 
peak area ratio between the respective virus species and DMSO as internal standard, we 
found that our putative 135S particles sediment slower than viral 150S particles, i.e. were 
found in lower numbered fractions from sucrose gradient centrifugation (figure 30).  
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Fig. 30: Sedimentation of 150S viral and 135S subviral particles in a 10 - 40 w/w% sucrose 
gradient. Plotted are peak area ratios between the respective viral or subviral species and DMSO 
as internal standard. It is apparent that the apex for the 135S / DMSO curve can be found in 
fractions corresponding to higher positions in the vial (lower index in the figure) than the apex for 
the 150S / DMSO curve. This signifies that subviral 135S particles sediment slower than intact 
virions. 
 
(ii) We suggested reactivity of monoclonal antibody 2G2 with 135S particles. Such an 
immunaffinity reaction had been shown to work with 80S particles but not with intact 
virions ([57] and Fig. 26). Figure 31 depicts the resulting electropherograms of 135S 
particle containing samples before and after addition of mAb 2G2. The respective peak at 
approximately 4.8 min disappeared from the electropherogram with a concomitant 
appearance of a large number of spikes from resulting aggregates between mAb 2G2 and 
subviral 135S particles which demonstrates mAb binding.  
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Fig. 31: CE of HRV2 subviral 135S particles (i) and an electropherogram obtained upon mixing 
of 135S particles with mAb 2G2 (ii). Incubation of subviral 135S particles with aggregating mAb 
2G2 results in the disappearance of the peak obtained for 135S particles with the concomitant 
appearance of a large number of spikes (similar to mAb 2G2 precipitating subviral 80S particles). 
CE conditions as with figure 26. 
 
(iii) SEC allows separation of low molecular mass material from large moieties like virions 
and subviral particles. When we applied a sample with putative subviral 135S particles to a 
spin SEC followed by CE analysis, we found the corresponding peak with the mobility of 
17.8 x 10
-9
 m
2
/Vs (putative 135S particles) in the void volume (figure 32).  
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Fig. 32: CE results of spin SEC fractions (7.0 µL fraction volume each). Fraction 2 compromised 
the main fraction for subviral particles. Coelution of putative 135S particles with other subviral 
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particles and the contaminant of the virus preparation was observed. Therefore, it was concluded 
that the peak recorded at approx. 5.1 min corresponded to the large biological assembly of a 
subviral particle. CE conditions as with figure 26. 
 
Furthermore, coelution of putative 135S particles with 80S particles, released RNA and the 
contaminant of the virus preparation was observed, which allowed estimation of the size of 
the corresponding particle as comparable to other subviral species. It is of note that via 
SEC we could greatly diminish the level of spikes previously obtained for unpurified 
subviral 135S particle samples. Upon heating (10 min at 56.0°C) of the main 135S particle 
containing SEC fraction (number 2) and subjection to CE analysis in SDS containing BGE, 
we detected the absence of one of the four peaks related to viral proteins (figure 33). We 
thus reasoned this peak to correspond to VP4 which is missing in 135S particle samples. 
From the sum of our carried out experiments we could conclude that we were able to target 
subviral 135S particles specifically. 
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Fig. 33: Electropherograms of virus containing samples in SDS buffer before (i) and after (ii) 
135S preparation and spin SEC. Heating (10 min at 56.0°C) of virus samples in SDS containing 
BGE before SEC yields 4 peaks for the viral proteins (VP 1 – 4) and a peak for the viral RNA. 
However, likewise treatment of virus samples after 135S preparation and SEC yields only 3 peaks 
of viral proteins, the peak for VP4 is missing. Furthermore, RNA is already slightly degraded 
resulting in several small underlying peaks. Different migration times between trace i and ii 
resulted from slightly varying EOF values. BGE included 10 mM SDS instead of Thesit, other CE 
conditions as with figure 26. 
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Conversion of subviral 135S to 80S particles 
Upon further heating of 135S particles to 56.0°C a gradual conversion of 135S to 80S 
subviral particles can be observed. Figure 34 depicts the resulting electropherograms of 
additional 4 min heating steps. Additional heating resulted in a decrease of the 135S 
particle peak with a concomitant increase of the peak for 80S particles. Also the 
appearance of spikes, which were recorded frequently for 135S particle samples, greatly 
diminished upon further heating. After 12 min of additional sample heating, subviral 135S 
particles almost quantitatively converted to 80S particles. Therefore, we could demonstrate 
that subviral 135S particles are no artificial end points or aborted particles in the course of 
virus infection, but can be further transformed to subviral 80S particles in vitro. 
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Fig. 34: Conversion of subviral 135S to 80S particles induced via additional sample heating to 
56.0°C. Samples were analyzed after 4 min incubation steps at elevated temperature. 
Electropherograms obtained after additional heating steps are depicted from top to bottom. The 
peak obtained for the subviral 135S particles migrating at approximately 4.8 min disappears with 
the concomitant appearance of the peak for subviral 80S particles migrating at approximately 
4.0 min. CE conditions as with figure 26. 
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Negative stain TEM imaging of 135S particles 
TEM imaging of subviral 135S particles showed intermediates of the virus uncoating 
process. Whereas viral 150S particles appear as bright dots of uniform density and subviral 
80S particles as bright coronas with stained centers, 135S particles appear differently 
(figure 35). The interior of the virus capsid shows considerably more contrast than intact 
virions and is as well surrounded by a corona. The grainy texture of the interior of 135S 
particles is in good accordance with the theory of virus uncoating: Subviral 135S particles 
have lost already the innermost viral capsid protein but still include the RNA genome. 
Therefore, due to lacking VP4 and conformational change of the other viral proteins in the 
course of pore formation in the viral capsid, contrast medium of TEM imaging can access 
the virus interior. However, due to still encapsulated viral RNA, the stain cannot fill the 
complete interior of particles as for completely empty subviral 80S particles.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 35: TEM image of subviral 135S particles. The intact viral capsid of 150S particles does not 
allow for stain penetration into the virus lumen. Subviral 135S particles have expelled the 
innermost capsid protein VP4 and have undergone already structural changes of the virus capsid. 
Therefore, they are more accessible to stain than intact virions. However, subviral 135S particles 
are stained to a less extend than empty 80S capsids, which no longer encapsulate the viral RNA 
genome and allow therefore even better for stain penetration. TEM imaging as with figure 1. 
135S
80S
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Conclusion 
Conversion of native HRV2 virions sedimenting at 150S to subviral particles can be 
achieved in vitro either through acidification or through heat denaturation. For the latter we 
demonstrated the conversion to subviral 135S particles in detail. Depending on the dilution 
of virus stock uncoating intermediates can be targeted specifically: Heating of HRV2 
samples of low virus content preferentially yields subviral 80S particles that have lost VP4 
of the viral capsid as well as the viral genome. Heating of less diluted HRV2 samples 
allows for targeting of subviral 135S particles. Subviral 135S particles have lost already 
VP4 but still include the viral RNA genome. Through additional triggers of virus 
conversion we could demonstrate that subviral 135S particles are no artificial end points or 
aborted particles in the course of virus infection, but can be further transformed to subviral 
80S particles. Additionally, we carried out several experiments for identification and 
confirmation of the 135S species besides CE analysis – UV absorption, sucrose density 
centrifugation, immunoaffinity reaction and spin SEC. Finally, we visualized this 
transitional step of virus uncoating via TEM. Specific targeting of subviral 135S particles 
as intermediates of the uncoating process is of importance for further understanding of the 
infection pathway. We describe the generation of a well defined starting material for 
structural elucidation techniques. 
 
Experimental Section 
Chemicals: Boric acid (99.99%), sodium dodecyl sulphate (SDS of reagent plus grade), His-select® Nickel 
Affinity Gel (suspension in 30% ethanol / H2O), and the three fatty acids – myristic (99%), palmitic (99%) 
and stearic (98.5%) acid – were purchased from Sigma Aldrich (Steinheim, Germany). Fatty acids were 
suspended in SB at 21 mM via extensive vortexing and ultrasonication. Larger debris was removed via 
spinning (10sec at 100 rcf) on a table top centrifuge (model 5415D, Eppendorf, Hamburg, Germany). Sodium 
hydroxide (pellets pure) was from E. Merck (Darmstadt, Germany) and Sephadex G-50 (DNA grade) from 
Amersham Bioscience (Little Chalfont, England). Sucrose (D(+)-Saccharose) was from Carl Roth 
(Karlsruhe, Germany). Thesit (Polyethylene glycol dodecyl ether; membrane research grade) and DMSO 
(p.a.) were from Fluka (Buchs, Switzerland). A 1:200 dilution of DMSO in water was employed as 
intermediate DMSO stock. Phospho-tungsten acid, 2% in water, pH 7.3 was employed as negative stain for 
TEM imaging. Water was bidistilled from a quartz apparatus.  
 
Biological Material: HRV2 was produced and its purity and concentration assessed as described [8, 46]. 
Three preparations in sodium borate (50 mM boric acid, ad pH 7.4 via sodium hydroxide) with 
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concentrations of approx. 1.9 mg/mL, 4.0 mg/mL and 5.2 mg/mL virus were employed. All three HRV2 
preparations were used for recording of the concentration dependence of subviral particle formation upon 
heat denaturation. The HRV2 preparation with 1.9 mg/mL was employed as well for experiments concerning 
the influence of fatty acids on subviral 135S formation, the HRV2 preparation with 5.2 mg/mL for sucrose 
gradient separation. All other measurements were carried out with the 4.0 mg/mL HRV2 preparation. 
Monoclonal antibody 2G2 (mAb 2G2) was prepared in 50 mM Tris, pH 8.0 at a concentration of 9.0 mg/mL. 
 
Instrumentation: CE analyses were carried out on two 3D CE instruments (Agilent, Waldbronn, Germany) 
in parallel. Fused silica capillaries (50 µm inner diameter, 375 µm outer diameter) were from Polymicro 
(Phoenix, USA), obtained via Optronis (Kehl, Germany). Both capillaries measured 60.0 cm in total with a 
respective effective length of 51.5 cm. Electrophoresis was carried out in positive polarity mode at 2.5 x 
10
4
 V. The cassettes of the instruments were cooled to 20.0°C, samples were injected by application of 
pressure (50 mbar for 9 sec). Analytes were detected via their UV absorption at 205 nm and 260 nm, 
respectively. Sodium borate (100 mM boric acid adjusted to pH 8.3 via 3 M sodium hydroxide solution) was 
employed as sample buffer (SB), the BGE additionally contained 10 mM Thesit as detergent. For virus 
denaturation to viral proteins and RNA, SDS instead of Thesit was employed as surfactant, as well at 10 mM. 
For spin SEC experiments, SB was diluted to 50 mM boric acid concentration (½ SB). SB and BGEs were 
filtered through syringe filters (CA membrane, 0.20µm from Minisart obtained via Wagner&Munz, Vienna, 
Austria) and spinned (1 min at 400 rcf). Before each run, the capillary was flushed for 2 min with BGE for 
preconditioning. Postconditioning was carried out via flushing of the capillary for 2 min with 1 M sodium 
hydroxide solution and bidistilled water. TEM imaging was carried out on a Morgani 268 Transmission 
Electron Microscope (FEI Tecnai, Eindhoven, The Netherlands) employing a Morada CCD camera at 8.9 x 
10
4
 fold magnification. Sucrose gradient centrifugation was done on a Beckman L7 ultracentrifuge 
employing a SW50.1 rotor at 4.5 x 10
4
 rpm for 35 min at 4.0°C. 
 
Procedures: Heat denaturation of HRV2 was performed in a water bath at 56.0°C for 10 min. Storage 
solution of His-select® Nickel Affinity Gel was replaced by ½ SB. Spin SEC was carried out on an 
Eppendorf table top centrifuge employing spin X filters (CA membrane, 0.45 µm from Corning obtained via 
Sigma Aldrich, Schnelldorf, Germany). Filter inlets were filled with Sephadex G-50 swelled in ½ SB and the 
column was dried via spinning. Four µL of heat denatured HRV2 were mixed with 1.5 µL of a recombinant 
soluble receptor fragment of the very-low-density-lipoprotein receptor (MBP-V33333 at 5.5 mg/mL in 
20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 20 mM CaCl2) and with 1.5 µL of His-select® Nickel Affinity Gel 
(in ½ SB). Incubation of virions was 1 hour on ice with receptor fragments followed by 15 min incubation 
with Nickel Affinity Gel. The receptor fragment is known to bind intact viral capsids [10, 58, 75] and was 
grafted with a His6-tag at its C- terminus, allowing for binding of free valences of Ni
2+
 ions. Upon 
application of 7.0 µL of the analtye solution to a spin SEC column followed by sample elution via spinning 
(30 sec at 800 rcf), gel bound (via receptor molecules) viral 150S particles remained on the filter inlet. The 
spin SEC column was flushed with 7.0 µL ½ SB 3 times consecutively via spinning (30 sec at 800 rcf) and 
the respective fractions were collected.  
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For TEM imaging spin SEC was carried out with 4.8 µL of a heat denaturated virus sample via spinning 
(30 sec at 800 rcf). The column was flushed with 5.0 µL SB 8 times consecutively via spinning (30 sec at 
800 rcf) and the respective fractions were collected and analyzed on CE. TEM imaging of 135S particles was 
carried out by combining fractions 4 and 5 of spin SEC and dilution of the resulting solution 1:25 in SB. 
Glow discharged (20 mA, 30 sec) carbon coated copper grids were employed for imaging with 2 % phospho-
tungsten acid pH 7.3 as contrast medium. Four µL of each sample were applied to a grid for 1 min, washed 
and stained for 1 min. For sucrose gradient centrifugation 4.8 mL of a 10 - 40 [w/w%] sucrose gradient in 
½ SB were prepared in 13 x 51 mm Beckman Ultraclear 
TM
 centrifuge tubes. 16.0 µL HRV2 stock was heat 
denatured and 8.0 µL of native virions were added. This mix of viral and subviral particles was stored over 
night at 4.0°C. Twenty µL of the viral / subviral particle mix were subjected to sucrose gradient 
centrifugation. 240 µL fractions were collected from the top of the gradient and the protein content of the 
fractions was assessed via a Nanodrop ND-1000 spectrophotometer (PEQLAB, Erlangen, Germany). UV / 
Vis absorption was assessed at 225 and 260 nm in parallel. 30 µL of fractions showing highest protein 
content were subjected to spin SEC prior to CE analysis after addition of DMSO as neutral EOF marker. 
Peak area ratios between the respective viral or subviral species and DMSO as internal standard were 
calculated. 
 
Sample preparation: For analysis of 150S and 80S particles the HRV2 stock was diluted 1:13 in DMSO 
containing sample buffer; an aliquot of this dilution was heat denaturated. Heated and unheated aliquots of 
such HRV2 dilutions were mixed with SB yielding samples of 150S viral or 80S subviral particles. In 
parallel, this mixing step was carried out with mAb 2G2 stock. The final HRV2 concentration valued 
24.0 nM, mAb 2G2 was applied in roughly 30.0 fold molar excess. The final DMSO dilution valued 1:2.0 x 
10
3
. Incubation of viral particles with mAb 2G2 was carried out for 10 min at ambient temperature. Sample 
preparation of native 150S viral particles for TEM imaging was accomplished after 1:100 fold dilution of the 
virus stock in SB. Heat denaturation of such a stock produced 80S particles for TEM imaging. 
 
For analysis of the concentration dependence of subviral particle formation, HRV2 stocks were diluted with 
SB to respective concentration values and heat denaturated. Before analysis, the sample volume was adjusted 
with SB and DMSO to a final 1 : 10 virus and a 1 : 4.0 x 10
3
 DMSO dilution.  
 
For experiments concerning the influence of fatty acids with different alkyl chain lengths on the formation of 
subviral 135S particles, HRV2 stock was diluted 1:2 in SB or SB / fatty acid suspensions prior to heat 
denaturation. After virus conversion, samples were further diluted with SB and DMSO to a final dilution of 
1:15 for virus and 1 : 4 x 10
3
 for DMSO. 
 
For analysis of spin SEC fractions, samples were diluted 1 : 2 in ½ SB containing DMSO to a final DMSO 
dilution of 1 : 4.0 x 10
3
. 
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For complete denaturation of 150S particles to viral proteins and RNA, HRV2 was diluted 1 : 20 in SDS 
containing BGE including 1 : 4.0 x 10
3
 DMSO and heat denaturated. Subviral 135S particles of spin SEC 
fraction 2 were heat denaturated after 3 : 7 dilution in ½ SB additionally containing DMSO (final dilution 1 : 
4.7 x 10
3
) and SDS (final concentration 8.5 mM)  
 
Other 135S particle containing samples were obtained after dilution of the 4.0 mg/mL HRV2 stock to 3.3 
mg/mL virus content with SB followed by heat denaturation. CE was carried out after further dilution of this 
135S particle incubation solution with SB including DMSO and for some aliquots mAb 2G2 as well. The 
HRV2 content of samples valued 27.3 nM, mAb 2G2 was employed in approximately 31.0 fold molar 
excess. The final DMSO dilution factor in samples valued 2.0 x 10
3
. For tracing the conversion of subviral 
135S to 80S particles, a sample prepared in such a way (without mAb 2G2) was heated in a water bath at 
56.0°C. CE was carried out after 4 min heating steps. 
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3.2 Receptor Mediated Attachment of Virions to Liposomes 
 
Publication: Mimicking virus attachment to host cells employing liposomes: Analysis by 
chip electrophoresis 
State of publication: published in Electrophoresis 2009, 30, 2123 – 2128 
Experimental contributing authors:   Victor U. Weiss – 55% 
      Gerhard Bilek – 30% 
      Angela Pickl-Herk – 15% 
 
 
 
 
Research Article
Mimicking virus attachment to host cells
employing liposomes: Analysis by chip
electrophoresis
Electrophoresis on a chip increasingly replaces electrophoresis in the capillary format
because of its speed and containment of the sample within a disposable cartridge. In this
paper we demonstrate its utility in the analysis of the interaction between a virus and a
liposome-anchored receptor, mimicking viral attachment to host cells. This became
possible because detergents, obligatory constituents of the BGE for capillary electro-
phoretic separation of the virus, were not necessary in the chip format. Separations were
carried out in sodium borate buffer, pH 8.3. Liposomes and virus were both labeled for
laser-induced fluorescence detection at lex/lem 630/680 nm. Free virus and virus-
receptor complexes were resolved from virus attached to receptor-decorated liposomes in
the absence of additives or sieving matrices within about 30 s on commercially available
microfluidic chips.
Keywords:
Chip electrophoresis / Fluorescence labeling / Human rhinovirus / Liposome /
Very-low-density lipoprotein receptor DOI 10.1002/elps.200900108
1 Introduction
Human rhinoviruses (HRVs), main causative agents of the
common cold, bind different cell surface receptors for
infection. HRV2 belongs to the minor group of HRVs that
recognize members of the low-density lipoprotein receptor
family [1]. The ligand-binding domain of these receptors is
composed of various numbers of modules of about 40
amino acid residues in length and arranged in tandem that
differently contribute to ligand binding [2]. In order to better
understand the structural basis of ligand recognition,
recombinant concatemers of module 3 of the very-low-
density lipoprotein receptor (VLDLR) have been used in a
number of studies [3–5]. As a result, it is now clear that up to
five modules within a single receptor molecule can attach to
five icosahedral-symmetry-related binding sites around one
vertex of the viral capsid [6, 7].
Attachment of viruses to cells can be mimicked in vitro
by using receptor-carrying liposomes [8, 9]. In previous work
we used electrophoresis in coated fused-silica capillaries to
monitor this process. Attachment of HRV2 to fluorescent
unilamellar liposomes decorated with maltose-binding
protein (MBP)-V33333, a his6-tagged receptor consisting of
five repeats of module 3 of human VLDLR and expressed as
a fusion with MBP, resulted either in a shift of the liposome
peak or in its disappearance; concomitantly, a large number
of spikes were observed, which we attributed to aggregates
[10].
Detergents proved essential in preventing aggregation
of viral particles in CE with fused-silica capillaries, inde-
pendent of whether bare or coated [11]. However, work with
liposomes precludes the use of surfactants. A solution to
this problem was our finding that chip electrophoresis
rendered neat virus peaks even in the absence of detergents
for reasons that are not fully clear to us. We assume that
it might be related to the much shorter residence time
in the chip compared with the capillary. However, we first
used chip electrophoresis for the analysis of complex
formation of virus with different soluble concatemers of
module 3 [12, 13]. In the present paper the recombinant
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his6-tagged MBP-V3333 molecules were attached to the
membrane via 1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-
carboxypentyl) iminodiacetic acid)succinyl] (nickel salt)
(DOGS-NTA). In order to follow the binding of the virus to
the membrane, we then employed fluorescence (FL) detec-
tion of both virus and liposomes. For this purpose virus was
labeled within its protein coat with the amine-reactive dye
Cy5, whereas liposomes were visualized via encapsulation of
Atto 637 (free acid form) in their aqueous core. We here
demonstrate the utility of chip electrophoresis for the
assessment of the interaction of virus with receptor-deco-
rated liposomes.
2 Materials and methods
2.1 Chemicals
Sephadex G50 (DNA grade) and Cy5 were obtained from
Amersham Bioscience (Little Chalfont, England). Cy5 was
dissolved in DMSO (499.9%, Sigma Aldrich, Steinheim,
Germany) to yield a 25 mM stock solution. Atto 637 (in free
acid form) was obtained from Fluka (Buchs, Switzerland).
Boric acid (99.99%) was from Sigma Aldrich. Sodium
hydroxide (497%) was from E. Merck (Darmstadt,
Germany). Water was doubly distilled from a quartz
apparatus. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-
N-[methoxy (polyethyleneglycol)-750] (ammonium salt)
(PEG750PE) and DOGS-NTA were from Avanti Lipids
(Alabaster, AL, USA) and purchased via Instruchemie
(Delfzyl, The Netherlands). DOGS-NTA was already loaded
with nickel ions upon delivery and was incorporated into
liposomes as such.
2.2 Biological materials
Preparation and purification of HRV2 and assessment of
purity and concentration were carried out as described
previously [14, 15]. A 5 mL aliquot of HRV2 at 9.5 mg/mL
(1.1 mM) in 50mM sodium borate, pH 7.4 was employed in
all chip electrophoresis experiments. The model receptor
consisted of four copies of ligand-binding module 3 of
human VLDLR arranged in tandem; it was fused to MBP at
its N-terminus and carried a his6-tag at its C-terminus
(MBP-V3333) [4]. The working solution was at 2.0 mg/mL
(32 mM) in TBSC buffer (20 mM Tris-HCl, 150 mM NaCl,
20 mM CaCl2, pH 7.5).
2.3 Instrumentation
Chip electrophoresis was carried out on the Agilent 2100
Bioanalyzer system applying commercially available DNA
chips (Agilent Technologies, Waldbronn, Germany). DNA
chips, produced from soda lime glass, allow analysis of up to
12 samples per chip. Analytes were monitored via FL,
employing both excitation wavelengths of the instrument
produced by a light-emitting diode (lmax5 470 nm) and a red
laser (lmax5 630 nm); chips were thermostated to 301C
during analysis. Data were collected with the Agilent 2100
Expert software. Prior to use BGE and sample buffer were
centrifuged for 10min on a tabletop centrifuge (5415D,
Eppendorf, Hamburg, Germany). The same centrifuge was
employed for spin size exclusion chromatography (spin SEC).
2.4 Buffers
Electrophoretic separations were carried out in 100mM
boric acid adjusted to pH 8.3 with 3 M NaOH. BGE was
prepared daily to attain the EOF values around 5 108m2/
Vs. BGE was diluted with bidistilled water to 80 mM boric
acid concentration (sample buffer; BGE0.8) and to 50 mM
boric acid concentration (labeling buffer; BGE0.5).
2.5 Chip handling
DNA chips were handled as described previously [12, 13]. In
short, chip channels were filled with 12 mL BGE on the Chip
Priming Station by the application of pressure (20 s, 1 mL
syringe volume, upper syringe clip position, position C of
the base plate) from the BGE outlet well. Twelve microliters
of Cy5 containing sample buffer (62.5 nM dye concentra-
tion) were applied to the ladder well for adjustment of the
instrument optics and 12 mL BGE to the remaining two
wells marked ‘‘G’’. Six microliters of the samples were
applied to the remaining wells. After the removal of the
chip, electrodes were cleaned with the Electrode Cleaning
Chip (filled with 380 mL doubly distilled water). The script
(defining all operational steps of the chip analysis) that is
normally employed for DNA analysis was modified to
positive polarity mode for both sample injection to the
separation channel and electrophoretic analysis. The injec-
tion voltage was set to 1300 V, the separation voltage to
800 V (approx. 19 kV/m).
2.6 Production of multilamellar vesicles
Lyophilized lipids were dissolved in chloroform at 10 mM
each prior to mixing in a round-bottom flask in the molar
ratio of POPC:PEG750PE:DOGS-NTA5 18:1:1. Chloroform
was added to about 3.0 mL; the solvent was evaporated and
the resulting lipid film was dried for at least 3 h under a
stream of nitrogen. The dry film was hydrated in 1.7 mL
BGE0.5 or BGE0.5 containing 11 mM Atto 637 (free acid
form) to obtain FL liposomes. The flask was rotated at room
temperature for at least another 3 h and vortexed several
times. The multilamellar vesicle suspension was kept
overnight at 41C for maturation and either extruded to
produce large unilamellar vesicles or stored at 401C.
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Assuming that all lipids were incorporated into liposomes,
the calculated total lipid concentration was 7.1 mM includ-
ing, 0.4 mM DOGS-NTA for unstained liposomes, and
5.9 mM, including 0.3 mM DOGS-NTA for FL liposomes.
2.7 Extrusion
To produce vesicles of defined size, the multilamellar vesicle
suspension was sequentially extruded through two overlaid
polycarbonate filters with pore sizes of 400, 200 and 100 nm
by using a Mini-Extruder (Avanti Lipids) placed on a heating
block pre-warmed to 501C. The suspension was passed 35
times through each couple of filters [16, 17].
2.8 Virus labeling
HRV2 was labeled by mixing 5 mL virus stock with 4.5 mL
BGE0.5 and 0.5 mL 25mM Cy5 in DMSO (approximate
2.2 103-fold molar excess of dye over virus). Incubation
was carried out overnight under light protection at ambient
temperature. Low-molecular-weight material was removed
from the labeled virus on spin columns; filters from
Corning Spin-X centrifuge tubes (cellulose acetate
membrane, pore size 0.45 mm, obtained from Sigma
Aldrich) were filled with Sephadex G50 swelled in BGE0.5
(slurry corresponding to 900 mL settled material in total,
applied consecutively in two 450 mL portions). The column
was spun dry on a table-top centrifuge; the labeling mix was
applied and the elution was started via spinning for 1 min at
800 rcf. The column was washed with 20 mL of BGE0.5 via
spinning (1 min, 800 rcf) and the total recovered eluate
(30 mL) was subjected to the same procedure on a fresh spin
column (washing with 15 mL). The final main fraction
contained 5.25 pmoles (i.e. 115 nM) HRV2. Only 6% of the
total virus remained on the columns and was recovered
upon additional washings with 20 mL buffer, each.
2.9 Liposome purification
Non-encapsulated Atto 637 was removed from the
FL-labeled liposomes via spin SEC on G50 Sephadex
columns as above, but equilibrated in bidistilled water.
Ten microliters of liposome suspension were applied
followed by elution at 800 rcf (1 min). The column was
then rinsed with 20 mL BGE0.5 (1 min, 800 rcf) and the total
eluted material was collected.
2.10 Sample preparation for chip electrophoresis
Cy5-labeled HRV2 was diluted 1:21, the receptor stock
solution 1:9 and the liposomes 1:10.5, all with BGE0.8. Note
that FL-labeled liposomes were about 3.6 times less
concentrated. Atto 495 was added as fluorescent EOF
marker (lex5 495 nm; 3.0 mM final concentration). The
final concentration of labeled HRV2 was 5.6 nM with the
receptor being present in approximately 50-fold molar
excess (based on a stoichiometry of 12 receptor molecules
binding one virion). The DOGS-NTA in the outer liposomal
membrane was in excess over receptor between 1.3- (labeled
liposomes) and 5.4-fold (unlabeled liposomes). Samples
were prepared by mixing constituents in the sequence
receptor, liposomes and labeled HRV2–followed by 20 min
incubation at ambient temperature under light protection.
3 Results and discussion
The experimental conditions were selected such as to enable
recording of free virus as well as receptor-decorated
liposomes and to obtain clear indications for virus attach-
ment to the vesicles. The present chip electrophoresis setup
relies on FL detection; therefore, the aqueous core of the
liposomes was filled with Atto 637 (lex5 635 nm) and the
virus was rendered fluorescent by reaction of Cy5
(lex5 649 nm) with the capsid proteins. This allowed for
monitoring within the instrument-specific 630 nm channel.
It is evident that separation is governed by the mobility
of the analytes and that of the EOF, whereby the mobility of
the liposomes might depend on their size (and certainly on
their composition) and that of the virus is affected by the
chemical modification of its capsid upon labeling [18].
Moreover, the mobility of virus and liposomes presumably
changes upon reaction with receptor fragments. Electro-
phoresis in the micro-device has the invaluable advantage
that no detergent is needed (which would most probably
disintegrate the liposomes). However, in general its
separation performance is lower than that of the classical
capillary format.
3.1 Liposomes
The employed liposomes consisted of POPC, PEG750PE
and DOGS-NTA in 18:1:1 molar ratio and were extruded
consecutively through filters of 400, 200 and 100 nm pore
size. Samples representative of the corresponding size
ranges taken after each extrusion step were analyzed by
chip electrophoresis (Fig. 1). When measuring at the apex of
the peaks, the largest vesicles (400 nm size) exhibited a
clearly longer migration time when compared with the
smaller ones (200 and 100 nm) that were barely distinguish-
able. Note that longer migration times correspond to higher
electrophoretic mobility, as the anionic particles are swept
by the EOF toward the cathodic end of the channel. The
liposomes with smaller diameter were apparently more
homogenous, as they gave narrower peaks. Signal fluctua-
tions within the sample zones of the larger-sized liposomes
most likely result from many slightly different species. Atto
637 was not completely removed by spin SEC; however, it
did not interfere as it was sufficiently resolved from the
Electrophoresis 2009, 30, 2123–2128 CE and CEC 2125
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
liposome peaks. The reproducibility of the migration times,
expressed by the standard deviation of the mean as
determined on three different days by using five different
chips (two samples per chip, ten samples in total) was 2.1%.
3.2 Virus–receptor–liposome complex
For the following binding experiments liposomes extruded
through 200 nm pore size filters were used. To allow for
decoration with his6-tagged receptors, liposomes were made
to contain about 5% DOGS-NTA. In the present work we
used MBP-V3333, a receptor fragment consisting of four
repeats of module 3 of human VLDLR arranged in tandem
and expressed with MBP at its N-terminus and a his6-tag at
its C-terminus. Figure 2A shows the electropherogram of
Atto 637-filled liposomes (l), Fig. 2B that of liposomes
decorated with MBP-V3333 receptor (l1r). Binding of the
receptor via its his6-tag to the DOGS-NTA in the membrane
does not significantly change the migration behavior of the
liposomes. However, a significantly different electrophero-
gram was obtained after incubation with virus (Fig. 2C).
Assuming a final lipid concentration of 190 mM with 4.8 mM
of DOGS-NTA being accessible at the outer leaflet, the molar
excess of the DOGS-NTA groups over receptor was 1.3-fold
(see Section 2). However, even when the DOGS-NTA-groups
in the membrane are in excess over the his6-tags, receptor
binding is not expected to be quantitative because the
dissociation constant is in the 106M range [19], which is
within the same order as the analyte concentrations. There-
fore, a peak attributed to virus bound to soluble receptor
fragments, indicated as virus–receptor complex (v– r) was
recorded as well (Fig. 2C). It has a slightly longer migration
time than the peak ascribed to a contaminant, c, present in all
virus preparations and also becoming labeled with amino-
reactive dyes [20]. The liposome peak is shifted to a shorter
migration time with concomitant zone broadening. This peak
corresponds to the DOGS-NTA-doped liposomes, decorated
with receptor and carrying receptor-attached virus (v–r–l).
There is an increase in noise, which probably reflects
heterogeneous species, either liposomes carrying various
numbers of virions or liposomes aggregated via bridging,
mediated by single or multiple virions.
To explicitly demonstrate the attachment of labeled HRV2
to our receptor-decorated model membrane, we repeated our
experiments with unlabeled liposomes. This approach allowed
us to follow exclusively the signal of labeled HRV2. Figure 3A
depicts an electropherogram of labeled HRV2 that comigrates
with the contaminant c (v1c). Incubation of the virus with
MBP-V3333 yields a peak with increased migration time
corresponding to (v–r), see Fig. 3B. After incubation of v–r
with unlabeled liposomes (Fig. 3C), a third peak, identical to
(v–r–l) in Fig. 2 was seen together with excess of v–r. Not only
the position but also the apparent noisiness of the peaks was
identical upon application of stained and unstained liposomes
(compare Figs. 2C and 3C). However, for unstained lipo-
somes the employed total lipid concentration for complex
formation was about 3.6 times higher than in experiments
with FL-labeled vesicles. Therefore, the ratio between DOGS-
NTA-groups and his6-tagged receptors was about 5.4 as
compared with the ratio of 1.3 in the experiment shown in
Fig. 2. As a consequence, less free v–r were recorded. This
suggests that v–r complexes do not dissociate significantly
from the liposomes during electrophoresis.
3.3 Is HRV–liposome binding specific?
In order to exclude direct interaction between virus and
liposomes in the absence of receptor, virus and DOGS-NTA-
doped liposomes were incubated. Figure 4 shows that virus
(and the contaminant, v1c) and liposomes (l) migrate
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Figure 1. Chip electrophoresis of liposomes, l, from the same
preparation but serially extruded through filters with 400, 200
and 100 nm pore size. The liposomes were FL labeled by
inclusion of an aqueous solution of Atto 637 into the vesicle
core. Total lipid concentration approximately 190 mM. BGE,
100mM boric acid adjusted to pH 8.3 with 3M NaOH. Sample
buffer was BGE diluted to 80mM boric acid concentration.
Separations were carried out at 800 V (approx. 19 kV/m). FL
signal recorded at lex/lem 630/680 nm (arbitrary units).
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Figure 2. Chip electrophoresis of FL liposomes, l, upon incuba-
tion with receptor, r, and Cy5-labeled HRV2, v. (A) Atto 637-
labeled liposomes, (B) Liposomes as in (A) after decoration with
receptor; (C) Electropherogram obtained after incubation of the
receptor-decorated liposomes with HRV2 resulting in binding of
virus (v–r–l complex). Sample buffer, BGE, separation conditions
and FL detection as with Fig. 1; c, contaminant of the virus
preparation.
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identically regardless of whether analyzed separately (A and
B) or as a mixture (C). Taken together, these results prove
that specific interaction between receptor-decorated lipo-
somes and virus can be monitored by chip electrophoresis in
very short times.
4 Concluding remarks
Chip electrophoresis was employed to study the early steps in
viral infection by using a liposome-based system. Liposomes
as model membranes and a rhinovirus were detected on-chip
upon FL labeling. The electrophoretic separation was carried
out in a buffer solution without detergent; this is a clear
advantage over CE where such additives are mandatory for
reproducible analysis of virus. However, detergents disrupt
liposomes. Only the conditions of chip electrophoresis
allowed for the preservation of the components and the
analysis of both components and their interaction products.
Liposomes were functionalized via incorporation of DOGS-
NTA, allowing for decoration with soluble his6-tagged
recombinant receptor fragments. Receptor-carrying lipo-
somes, in turn, were able to specifically bind HRV2. The
individual analytes and liposome-bound virus appear as
baseline-resolved peaks in the electropherograms; the latter is
clearly distinguished from the peaks of their constituents.
This analytic system constitutes a starting point for the
investigation of the early infection steps of non-enveloped
viruses, which are still not fully understood. These include
interactions of the viral capsid with a receptor anchored in a
lipid membrane followed by the transfer of the viral genome
into the cytosol. Indeed, we are currently investigating RNA
release into receptor-decorated liposomes on acidification of
within late endosomes. Furthermore, we are in the process of
comparing the receptor-binding parameters of the mono-
nitrilo-triacetate lipid used in this report with a Tris-nitrilo-
triacetate lipid in order to limit dissociation of the receptor from
the liposome membrane. These findings will be the subjects of
forthcoming publications. Collectively, using a HRV as a model
system, our experiments set the stage to make the first step in
this process accessible to rapid analysis by chip electrophoresis.
This work was supported by the Austrian Science Founda-
tion (Project P19365). The authors thank Agilent Technologies
GmbH, Waldbronn, for support and Irene Goesler for virus
preparation.
The authors have declared no conflict of interest.
5 References
[1] Vlasak, M., Roivainen, M., Reithmayer, M., Goesler, I.,
Laine, P., Snyers, L., Hovi, T. et al., J. Virol. 2005, 79,
7389–7395.
[2] Blacklow, S. C., Curr. Opin. Struct. Biol. 2007, 17,
419–426.
[3] Konecsni, T., Kremser, L., Snyers, L., Rankl, C., Kilar, F.,
Kenndler, E., Blaas, D., FEBS Lett. 2004, 568, 99–104.
[4] Moser, R., Snyers, L., Wruss, J., Angulo, J., Peters, H.,
Peters, T., Blaas, D., Virology 2005, 338, 259–269.
[5] Wruss, J., Runzler, D., Steiger, C., Chiba, P., Ko¨hler, G.,
Blaas, D., Biochemistry 2007, 46, 6331–6339.
[6] Verdaguer, N., Fita, I., Reithmayer, M., Moser, R., Blaas,
D., Nat. Struct. Mol. Biol. 2004, 11, 429–434.
[7] Querol-Audi, J., Konecsni, T., Pous, J., Carugo, O., Fita, I.,
Verdaguer, N., Blaas, D., FEBS Lett. 2009, 583, 235–240.
[8] Bubeck, D., Filman, D. J., Hogle, J. M., Nat. Struct. Mol.
Biol. 2005, 12, 615–618.
[9] Bilek, G., Kremser, L., Blaas, D., Kenndler, E., Electro-
phoresis 2006, 27, 3999–4007.
[10] Bilek, G., Kremser, L., Wruss, J., Blaas, D., Kenndler, E.,
Anal. Chem. 2007, 79, 1620–1625.
0 10 20 30 40 50
36
40
44
48
52
C
B
A
c
c
v-r
Cy5
(v-r-l) complex
v + c
FL
time [sec]
Figure 3. Shift of the labeled HRV2 peak upon subsequent
incubation with receptor and unlabeled liposomes. Electropher-
ogram of (A) HRV2 comigrating with the contaminant of the
virus preparation; (B) upon incubation with soluble receptor
fragments; (C) after incubation of (B) with liposomes. Sample
buffer, BGE, separation conditions and FL detection as with
Fig. 1; c, contaminant resulting from the virus preparation; small
excess of Cy5 is also detected.
0 10 20 30 40 50
40
50
60
70
C
B
A
Atto
v+c l
l
v+c
FL
time [sec]
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Abstract  
 
In first attempts at elucidating the transfer of the RNA genome of a human rhinovirus through lipid 
membranes in vitro we made use of liposomes decorated with recombinant receptors. This model 
system was characterized previously by capillary electrophoresis but suffered from the requirement 
for inclusion of polyethylene glycol-modified lipids for reliable separations [Weiss et al. (2009) 
Electrophoresis, 30,2123-2128]. We here report the analysis of liposomes with a lipid composition 
much more similar to that of biological lipid bilayers. We found that vesicles containing and 
lacking this non-physiologic lipid differ significantly in their electrophoretic mobility (by factor 2) 
although the concentration of charge-bearing lipids in their bilayers is the same. We demonstrate 
that binding of a human rhinovirus to the latter liposomes decorated with a cognate receptor can be 
analyzed via electrophoresis on microchips; we support our results with transmission electron 
microscopy. 
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1 Introduction 
 
A keystone in viral infection is the transfer of the viral genome from the virion into the host cell. 
In the case of non-enveloped viruses entering via receptor-mediated endocytosis, this is achieved 
either by disruption of vesicular membranes or by transferring the nucleic acid through a pore. 
Human rhinoviruses (HRVs), main causative agents of the common cold, are valuable models for 
the study of these processes because they are well characterized and different HRV types appear to 
exploit either of these mechanisms depending on the receptor used. HRV2, a minor group virus 
binds members of the low-density lipoprotein receptor (LDLR) family and is taken up via clathrin-
mediated endocytosis. The low pH environment of late endosomes then triggers the structural 
conversion of the virions into subviral particles that is accompanied by the transfer of the RNA 
through the vesicular membrane [1] . The latter step is only poorly understood; hence, there is a 
strong demand for an in vitro system allowing for a detailed dissection of this process.  
 In a first step towards this goal we established a liposome system where recombinant 
His6-tagged derivatives of a cognate receptor, the very-low density lipoprotein receptor (VLDLR), 
were attached to the liposomes via NTA-lipids in the presence of Ni-ions. Virus can be bound to 
these receptors and conformational modifications be triggered by incubation at low pH. However, 
the versatility of the system was compromised by the requirement to include polyethylene-
modified lipids to allow for analysis of the liposomes by capillary electrophoresis [2]. Assuming 
that the same applied for chip electrophoresis, earlier work was done with liposomes (henceforth 
called “non-physiologic liposomes”; n-phl) made of 90 % POPC, 5 % PEG750PE and 5.0 % 
DOGS-NTA (see list of abbreviations), which is a highly non-physiologic composition [3] (Table 
1). The liposomes dealt with in the present communication have a significantly reduced POPC 
content and PE, SM and Ch were incorporated into the lipid bilayer. Ch and SM affect membrane 
fluidity and allow for raft formation; PEG750PE, which is not present in natural membranes, was 
omitted. DOGS-NTA was maintained in order to enable decoration with receptor fragments. In 
addition, filling the vesicle core with an aqueous solution of a FL dye, as previously employed for 
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detection, was replaced by inclusion of NBD-PC, a fluorescent lipid, into the membrane. The 
implementation of the FL lipid was done in order to enable a more reproducible way of vesicle 
labeling. Using this labeling method, one could apply liposomes without purification steps to 
separate free dye material. Such purification steps were necessary for the previous labeling method 
where soluble dye molecules had been encapsulated in the liposomal lumen. Moreover, 
encapsulated dye always tends to leak out to some extent from the liposomal compartment, 
whereas lipid-labeled dyes stay permanently in the membrane. Overall, the membrane 
composition was similar to that commonly employed in experimental membrane fusion and in 
studies of virus interaction with membranes [4-8]. Liposomes with this more physiologic 
composition we here term “physiologic liposomes” (phl). 
 We describe the use of a microdevice for the electrophoretic characterization of phl in 
comparison to n-phl and the tracking of phl carrying recombinant receptors and HRV2. The system 
enables, by default, parallel detection in two fluorescence channels. As found in previous work 
with chip electrophoresis [9, 10] and in agreement with a recent paper dealing with n-phl [3], 
aggregate formation of viruses was absent in chip electrophoresis even when detergents were 
omitted. This is important because detergents usually render liposomes unstable. We here 
demonstrate that virus attachment to liposomes of a lipid composition closely matching that of 
plasma membranes can be reliably and rapidly analyzed by electrophoresis on microchips; the 
nature of the analytes separated by chip electrophoresis was confirmed by electron microscopy. 
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2 Experimental Section 
 
2.1 Chemicals 
Lipids were from Avanti Lipids (Alabaster, US) and purchased via Instruchemie (Delfzyl, 
Netherlands). 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC), L-α-
Phosphatidylethanolamine, Transphosphatidylated (PE) from chicken egg, Sphingomyelin (SM), 
Cholesterol >98% (Ch), 1,2-Distearoyl-sn-Glycero-3-Phosphoethanolamine-N-
[Methoxy(Polyethylene glycol)-750] (Ammonium Salt) (PEG750PE), 1,2-Dioleoyl-sn-Glycero-3-
[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (nickel salt) (DOGS-NTA), and 1-
Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-Glycero-3-
Phosphocholine (NBD PC) were used. 
Boric acid (99.00%) and DMSO (>99.9%) were from Sigma Aldrich (Steinheim, 
Germany). Cy5 was purchased from Amersham Bioscience (Little Chalfont, England) and 
dissolved in DMSO to a final concentration of 25 mM. Sephadex G50 (DNA grade) was also from 
Amersham Bioscience. The free acid form of Atto 495 (Fluka, Buchs, Switzerland) was used as 
mobility marker. Tris(hydroxymethyl)-aminomethan (Tris, ultrapure grade) was purchased from 
Applichem (Darmstadt, Germany) and NaOH pellets (>97%) from E. Merck (Darmstadt, 
Germany). 
 
2.2 Biological material 
HRV2 was prepared, purified and its concentration determined as described [11, 12]. For chip 
electrophoresis a virus preparation at 9.5 mg/mL and for TEM imaging a preparation with 
5.5 mg/mL was used (both in 50 mM sodium borate, pH 7.4). A recombinant receptor derived 
from the very-low-density lipoprotein receptor (VLDLR) was employed for liposome decoration. 
It consisted of 4 tandem repeats of module 3 (V3), a maltose binding protein (MBP) at its N-
 66 
terminus and a His6-tag at its C-terminus [13]. A stock solution at 2.0 mg/mL in TBSC buffer 
(20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 20 mM CaCl2) was used. 
 
2.3 Instrumentation 
Sample analysis on commercially available soda lime glass chips (DNA chips from Agilent 
Technologies, Waldbronn, Germany) was carried out on the Agilent 2100 Bioanalyzer system as 
previously described [9, 10]. Chip electrophoresis employed positive polarity mode for 
electrophoretic sample injection into the separation channel as well as for analysis itself, i.e. 
migration was towards the cathode at 1300 V for injection and 800 V (approx. 19 kV/m) for 
separation. The background electrolyte (BGE) was 100 mM boric acid adjusted to pH 8.3 with 3 
M NaOH. It was freshly prepared daily to attain EOF values of around 55 x 10
-9
 m²/Vs. BGE 
diluted with bidistilled water to 80 mM boric acid concentration was used as sample buffer and 
diluted to 50 mM concentration as labeling buffer and for swelling of Sephadex G50. Fluorescent 
analytes were detected by employing both excitation wavelengths of the instrument (maximum λex 
at 470 nm and 630 nm, respectively). For imaging, a Morgani 268 transmission electron 
microscope (FEI Tecnai, Eindhoven, The Netherlands) was employed.  
 
2.4 Liposome Production 
The preparation of multi-lamellar liposome and their extrusion to large unilamellar vesicles 
(LUVs) with a diameter of 200 nm was as previously described [14-16]. In addition to the 
previously described lipid composition [3], LUVs with a more biological composition 
(“physiologic liposomes”, phl), similar to that given in [4-8], were fabricated. They consisted of 
POPC : PE : SM : Ch : DOGS-NTA : NBD-PC at a molar ratio of 1 : 1 : 1 : 1.5 : 0.5 : 0.05. If not 
indicated otherwise, liposomes were hydrated in 50mM Tris-HCl buffer (pH 8.0) giving a total 
lipid concentration of about 7.8 mM. In few cases hydration was carried out in 50 mM borate 
buffer, pH 8.3. 
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2.5 Virus labeling 
Five µL of HRV2 stock solution were diluted to 9.5 µL with labeling buffer before addition of 
0.5 µL Cy5 at 25 mM in DMSO (2.2 x 10
3
 fold molar excess of dye over virus during labeling). 
Incubation was for 18 hrs at ambient temperature in the dark. Low molecular mass material was 
removed via spin size exclusion chromatography (spin SEC) on Sephadex G50 as described [3]. 
Cy5 labeled virus at approximately 115 nM was obtained. 
 
2.6 Sample preparation for chip electrophoresis 
Purified Cy5 labeled HRV2 was diluted 1:21, the receptor stock solution 1:9 and liposomes 1:10.5 
all in sample buffer. Atto 495 was included as fluorescent EOF marker (λex at 495 nm) at a final 
concentration of approximately 3 µM. Fluorescence labeled virus at 5.6 nM was thus incubated 
with an approximately 640 fold molar excess of soluble receptor fragments. DOGS-NTA lipid was 
present at 10 fold molar excess over receptor molecules. Incubation was carried out at ambient 
temperature under light protection for approximately 20 min. 
 
2.7 Transmission electron microscopy 
Liposomes were diluted 1:20 (0.4 mM total lipid concentration) for imaging. HRV2 was diluted 
1:100 (6.4 nM final virus concentration). Liposome-attached virus was obtained by mixing 
receptor-decorated liposomes (10 µL liposome stock with 1 µL of receptor stock resulting in a 120 
fold molar excess of receptor over DOGS-NTA lipid; incubation at ambient temperature for 
20 min) with HRV2 (10 µL of a 1:50 dilution; incubation at ambient temperature for 20 min). 
After incubation, the liposome/virus/receptor mixture was brought to 200 µL. To assess non 
specific attachment 1 µL liposome stock was incubated with 1 µL of a 1:50 dilution of the HRV2 
stock for 20 min at ambient temperature, and the mixture was brought to 20 µL. All dilutions were 
carried out in 50 mM Tris-HCl buffer, pH 8.0. Carbon coated copper grids were glow discharged 
at 20 mA for 30 s. Four µL sample was applied to a grid for 1 min, washed and negatively stained 
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with 2 % phosphotungstic acid (pH 7.3) for 1 min. Photographs were taken at 5.6 x 10
4
 fold 
magnification using a Morada CCD camera. 
 
3 Results and Discussion 
 
3.1 Chip electrophoresis of liposomes of different composition 
We endeavored to compose liposomes, which come closer to the composition of biological 
membranes. However, membranes are very heterogeneous with regard to their lipid-ratios. 
Therefore, one representative composition was chosen, which met best the lipid compositions given 
in literature [4-8]. In previous work we found that n-phl consisting of 90% POPC, 5% PEG750PE 
and 5% DOGS-NTA migrate as anions in CE [3]; note that both PEG750PE and Ni-loaded DOGS-
NTA possess a negative charge at the pH of the BGE (see Table 1). PEG750PE contains a single 
charged phosphate group; the Ni-loaded DOGS-NTA has also one negative charge in excess 
because of the 3 anionic acetate moieties from which only two are compensated by the Ni
2+
 ion. 
From the electropherogram shown in Figure 1, upper trace, it can be seen that these n-phl are 
recorded at the detector with a relatively short migration time, closely after the peak of residual 
Atto 637. The vesicles are carried to the detector at the cathodic end of the channel by the EOF, 
which has a mobility of about 55 [10
-9
 m² V
-1
 s
-1
]. Concerning the electrophoretic mobility of the 
anionic vesicles an apparent trend is found on the particle size. The 200 nm diameter particles as 
shown in Figure 1 have an average mobility of 19.2 [10
-9
 m² V
-1
 s
-1
] (Table 2). The EOF mobility 
was obtained from Atto 495, which is zwitterionic at pH 8.3 and thus migrates as a neutral 
substance. The distribution of the mobility of the vesicles which are migrating in the 
electrophoretic peak is derived from the span covering plus/minus three times the standard 
deviation of the peak around the maximum. It values 4.2 [10
-9
 m² V
-1
 s
-1
] which means that around 
99% of the liposome species have a mobility between 17.1 and 21.3 [10
-9
 m² V
-1
 s
-1
]. 
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The average mobility is slightly larger (20.2 [10
-9
 m² V
-1
 s
-1
]) for n-phl of the same composition, 
but 400 nm in size, and slightly smaller for 100 nm sized vesicles (18.4 [10
-9
 m² V
-1
 s
-1
]). However, 
there is no statistically significant difference in the average mobilities if we consider their standard 
deviations (n is 12 or 10, respectively). The mobility distribution of the vesicle peaks differs 
slightly between the species (see Table 2): the smaller particles have a smaller span (absolute and 
relative) than the 400 nm vesicles; it seems that their population is more homogeneous with respect 
to the mobility. 
Relating the negative charge of the vesicle to individual anionic lipids in the bilayer seems 
an oversimplification if we consider the mobility of liposomes with the same size of 400 nm, but 
with a lower concentration of the charged lipids. We have measured the mobility of liposomes 
without DOGS-NTA, consisting of 95% POPC and 5% PEG750PE. Although these liposomes 
contained only half of the anionic lipids (5% instead of 10%), their mobility increased slightly to 
21.2 [10
-9
 m² V
-1
 s
-1
] instead of decreasing. It should be pointed out that even bilayers consisting of 
only POPC are negatively charged, although the lipid is zwitterionic and thus formally neutral. This 
demonstrates that for such vesicles the relation of charge properties of the electric double layer, 
zeta potential, and mobility is complex. 
An electropherogram of phl is shown in Figure 1, lower trace. A very broad peak appears at 
about twice the migration time of the n-phl peak. At first sight it appears that phl are much more 
heterogeneous than n-phl. However, a closer view on the mobility and its distribution (Table 2) 
leads to the conclusion that (i) the mean electrophoretic mobility of the phl is by a factor of 2 larger 
than that of the n-phl, with an average of 40.0 [10
-9
 m² V
-1
 s
-1
] (taken from the peak apex). This is 
surprising because the percentage of negatively charged lipids in the vesicles (around 10%, 
originating from DOGS-NTA and NBD-PC) is the same. This result again shows that the simple 
addition of formal charges of the individual lipids in the bilayer is not appropriate to explain the 
electrophoretic properties of the vesicles. (ii) Although the phl migrate as a very broad peak in the 
electropherogram, their mobility distribution, as given by the span (Table 2) is even lower in 
absolute units (1.8 [10
-9
 m² V
-1
 s
-1
]) as compared to the n-phl. The population is also more 
homogeneous, as the mobility of more than 99% of the species varies only within 5% around the 
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average. For practical reasons the following experiments were carried out with liposomes prepared 
in Tris-HCl, pH 8.0 buffer; the liposomes with the same composition, but hydrated in sodium 
borate, pH 8.3, exhibited a similarly high mobility (average mobility is 35.8 [10
-9
 m² V
-1
 s
-1
], 
standard deviation 0.9 [10
-9
 m² V
-1
 s
-1
]). This indicates that the lipid composition governs the 
electrophoretic behaviour. 
 
3.2 Analysis of the receptor-mediated binding of virus to liposomes 
Inclusion of DOGS-NTA in the lipid bilayer creates an anchor for attachment of recombinant 
receptor fragments via their His6-tag (most likely with 1:1 stoichiometry). The applicability of this 
approach has been successfully demonstrated previously [17]; here we investigated whether 
receptor decoration of phl can also be tracked via chip electrophoresis. Note that the POPC content 
was reduced from 90% to about 20%, that PE and SM are now constituents with about 20% each, 
and that Ch (at about 30%) was included. Labeling of the vesicles previously carried out by 
incorporation of a soluble dye into the aqueous vesicle core is here substituted by incorporation of 
a fluorescent lipid in the bilayer. The drastic changes in membrane composition have no influence 
on decoration of the liposome with the receptor. This can be seen from the shift of the liposome 
peak towards a shorter migration time (compare Figure 2 upper and middle trace). Note that only 
liposomes are detected as they contain the fluorescent nitro-benzoxadiazol-4-yl amino group. 
The large shift of the phl peak from 42 to 30 sec migration time results from attachment of 
the receptor. It is interesting that this is caused by the much smaller reduction of the 
electrophoretic mobility by roughly 10% (from (-)40 [10
-9
 m² V
-1
 s
-1
] to about (-)35 [10
-9
 m² V
-1
 s
-
1
]). The much more pronounced effect on the migration time is the result of the relation between 
the analyte mobility and that of the counter-directed EOF, which is around (+)55 [10
-9
 m² V
-1
 s
-1
]. 
Therefore the resulting apparent mobility of the analyte (which determines the migration time) of 
around 55-40=(+)15 [10
-9
 m² V
-1
 s
-1
] is increased to around 55-35=(+)20 [10
-9
 m² V
-1
 s
-1
]; this 
leads to the observed significant change of the migration time. 
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Note that interaction of the uncharged His6 with DOGS-NTA does not change the overall 
charge as the former replaces two water molecules from the latter (see the structural formula given 
in Table 1). However, the receptor adds 39 formal negative charges (90 aspartic and glutamic acid 
versus 51 arginine and lysine residues). Indeed, the free receptor fragment migrates as anion at pH 
8.3 with a mobility of about 20 [10
-9
 m² V
-1
 s
-1
], which is much lower than the mobility of the bare 
liposome. Taken together, it is plausible that liposomes carrying receptor fragments exhibit a 
mobility between that of the components. 
Incubation of the receptor-decorated liposomes with virus (v) results in the 
electropherogram shown in Figure 2, lower trace. A marginal further shift of the peak maximum to 
a shorter migration time is observed. As the virus is not detectable, there is no proof for assembly 
between virus and receptor-decorated liposome. Therefore, HRV2 was FL labeled with Cy5, 
which has an excitation wavelength of 630 nm. 
The electropherogram recorded at λex 630 nm is presented in Figure 3. The upper trace 
shows the signal obtained from the labeled virus taken as reference. Due to the absence of any 
detergent in the BGE, virus (v) and a contaminant, which is always present in the virus 
preparations, are migrating unresolved as a neat peak with about 12 s migration time. Upon 
incubation of the virus with receptor (r) the peak of the resulting complex shifts to a slightly 
longer migration time, with improved resolution from the (unchanged) contaminant peak (Figure 
3, middle trace). Finally, the formation of the assembly between virus, receptor and liposome (phl) 
can be clearly seen from the electropherogram of the incubation mixture of these three constituents 
(Figure 3, lower trace). The peak of this (v+r+phl) assembly has the same migration time and 
shape than that obtained with the blue laser (compare with Figure 2, lower trace).  
 To assess the specificity of the interaction, virus was also mixed with bare liposomes and 
analyzed. Comparison of the electropherograms of the virus alone (Figure 4, upper trace) with that 
obtained from an incubation mixture of liposomes with virus in the absence of receptors (Figure 4, 
lower trace) shows that the virus peak remains completely unchanged. This proofs that the virus 
only binds to receptor decorated liposomes. 
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3.3 Transmission electron microscopy 
Virus binding to receptor-decorated liposomes was also assessed via electron microscopy. Figure 5 
shows pictures of phl, virus, assemblies resulting from mixing receptor-decorated phl with virus, 
and a mixture of bare liposomes (lacking receptor) with virus, respectively. Samples corresponding 
to those analyzed in the Figures 2-4 were applied to glow-discharged carbon coated copper grids 
and negatively stained with 2% phosphotungstic acid, pH 7.3. Liposomes appear as circular density 
with diameters ranging from about 50 nm to 200 nm (Fig. 5A). Due to adsorption and dehydration 
as part of sample preparation, they are not perfectly round. The image confirms that extrusion leads 
to a size distribution with a maximum diameter of 200 nm, limited by the pore size of the 
polycarbonate filter. HRV2 is shown in Figure 5B. The particles are well dispersed and not 
aggregated. Figure 5C shows receptor-decorated liposomes after incubation with virus. The virions 
are no longer distributed randomly but are preferentially seen attached to liposomes and only few 
free virus particles are detected. To again confirm the specificity of the interaction, virus was 
incubated with bare liposomes (Fig. 5D). Liposomes and virus particles are randomly distributed 
and no virions are attached to the lipid vesicles. This confirms that the virus does not interact with 
the membrane per se but depends on the receptor for attachment. These findings support our results 
obtained by chip electrophoresis. 
It can be further seen that liposomes with attached viral particles appear to have somewhat 
changed their shape. This is because a virion can bind several receptor-molecules and thus is able 
to bind a number of nickel-complexing lipids (DOGS-NTA). This results either in the virion-
mediated aggregation between liposomes or a slight engulfment of the virus particle in the lipid 
membrane. Concerning the latter phenomenon, DOGS-NTA lipids most probably enrich at the 
position of virus binding and thus the membrane can bend around receptor-bound virus. Both 
effects can contribute to a slight change in the liposome appearance upon receptor-mediated virus 
binding. 
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4 Conclusion 
 
Liposomes with a composition similar to that of native cell membranes were made (termed phl). 
They were labeled by incorporating a FL lipid into the bilayer. To allow for binding of a His6-
tagged viral receptor a Ni-NTA lipid was included. We demonstrate that such liposomes can be 
electrophoresed on a chip and migrate with a mobility much larger than that of liposomes with a 
high content of POPC and PEG750PE (termed n-phl). The phl deliver a broad peak at a longer 
migration time which is a consequence of the smaller difference between the EOF mobility and 
that of the vesicles. Despite the broader peak, these liposomes are more homogeneous in terms of 
the mobility of the vesicle population than n-phl. 
Binding of FL labeled virus to these receptor decorated liposomes was assessed by chip 
electrophoresis with FL detection at λex 470 nm (liposomes) and at λex 630 nm (virus). Virus 
binding to the liposomes was dependent on the presence of the receptor. This was confirmed by 
electron microscopy. 
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Table 1.  Lipid constituents of the liposomes investigated.  
 
 Abbreviation Content 
(mol%) 
Structural formula Formal 
Charge 
n-phl 
a)
 POPC 90.0 
(95.0) 
O
P
O
N
O
O
O H
O
O
O
-
+
 
0 
PEG750PE 5.0 
(5.0) 
O
P
O
N
O
O H
O H
O
O
O
C
O
(OCH
2
CH
2
)
16
OCH
3
-
 
-1 
DOGS-NTA 5.0 
(0) 
O
H
2
OO
N O
Ni
O
C
C
H
2
O
O
N
H
O
O
O
O
O
O
HO
O
 
-1 
     
phl 
b)
 POPC 19.8  0 
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 PE 19.8 
O
P
O
O
O
O H
O
O
O
NH
3
-
+
 
0 
 SM 19.8 
O
P
O
N
O
O
NH
O
OH
-
+
 
0 
 Ch 29.7 CH3
CH
3
CH
3
H
CH
3
H H
CH
3
H
OH  
0 
 DOGS-NTA 9.9  -1 
 NBD-PC 1.0 
-
+
N
O
N
N
H
N
+
O
O
O
P
O
N
O
O
O
H
O
O
O  
-1 
 
a)
 n-phl: “non-physiologic” liposomes; b)phl: “physiologic” liposomes 
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Table 2 Electrophoretic mobility distribution of liposomes with different composition, size or 
buffer used during their preparation.  
Mobility, standard deviation and mobility span in [10
-9
 m² V
-1
 s
-1
]. The span covers species within 
± 3 times the standard deviation of the electrophoretic peak. 
 
Liposome Size, 
nm 
Average 
Mobility 
Standard 
deviation 
n RSD% Span 
POPC:PEG750PE 
a) 1)
 400 21.2 0.5 12 2.4 3.0 
POPC:NTA:PEG750PE 
b) 1)
 400 20.2 1.0 10 5.0 6.0 
POPC:NTA:PEG750PE 
b) 1)
 200 19.2 0.7 10 3.6 4.2 
POPC:NTA:PEG750PE 
b) 1)
 100 18.4 0.7 10 3.8 4.2 
POPC:PE:SM:Ch:DOGS-
NTA:NBD-PC 
c) 1)
 
200 35.8 0.9 5 2.5 5.4 
POPC:PE:SM:Ch:DOGS-
NTA:NBD-PC 
c) 2)
 
200 40.0 0.3 5 0.8 1.8 
 
a) 
19:1; 
b) 
18:1:1; 
c) 
1:1:1:1.5:0.5:0.05. molar ratio; 
1)
 liposomes prepared in 50 mM boric acid 
adjusted to pH 8.3 with NaOH; 
2)
 liposomes prepared in 50 mM Tris-HCl buffer, pH 8.0 
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Figure Legends 
Figure 1. Chip electrophoresis of liposomes with different membrane composition. Upper trace: 
non-physiologic liposomes (n-phl), 200 nm diameter, the free acid form of Atto 637 was 
encapsulated for detection at λex/λem 630/680 nm. Total lipid concentration: 190 µM [3]. Lower 
trace: physiologic liposomes (phl), 200 nm diameter, membrane labeled with NBD-PC for 
detection at λex/λem 470/525nm. Total lipid concentration: 740 µM.  Separation conditions: soda 
lime glass chip, BGE: 100 mM boric acid, adjusted to pH 8.3 with NaOH. Sample buffer: BGE 
diluted with bidistilled water to 80 mM boric acid concentration. Separation voltage: 800 V 
(approx. 19 kV/m).  
 
Figure 2. Attachment of FL labeled virus (v) to physiologic liposomes (phl) via a VLDL-receptor 
derivative (r). Detection of liposomes at λex = 470 nm; Cy5 labeled virus is not detectable at this 
wavelength. Atto 495 was employed as EOF marker. Sample components: 5.6 nM FL labeled 
HRV2; 640 fold molar excess of receptor over virus; 10 fold molar excess of accessible DOGS-
NTA lipid over receptor; total lipid concentration in the samples 740µM. BGE, sample buffer and 
separation conditions as in Figure 1.  
 
Figure 3. Binding of FL labeled virus (v) to physiologic liposomes (phl) via a recombinant 
receptor derivative (r) detected at λex = 630 nm. Labeled liposomes are not detectable at this 
wavelength. Other conditions as in Figure 1. Cont., contaminant in the virus preparation. 
 
Figure 4. Attachment of HRV2 to liposomes depends on the receptor. Upper trace: virus. Lower 
trace: incubation mixture of virus (v) and bare phl in the absence of receptor. Concentration of 
analytes as in Figure 2, BGE, sample buffer and separation conditions as in Fig. 1. Detection at λex 
= 630 nm. 
 
Figure 5. Virus binding to liposomes depends on the receptor. TEM images of liposomes (A); 
HRV2 (B); a mixture of virus and receptor-decorated liposomes (C); a mixture of virus and bare 
liposomes (D). Samples were adsorbed to glow-discharged carbon coated copper grids and 
negatively stained with 2% phosphotungstic acid, pH 7.3. Images were taken at a 5.6 x 10
4
 fold 
magnification. Size bar = 100 nm  
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3.3 Determination of Leakage from Lipid Vesicles via 
Electrophoresis 
 
Various leakage assays are reported in literature, for instance based on de-quenching 
effects upon release of a fluorophore like calcein previously encapsulated at self-quenching 
concentrations inside liposomes [e.g. 76], or based on encapsulation of a fluorophore / 
quencher pair (ANTS/DPX) followed by the release of both molecules upon membrane 
permeabilization [e.g. 77, 78] or based on separation of Tb
3+
 and dipicolinic acid (DPA) 
via a membrane [e.g. 79 – 81]. In those leakage assays permeabilization of the respective 
membranes causes an increase in fluorescence, either by a drop in the fluorophore 
concentration below its self-quenching level, by high dilution of a fluorophore / quencher 
solution upon its release from liposomes or by complex formation between two previously 
separated molecules. However, all these described leakage assays also exhibit drawbacks. 
In the case of encapsulated fluorophores at self quenching levels already partial leakage of 
fluorophore molecules from inside of liposomes might be sufficient to obtain a 
disproportionally high fluorescence response, since the fluorophore concentration inside 
the lipid vesicles has already dropped below self-quenching values. In the case of leakage 
assays that rely on interaction between two different molecules, like for instance the 
fluorophore / quencher pair ANTS/DPX, preferential leakage of one molecule over the 
other was reported [78] and leakage assays have to be corrected for that effect. 
 
In previous experiments we opted for unilamellar liposomes as model membrane 
encapsulating a fluorescent dye (Atto 637, free acid form). Application of our samples to 
Agilent 2100 Bioanalyzer DNA chips allowed for electrophoretic baseline separation of 
free and still encapsulated dye (as demonstrated in 3.2). Therefore, it was reasoned that 
chip electrophoresis allows for tracking of both dye contingents during leakage 
experiments – still encapsulated and already released fluorophores. The degree of leakage 
caused by peptides and viral proteins could thus be regarded as the ratio between the area 
of the liposome peak (ALiposome
Leak
) and the area of the free dye peak (ADye
Leak
). This 
obtained value was further corrected for unspecific liposome leakage by relating the 
original ratio (ALiposome
Leak
 : ADye
Leak
) to an average ratio Ã of two blank ratios 
(ALiposome
Blank
 : ADye
Blank
)  measured in the absence of membrane disrupting agents at the 
beginning and at the end of each respective chip. Therefore, leakage could be expressed in 
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terms of intact liposomes as ratio of (ALiposome
Leak
 : ADye
Leak
) to Ã. Data points were finally 
obtained as average values of at least four measurements from two independent chips. 
 
Several peptides are known to induce leakage of model membranes. Two of those peptides, 
GALA [82, 83] and the 24 amino acid long N-terminus of the HRV2 viral capsid protein 
VP1 [76], were chosen as positive controls for our chip based liposome leakage assay. On 
the other hand Insulin Chain A and a peptide of the HRV2 viral capsid protein 2 (VP2) 
termed 8F5 antigen were chosen as negative controls. A series of resulting 
electropherograms obtained for GALA induced leakage is presented in figure 36. An 
increase in the first peak (the free dye) as well as a concomitant decrease of the second 
peak (the liposomes encapsulating dye molecules) is observable with increasing peptide 
concentrations.  
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Fig. 36: Electropherograms obtained for liposomes pre-treated with increasing GALA 
concentrations, a leakage inducing peptide. An increase of the peak for the free dye as well as a 
concomitant decrease of the peak for the encapsulated dye upon incubation with GALA is 
observable. 
 
The resulting leakage curves for tested peptides are presented in figure 37. It is of note that 
for the N-terminus of VP1 problems with the protein stock solution were experienced. In 
fact, already for very low concentrations milky solutions were obtained, probably due to 
aggregating peptide fragments. Therefore, leakage experiments were repeated with a 
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slightly modified VP1-N peptide. Addition of six lysines increased the water solubility of 
the N-terminal peptide dramatically which was also reflected in the obtained leakage 
curve: Already at 1 mM concentration the modified VP1-N peptide lead to complete 
liposome leakage, whereas at that concentration for the original peptide still roughly 90 % 
of all liposomes remained intact.  
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Fig. 37: Liposome leakage obtained for various peptides. Insulin and 8F5 antigen were employed 
as negative controls, GALA and the N-terminal peptide of VP1 as positive controls. Leakage was 
calculated as described in the text. 
 
For the future we plan to record TEM images of lipid vesicles treated with our control 
peptides followed by statistic analysis of the obtained liposomes. We suggest that phospho-
tungsten acid, the contrast medium for TEM imaging, can enter permeabilized liposomes, 
i.e. liposomes exhibiting pores in their lipid bilayer. Such, we want to support our chip 
electrophoretic results. 
 
Experimental Section 
Chemicals: Boric acid (99.99%) was purchased from Sigma Aldrich (Steinheim, Germany), sodium 
hydroxide (pellets pure) and sodium acetate trihydrate (ACS grade) were both from E. Merck (Darmstadt, 
Germany). Atto 495 in its free acid form (Atto Tec, Siegen, Germany) was obtained from Sigma Aldrich as 
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well. Sephadex G50 (DNA grade) and Cy5 were from Amersham Bioscience (Little Chalfont, England). Cy5 
was dissolved in DMSO to obtain a 25 mM stock solution. DMSO (p.a.) and acetic acid (99%) were from 
Fluka (Buchs, Switzerland). Water was of Millipore grade. Lipids were as described (refer to 3.2) for n-phls 
and obtained from Avanti Lipids (Alabaster, AL, USA) via Instruchemie (Delfzyl, The Netherlands). 
Liposomes (90% POPC, 5% PEG750, 5% Ni-NTA; encapsulating 11µM Atto 637, free acid form; in 50 mM 
sodium borate, pH 8.3; extrusion to 200 nm diameter) were prepared as detailed (refer to 3.2) and purified via 
spin SEC on the day of analysis (Sephadex G50 swelled in 50 mM sodium acetate buffer, pH 5.0; lipid 
concentration after SEC at approx. 1.96 mM). The peptides GALA 
(WEAALAEALAEALAEHLAEALAEALEALAA), VP1-N (NPVENYIDEVLNEVLVVPNINSSN) and 
VP-N + 6Ks (NPVENYIDEVLNEVLVVPNINSSNKKKKKK) were from GenScript (Piscataway, US); the 
peptide 8F5 antigen (VKAETRLNPDLQPTE) was from Pi Chem (Graz, Austria). Insulin chain A 
(ammonium salt from bovine pancreas, HPLC grade) was obtained from Sigma Aldrich. 
 
Instrumentation: Chip electrophoretic leakage assays were carried out on Agilent 2100 Bioanalyzer 
employing DNA chips (Agilent Technologies, Waldbronn, Germany). Modifications in chip handling and 
analysis were as described (refer to 3.2). 100 mM sodium borate, pH 8.3 was employed as BGE. 
 
Sample preparation: Leakage assays of peptides were carried out with 10 mM stocks of the investigated 
proteins solved in 50 mM sodium acetate buffer, pH 5.0. Starting from those stocks several lower 
concentrated protein stocks in the same buffer were prepared. Constant liposome sample volumes (1.5 µL 
after SEC) were mixed with respective protein solutions and the total volume was adjusted via 50 mM 
sodium acetate buffer, pH 5.0 to 3.0 µL, if necessary. For preparation of blank samples, liposomes were 
mixed with plain sodium acetate buffer. Incubation was carried out under light protection for 15 min at 
ambient temperature. Samples were re-neutralized with 12.0 µL of 80 mM sodium borate, pH 8.3 
additionally containing approx. 3.8 µM Atto 495 as EOF marker.  
 
Data analysis: Samples were analyzed twice on each of two independent DNA chips and the degree of 
leakage was calculated as ratio between peak areas of encapsulated and free dye related to an average ratio 
measured in the absence of any membrane permeabilizing agents. 
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3.4 Investigation of Membrane Disrupting Abilities of HRV2 
 
After development of a chip based electrophoretic leakage assay (refer to 3.3) membrane 
disrupting abilities of intact HRV2 virions were assessed. Transfer of viral RNA through 
the endosomal membrane in the course of virus infection is either related to membrane 
disruption or to pore formation in the lipid bilayer. However, in the case of HRV2 the latter 
case was presumed (refer to 2.1.1). Literature further emphasizes membrane disrupting 
abilities of VP1 [76] and VP4 [84]. Therefore, I took interest in leakage from lipid vesicles 
caused by intact virions at different pH values. Furthermore, the degree of leakage caused 
by subviral particles as well as the role of receptor molecules in the leakage process was 
investigated. 
 
A first experimental approach targeted leakage from lipid vesicles via intact virions of 
HRV2 at different pH values in the absence of receptor molecules. pH values were 
adjusted via 50 mM sodium acetate according to table 1. Samples were reneutralized via 
80 mM sodium borate, pH 8.3 before chip electrophoresis. A surface fitted to resulting data 
points displays the interaction of virions with liposomes at different pH values and is 
presented in figure 38 for visualization of overall results (for presentation of individual 
data points refer to figure 39). As expected, especially for acidic pH values < 6.0 
interaction of HRV2 with liposomes was found. No such interaction could be found for 
neutral pH values. 
Acidification via 
50 mM sodium acetate 
at indicated pH 
pH value of incubation 
solution 
Reneutralization via 
80 mM sodium borate 
pH 8.3 
pH value of 
reneutralized solution 
5.0 5.1 8.0 
5.3 5.5 8.1 
5.6 5.9 8.2 
5.7 6.6 8.3 
5.8 7.1 8.3 
Table 1: pH values during chip electrophoretic leakage assays employing intact virions. 
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Fig. 38: Fitted surface based on data points obtained for chip electrophoretic leakage assays 
employing intact HRV2 virions as disrupting agents for lipid membranes at different pH values 
for visualization of overall results. Data points were obtained as peak area ratio between still 
encapsulated and already released dye and related to blank measurements (refer to 3.3). 
 
In the course of chip electrophoretic leakage assays several problems related with leakage 
caused by intact virions occured: 
 
(i) At virus concentrations of 5 nM (approx. 10 fold molar excess of virions over 
liposomal particles) and higher often spikes were recorded. Such results were 
assumed to be related to liposomes bridged together via hydrophobic viral 
intermediates.  
 
(ii) In contrast to electropherograms obtained for leakage induced by GALA (figure 
36), leakage induced by HRV2 virions never resulted in a prominent increase in 
the area recorded for the free dye as concomitant effect for the decrease in the 
liposome signal.  
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(iii) Even for incubation of virus / liposome mixtures at pH 5.1 no complete leakage 
of liposomes was detected. Seemingly, upon completed virus uncoating, 
subviral particles detached again from the liposome surface no longer allowing 
for leakage of dye molecules from lipid vesicles. Also, MVVs (refer to 2.1.2) 
might be responsible for incomplete leakage. Upon membrane disruption via 
HRV2, still some liposomes remained intact, which were previously 
encapsulated by other lipid membranes and could thus not been targeted by 
virions in the course of their uncoating. 
Nevertheless, the pH and concentration dependence of virus interaction with liposomes 
could be assessed via chip electrophoretic leakage assays. Figure 39 highlights these 
features. Interaction between liposomes and virions is only detectable at sufficiently low 
pH values and sufficiently high virus concentrations (measured at a calculated constant 
liposome concentration of approximately 0.5 nM). No virus / liposome interaction is 
detectable if one of these requirements is not met. These findings are in excellent 
accordance with results following the viral RNA transfer through plasma membranes via 
encapsulated RT-PCR kits (Bilek, G. et al., results under publication). Processing of 
transferred viral RNA was only detected in the case of complete shielding of encapsulated 
kits in the liposome interior from the employed external matrix. However, this shielding 
could only be accomplished for sufficiently low virus concentrations. Corresponding virus 
concentrations did not result in liposome leakage in chip electrophoretic experiments. 
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Fig. 39: Interaction between liposomes and HRV2 virions is dependent on sufficiently low pH 
values and sufficiently high virus concentrations (measured at a constant liposomes concentration 
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of approximately 0.5 nM). If one of these requirements is not met, no virus / liposome interaction 
is detectable. Virus / liposome interaction was assessed via chip electrophoretic leakage assays as 
described (refer to 3.3). 
 
Interaction of liposomes and virions is also conclusive from liposome mobility data 
obtained from measurements at pH 5.1 incubation (figure 40). Recorded was the mobility 
shift of the liposome peak upon incubation with different virus concentrations measured at 
a constant liposome concentration of approx. 0.5 nM. This mobility shift was related to the 
peak of non encapsulated Atto 637 as internal standard. Interestingly, a decline in the 
mobility difference of liposomes and the internal standard with increasing virus 
concentrations was detectable. It resulted from viral modifications (either subviral capsids 
adherent to or viral proteins anchored in the lipid membrane) of the liposome surface. 
Investigation of the effect of higher virus concentrations on liposome mobility was limited 
because of spike formation and finite concentrations of virus stock solutions. 
 
0 5 10 15 20 25 30
8
9
10
11
12
13
m
o
b
ili
ty
 d
if
fe
re
n
c
e
 t
o
 s
ta
n
d
a
rd
[1
0
-9
m
²/
V
s
]
[nM] HRV2 in incubation solution
 
Fig. 40: Mobility shift of liposome peak upon its modification via subviral particles or viral 
proteins. Recorded was the mobility shift of the liposome signal related to free Atto 637 as 
internal standard. Chip electrophoretic leakage assays were carried out with intact virions and 
incubation at pH 5.1. 
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Following experiments dealt with leakage caused by subviral particles. Therefore virions 
were acidified to pH 5.1 before liposomes were introduced to the samples. Chip 
electrophoretic leakage assays were carried out as described (refer to 3.3). From the 
resulting curves (figure 41) it was concluded that spatial proximity of virions to 
membranes during the viral uncoating process was essential to observe leakage from lipid 
vesicles.  
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Fig. 41: Comparison of leakage induced via viral and preformed subviral particles upon 
incubation with liposomes at pH 5.1. Clearly no leakage is detectable for incubation with 
preformed subviral particles, whereas for virus conversion in the presence of liposomes a high 
amount of leakage is detected. Data points resulted from chip electrophoretic leakage assays (refer 
to 3.3). 
 
Finally, also the contribution of receptor mediation to liposome leakage was assessed. Chip 
electrophoretic leakage experiments were carried out after incubation of liposomes with 
two different recombinant soluble receptor fragments. Receptor decoration was followed 
by virus attachment to receptor decorated membranes and acidification of obtained 
assemblies to pH 5.1 (for characterization of assemblies refer to 3.2). Two different 
receptor fragments were employed exhibiting different binding strengths to HRV2 virions, 
respectively. Those receptor fragments were derived from the cellular receptor VLDLR, 
which is supposed to facilitate HRV2 endocytosis (refer to 2.1.1). VLDLR consists of 8 
binding domains from which the third binds strongest to binding sites around the fivefold 
axis on the viral capsid. According to the viral icosahedral symmetry up to five receptor 
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domains are able to bind simultaneously to star-shaped dome sites on the capsid. A 
recombinant soluble receptor consisting of five binding domains number 3 of the VLDLR 
arranged in tandem (MBP-V33333) therefore exhibits strongest binding affinity to the 
virus surface [75]. It was therefore chosen as one receptor fragment for the experimental 
setup. On the other hand a recombinant receptor derived from domains 1 – 3 of VLDLR 
(MBP - V123) was investigated as well. This receptor fragment exhibited lower binding 
affinity to virions than MBP-V33333. Figure 42 depicts the resulting leakage curves. 
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Fig 42: Contribution of receptor mediation to virus induced liposome leakage detected via chip 
electrophoresis. Upon application of soluble receptor fragments for virus / receptor / liposome 
adduct formation followed by acidification of obtained mixtures a shift in the obtained leakage 
curves to higher virus concentrations was observed. This shift probably resulted from receptor 
molecules in free solution stabilizing virions during the uncoating process. Interestingly, receptor 
fragments could not be attached completely to liposome surfaces albeit a molar excess of Ni
2+
 
over His6-tags as observed already for the formation of receptor mediated assemblies (refer to 
3.2). 
 
Interestingly, upon acidification of a virus / liposome adduct mediated via MBP-V33333 
(liposome concentration approx. 0.5 nM; receptor concentration approx. 6.3 µM; virus 
concentration as indicated) leakage was shifted to higher virus concentrations than in the 
absence of receptor mediation. Also, at high virus concentrations, less intact liposomes 
were obtained upon receptor mediation. Furthermore, also the drop in a curve fitted to the 
data points obtained for leakage upon receptor mediation was limited to a smaller virus 
concentration window. It was thus concluded that: 
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(i) Not all receptor molecules were attached to Ni2+ although Ni2+ loaded lipid was 
employed in molar excess over receptor molecules. This result, though 
unexpected, is in good accordance with data presented under 3.2, where 
receptor mediated adduct formation between virions and liposomes was 
investigated in detail. In the course of these experiments it was observed as well 
that binding of His6 tagged receptor fragments to Ni
2+
 loaded liposome surfaces 
was not complete (as deduced from recorded peaks for virus / receptor 
complexes even in the presence of liposomes). Also with these experiments 
Ni
2+
 had been employed in molar excess. 
 
(ii) Receptor molecules not bound to liposome surfaces but present in free solution 
do not facilitate virus interactions with membranes but additionally stabilize 
virions against uncoating [7]. This effect explains the shift to higher virus levels 
recorded in liposome leakage assays. 
 
(iii) The importance of receptor mediation for the transfer of viral RNA through 
membranes can be deduced from faster dropping leakage curves as well as from 
lower levels of intact liposomes upon carrying out leakage experiments under 
receptor mediation. As soon as the ratio between virions and recombinant 
receptor fragments is such that virus capsids are no longer stabilized but 
conditions allow for virus uncoating (virus concentrations of 20 nM or higher), 
dye leakage from liposomes is recorded for a comparatively narrow virus 
concentration window. However, it was reported that in vivo at acidic pH 
conditions of virus uncoating (around pH 5.6) the virus / receptor complex had 
already dissociated (refer to 2.1.1). We therefore suppose that the importance of 
receptor mediation does not lie with the transfer process itself, but with the 
arrangement of spatial proximity between virions and membranes before the 
actual uncoating process. 
 
(iv) As expected, application of a receptor with lower affinity to virions (MBP-
V123) in the course of the formation of receptor mediated virus / liposome 
adducts yielded intermediate leakage results in between those with receptor 
mediation via MBP-V33333 and those without receptor mediation.  
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Similar to leakage results in the absence of recombinant receptor fragments (refer to 
figures 38 – 39) again problems upon application of higher virus concentrations were 
experienced. In such electropherograms often spikes are recorded. In contrast to results 
without receptor mediation, however, the respective virus concentrations causing leakage 
from liposomes were shifted to higher values (depending on receptor affinity to virions and 
virus / receptor ratio).  
 
As for the non-receptor mediated case, data obtained from dye leakage experiments upon 
receptor mediation can be supported by liposome mobility data (figure 43). Depicted is the 
resulting curve for mediation via MBP-V33333 and acidification to pH 5.1. At low virus 
concentrations (up to approx. 2 nM HRV2) the recorded liposome mobility related to the 
mobility of released dye as internal marker changes strongest. After reaching a plateau in 
the mobility difference between liposomes and the marker (approx. 2 - 10 nM HRV2), the 
mobility difference is again decreasing upon application of higher virus concentration (10 
nM or higher HRV2 content). These findings can be explained by fairly stable virus / 
receptor conditions at the liposome surface for a HRV2 concentration window of approx. 2 
- 10 nM. Increasing the HRV2 concentration even further leads to a decrease in the 
receptor / virus ratio at the liposome surface. This in turn leads to a decline in liposomal 
mobility. In fact, comparison of liposome mobility shifts reveals that for high virus content 
shifts in liposome mobility slowly resemble, regardless of receptor mediation (figure 44). 
This can be explained by the decline of the number of receptor molecules compared to the 
number of virus particles. 
 
Interestingly, upon mediation via MBP-V33333, virus induced leakage from liposomes 
was only recorded for virus concentrations of 20 nM or higher, although mobility data 
suggests saturation of virions with recombinant receptor fragments at the liposome surface 
already for virus concentrations of approx. 10 nM. It seems as if in the virus concentration 
window between 10 and 20 nM still enough receptor fragments are present in solution to 
allow for additional virus stabilization against pH induced uncoating. However, the 
number of receptor molecules per virion is constantly declining. Below a threshold of 
receptor fragments per virion, no additional stabilization against virus uncoating is possible 
yielding dye leakage from liposomes. 
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Fig. 43: Interaction of virions with liposomes upon receptor mediation is accessible from mobility 
data. Depicted are results for MBP-V33333 mediation and acidification to pH 5.1. For virus 
concentrations up to approximately 2 nM a high shift in liposome mobility was recorded 
corresponding to the formation of receptor mediated virus / liposome complexes. The mobility 
shift then reaches a plateau (from 2 nM to approximately 10 nM virus concentration) which can 
be explained by a still sufficiently high number of recombinant receptor fragments in solution to 
allow for maintenance of virus / receptor conditions at liposome surfaces. At higher virus 
concentrations these conditions can no longer be maintained, the ration between receptor 
molecules and virus particles on the liposome surface decreases which in turn leads to a decrease 
of the liposomal mobility shift.  
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Fig. 44: Comparison of liposome mobility curves upon virus induced liposomal leakage. For high 
virus concentrations mobility curves start to slowly resemble regardless of receptor mediation 
because the ratio between recombinant receptor fragments and virus particles on the liposome 
surface declines. 
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As an overall result of these experiments one can conclude that a very important goal for 
future experiments lies in a better attachment of receptor molecules to the liposome 
surface. This effect might either be obtained by application of other Ni
2+
 chelating lipids in 
the liposome surface (for instance application of tris-nitrilotriacetate groups instead of 
mono-nitrilotriacetate moieties) or by application of native receptor molecules 
incorporated into the liposomal membrane. 
 
Experimental Section 
Chemicals: Boric acid (99.99%) was obtained from Sigma Aldrich (Steinheim, Germany), sodium hydroxide 
(pellets pure) and sodium acetate trihydrate (ACS grade) were from E. Merck (Darmstadt, Germany). Atto 
495 in its free acid from was from Atto Tec (Siegen, Germany) and obtained as well from Sigma Aldrich. 
Acetic acid (99%) and DMSO (p.a.) were from Fluka (Buchs, Switzerland). Sephadex G50 (DNA grade) and 
Cy5 were from Amersham Bioscience (Little Chalfont, England). Cy5 was dissolved in DMSO to obtain a 
25 mM stock solution. Water was of Millipore grade. Lipids were as described (refer to 3.2) for n-phl and 
obtained from Avanti Lipids (Alabaster, AL, USA) via Instruchemie (Delfzyl, The Netherlands). Liposomes 
(90% POPC, 5% PEG750, 5% Ni-NTA; encapsulating 11µM Atto 637, free acid form; in 50 mM sodium 
borate, pH 8.3; extrusion to 200 nm diameter) were prepared as described (refer to 3.2) and purified via spin 
SEC on the day of analysis (Sephadex G50 swelled in 20 mM sodium borate buffer, pH 8.3; lipid 
concentration after SEC at approx. 2.94 mM). 
 
Biological Material: Production of HRV2 as well as assessment of its purity and concentration was as 
described [8, 46]. An aliquot of 5.4 mg/mL in 50 mM sodium borate, pH 7.4 was employed for experiments. 
It was diluted to 2.2 mg/mL virus concentration with Millipore water prior to further dilution steps in 20 mM 
sodium borate, pH 8.3. Recombinant receptor fragments of the VLDLR were in 20 mM Tris-HCl, pH 7.5, 
150 mM NaCl and 10 mM CaCl2 [75]. One receptor consisted of five receptor domains number 3 arranged in 
tandem V33333, another of the first three receptor binding domains V123. Both recombinant receptors were 
fused to His6-tags at their C- and to MBP at their N-termini. MBP-V33333 was at 5.5 mg/mL and MBP-
V123 at 8.0 mg/mL. MBP-V123 was diluted to 4.8 mg/mL in its storage buffer prior to application. 
 
Instrumentation: HRV2 mediated dye leakage from liposomes was investigated as described (refer to 3.3). 
Upon relating the peak area of the free dye to the area of liposomes in case of leakage and upon relating this 
ratio again to an average from blank measurements sometimes values of 150% or higher were calculated 
(because of recorded spikes). However, these values (corresponding to 150% of intact liposomes upon 
application of leakage conditions or higher) were not considered for calculation of average values for intact 
liposomes under such investigated incubation conditions. 
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Sample preparation:  SEC purified liposomes were receptor decorated at ambient temperature for 10 min. 
Alternatively, for experiments in the absence of recombinant receptor molecules, receptor storage buffer was 
employed. Receptor decorated liposomes were incubated with virus dilutions in 20 mM sodium borate, pH 
8.3 again at ambient temperature for 10 min. Receptor mediated adducts (2.3 µL) were acidified with 50 mM 
sodium acetate buffer (2.9 µL) at different pH values for incubation at 5.1 - 7.1, respectively (ambient 
temperature, 15 min). Such, SEC purified liposomes were diluted 1:4, receptor stock 1:13, HRV2 in 20 mM 
sodium borate, pH 8.3, 3:26 for application in the incubation solution. Incubation solutions were 
reneutralized with 10.4 µL of 80 mM sodium borate, pH 8.3 prior to chip electrophoretic analysis. For 
formation of subviral particles in the absence of lipid membranes the mixing order of sample constituents 
was adapted. Virus was acidified (10 min, ambient temperature) before addition of a liposomes/receptor 
storage buffer mix was carried out. Subviral particles were incubated with lipid membranes for 15 min at 
ambient temperature. 
 
Data analysis: Leakage was calculated as described (refer to 3.3).  Mobility differences to the free dye peak 
were related to the middle of the liposomal signal. Because of recorded spikes mobility calculations with the 
apex of the liposomal peak did not seem reasonable. Apparent mobility values for both sample constituents 
were calculated and the mobility difference was plotted. 
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3.5 RNA Transfer of HRV2 through Membranes 
 
State of publication: experimental phase 
Contributing authors:  Victor U. Weiss – 60% 
    Gerhard Bilek – 25% 
    Xavier Subirats – 15% 
 
Introduction and Molecular Beacon Design 
Molecular beacons (MBs) are short single stranded oligonucleotides forming an 
intramolecular hairpin structure consisting of a stem and a loop region. Upon modification 
of the oligonucleotide arms with a corresponding fluorophore / quencher pair, MBs are 
functionalized as FL hybridization probes [e.g. 85 – 91]. The closed hairpin structure of 
beacons leads to spatial proximity of the fluorophore / quencher pair, which in turn renders 
the beacon non-fluorescent. According to the mode of quenching, FL is either quenched 
via direct energy transfer to the quencher that dissipates energy as heat or via fluorescence 
resonance energy transfer (FRET). In the latter case emitted light of the fluorophore leads 
to FL excitation of the quencher [88]. Emitted FL is thus shifted to longer wavelengths. 
Upon specific binding of the loop region to a corresponding target sequence, the MB 
undergoes a conformational change to an energetically more favourable intermolecular 
duplex strand. The hairpin structure of the beacon is thus severed and the spatial proximity 
of the fluorophore / quencher pair lost; FL is reported to occur instantaneously even for 
incubation at room temperature. For our experiments we developed an MB specifically 
targeting the HRV2 RNA genome. Upon encapsulation of molecular beacons in liposomes, 
we intended to follow the viral RNA genome transfer through membranes. The genome of 
several other viruses has already been targeted successfully in living cells upon application 
of MBs [92 – 94]. However, application of MBs in vivo often leads to problems because of 
MB digestion resulting in a high FL background. Furthermore, cellular ionic conditions 
tend to lead to false positive responses [89, 90]. Therefore, in order to circumvent those 
problems and also to concentrate on the viral RNA transfer itself through membranes, we 
opted for the well defined membrane conditions of our liposomal model system. We 
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intended to employ chip electrophoresis to detect FL liposomes, i.e. viral genome transfer 
through membranes reported via MBs. Although CE of beacons has already been reported 
[95], previous work was based on UV detection and solely concentrated on MB 
hybridization to short oligonucleotide target sequences. To my knowledge, neither has 
viral RNA been targeted previously via MBs in CE, nor was the RNA transfer through 
membranes targeted itself in an analytical electrophoresis setup. 
 
In the course of the MB design process several aspects have to be considered: 
 
(i) The oligonucleotide target region of the beacon loop has to be accessible for 
hybridisation, i.e. not highly structured [96, 97]. Therefore, we opted in our 
experimental setup for targeting of a loop region in the internal ribosomal entry 
site (IRES) of the HRV2 genome. This IRES sequence has already been 
predicted in our laboratory as single stranded RNA region via computational 
folding programs. 
 
(ii) Loop and stem regions of MBs have to be adjusted in nucleotide number and 
base content such, that formation of an intramolecular hairpin structure is 
energetically possible under the anticipated experimental conditions in free 
solution. However, formation of a duplex strand with the target sequence has to 
be energetically favoured over intramolecular hybridization. This requires the 
annealing temperature of the beacon loop to the target sequence to exceed the 
melting temperature of the stem region. Such, slightly increased temperatures 
lead to open hairpin structures that are still able to hybridize to target 
oligonucleotides. Annealing and melting temperatures can be estimated in 
several ways [98]. One approximation for short oligonucleotides (up to approx. 
15 nucleotides) estimates the contribution of each AT base pair with 2.0°C and 
of each GC pair with 4.0°C to the oligonucleotide melting temperature. Another 
way of estimating the melting temperature is based on the GC percentage of the 
nucleotide sequence. This method is proposed for long oligonucleotide 
sequences. The nearest-neighbour model finally considers thermodynamic data 
of neighbouring base pairs upon estimation of melting temperatures. The 
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Rensselaer bioinformatics web server of Michael Zuker [99 – 101] offers the 
opportunity of online prediction of melting and annealing temperatures of 
oligonucleotide sequences as well as prediction of oligonucleotide folding to 
thermodynamically stable structures.  
 
(iii) Computational approaches [101] can be employed for prediction of MB melting 
and annealing temperatures dependencies on various parameters. For instance 
buffer ionic strength (expressed via the concentration of the monovalent cation 
Na
+
) [89] as well as the Mg
2+
 content [87] of the buffer solution and the 
oligonucleotide concentration itself were found to influence melting and 
annealing temperatures of molecular beacons. Figure 45 demonstrates these 
dependencies. In short, it can be concluded that higher concentrations of 
monovalent cations, Mg
2+
 or oligonucleotides increase beacon melting and 
annealing temperatures: 
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Fig. 45: Predicted stem melting and loop annealing temperatures [99 – 101] for an exemplary 
molecular beacon of the design acgcTTTTTTTTTTTTTTTTTTTTTTTTTgcgt. Depicted are 
dependencies on [Mg
2+
] (A) at constant [Na
+
] of 10 mM (this value corresponds approximately to 
70 mM sodium borate, pH 8.3) and dependencies on [Na
+
] (B) in the absence of Mg
2+
. 
Calculations were carried out via the TM server for stem melting and via the 2-state hybridization 
server for annealing temperatures. Annealing was calculated to an oligonucleotide consisting of 
60 A at 1 µM total oligomer concentration (probe and target sequence together, half of the given 
strand concentration value is assigned to each sequence, respectively). (C) relates computed 
annealing temperatures to the total concentration of oligonucleotides present in the sample 
solution. Calculations were carried out for constant [Na
+
] at 10 mM in the absence of Mg
2+
 for 
annealing to a 60 A oligonucleotide. 
 
(iv) Proximal G-bases additionally quench attached fluorophore molecules [102].  
 
(v) The length of the loop region influences the relative position of the modified 
arms of the MB stem upon hybridization to the target sequence. For probe 
lengths of 13, 25 or 35 nucleotides both arms were found to form a trans-
position upon binding to the target sequence [87]. Trans-position of MB arms 
in the opened state is important because of increased spatial distance between 
fluorophore and quencher leading to a maximum FL signal upon probe binding. 
 
In accordance with the considerations detailed above, we designed a molecular beacon 
targeting the IRES region of the HRV2 genome (figure 46). We opted for a 5 nucleotide 
stem flanking a 25 nucleotide loop region. FL modification was carried out at the 5’ end 
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proximal to an A base. The beacon was modified via carboxyfluorescein (FAM) for FL in-
batch measurements and via Cy5 for CE because of higher detection sensitivity of the 
corresponding laser. The 3’ end was modified via a Black Hole Quencher (BHQ), 
respectively. The stem melting temperature was predicted to 48.4°C, the annealing 
temperature to 52.7°C in 10 mM Na
+
 including 0.5 mM Mg
2+
 (corresponding to 70 mM 
sodium borate, pH 8.3, 0.5 mM MgCl2) at 0.5µM total oligonucleotide concentration. 
These values corresponded to a free energy of -1.3 kcal/mol for closed hairpin structure 
and -19.0 kcal/mol for the hybridized beacon [101]. Annealing to a HRV2 genome 
sequence of 64 nucleotides including the IRES even resulted in a predicted temperature of 
58.8°C (free energy of -21.0 kcal/mol). In the latter case additional interactions of the 
beacon stem with nucleotide regions flanking the IRES sequence were regarded. 
 
 
 
 
 
 
 
           Fluorophore   Quencher 
Fig. 46: Folded MB targeting the IRES sequence of HRV2. Folding was predicted [99 – 101] and 
the image obtained from [101]. 
 
Results and Discussion 
Our experiments intended to evolve a chip electrophoretic method to follow the viral RNA 
transfer of HRV2 through membranes. In order to do so, we first had to ensure correct 
folding of the MB in free solution to its closed state to arrange for intramolecular 
quenching. Quenching of MBs can be influenced via ionic strength and Mg
2+
 content of 
respective buffer solutions as shown in the prediction above. Figure 47 demonstrates the 
resulting FL signals obtained via in-batch measurements of FAM labeled MB upon mixing 
with 50 mM sodium borate, pH 8.3 at different ionic strength values adjusted via NaCl (A) 
loop 
stem 
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or upon addition of MgCl2 (B). Quenching of the FL signal was found for NaCl 
concentrations of 100 mM or more or MgCl2 concentrations of 0.5 mM or higher. For 
further experiments, we opted for MgCl2 addition to buffers in anticipation of CE 
measurements; Application of buffers with high salt concentration creates high currents in 
CE and was therefore avoided.  
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Fig. 47: In batch measurements of an HRV2 IRES targeting molecular beacon; beacon sequence: 
agccgAAATATAAAGGAAAAAGTGAAACACcggct. The beacon was modified via FAM (5’) 
and via a BHQ (3’). Measurements were carried out with 100 nM MB concentration in 50 mM 
sodium borate, pH 8.3 and variable NaCl (A) or MgCl2 (B) concentration as indicated. 
Instrumentation: 1420 Multilabel Counter Victor² from Perkin Ellmer. 
 
After preliminary experiments on intramolecular quenching of MBs, we checked the 
applicability of MB samples with MgCl2 containing buffers in CE. In order to minimize 
sample stacking effects, we introduced the same concentration of MgCl2 to both 
electrophoresis buffers, the BGE and the sample buffer, respectively. In good accordance 
with results from in-batch measurements, we found the Mg
2+
 concentration of buffers 
crucial for complete intramolecular FL quenching of the beacon. Up to MgCl2 
concentrations of 0.25 mM we still obtained signals for completely or partially unquenched 
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MBs. Upon application of higher MgCl2 concentrations we did not obtain any FL peaks 
resulting from the beacon. Figure 48 depicts resulting electropherograms. 
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Fig. 48: CE of MBs depicting the influence of the MgCl2 content of electrophoresis buffers on 
MB conformation. A closed hairpin structure of the MB can be achieved by addition of 0.4 mM 
MgCl2 to electrophoresis buffers. CE at + 20 kV, 30.0°C and detection via Picometrics ZETALIF 
HeNe laser (λex = 633 nm); Capillary: fused silica, 50 µm inner diameter, 375 µm outer diameter, 
Ltot = 72.2 cm, Leff (UV) = 23.5 cm, Leff (FL) = 57.2 cm; BGE: 100 mM sodium borate, pH 8.3 
including variable MgCl2 concentrations; Sample: 100 nM MB targeting the HRV2 IRES 
sequence and labeled via Cy5, 25nM Atto 647 (internal standard) and DMSO 1 : 4 x 10
3
 in 50 
mM sodium borate, pH 8.3. The MgCl2 concentration of samples corresponded to respective BGE 
values. 
 
However, upon application of MgCl2 in the BGE we experienced a drop in EOF from 66.7 
± 1.9 x 10
-9
 m²/Vs (no MgCl2; n = 4 measurements) to 50.5 ± 0.6 x 10
-9
 m²/Vs (0.5 mM 
MgCl2; n = 10 measurements). Because of this decline in EOF we did not investigate 
application of higher MgCl2 concentrations in electrophoresis buffers. 
 
As shown in figure 48, the signal obtained for the MB declined upon addition of MgCl2 to 
electrophoresis buffers. Digestion of the MB via DNase I lead to regained FL. Such, we 
demonstrated the loss of FL upon application of MgCl2 to electrophoresis buffers to be 
related to intramolecular quenching of the beacon. Figure 49 depicts a respective 
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electropherogram for a digested MB sample. Upon application of electrophoresis 
conditions which previously yielded no FL signal for the beacon, we now obtained three 
FL peaks with mobility values of 18.5 ± 0.1, 23.4 ± 0.2 and 26.3 ± 0.2 [10
-9
 m²/Vs]. The 
FL intensity of different MB fragment peaks varied according to incubation conditions. 
However, from these results we concluded that via addition of MgCl2 to electrophoresis 
buffers we were able to shift the MB conformation to its closed state. For further 
measurements we finally opted for 0.5 mM MgCl2 addition to electrophoresis buffers in 
order to obtain complete intramolecular quenching. 
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Fig. 49: Digest of HRV2 IRES targeting MB, Cy5 labeled. FL was recorded under CE conditions, 
which had previously not yielded a peak for the undigested beacon (compare to figure 48). CE 
and capillary as with figure 48. BGE: 100 mM sodium borate, pH 8.3 including 0.5 mM MgCl2. 
Sample: 100 nM IRES targeting MB, Cy5 labeled, 50 nM Atto 647 (internal standard) and DMSO 
1 : 4 x 10
3 
in 50 mM sodium borate, pH 8.3 including 0.5 mM MgCl2. The sample was digested 
via DNase I. 
 
As expected and demonstrated from figure 50, intramolecular quenching of the MB 
achieved via addition of MgCl2 to electrophoresis buffers nevertheless did not influence 
the reactivity of the beacon towards its nucleotide target sequence. Upon incubation of MB 
samples with corresponding positive and negative control oligonucleotides under 
intramolecular quenching conditions, we only recorded a FL peak for samples including 
positive control oligomers. Interestingly, first results hinted a rather slow kinetic of duplex 
strand formation of the MB with the positive control oligonucleotide. In fact, even after 
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150 min incubation at ambient temperature we still recorded an increase in the product 
peak area related to the peak area of the internal standard (data not shown). 
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Fig. 50: Incubation of HRV2 IRES targeting MB, Cy5 labeled with negative and control 
oligonucleotide sequences. Only incubation with the positive control yielded an additional FL 
peak. CE and capillary as with figure 48, BGE and sample composition as with figure 49. 
Samples additionally contained 50 nM of control oligonucleotide sequences, respectively. 
Incubation was for approximately 40 min at 30.0°C in the sample tray of the instrument. 
 
Upon incubation of MB with RNA released from HRV2 capsids through heat denaturation 
we obtained several sharp peaks as presented with figure 51.  Obtained peaks were clearly 
no spikes and exhibited declining intensities. Recorded peak mobilities ranged from 19.3 ± 
0.2 to 20.2 ± 0.1 [10
-9
 m²/Vs] for 67.5 nM HRV2 and from 20.7 ± 0.02 to 21.4 ± 0.1 [10
-9
 
m²/Vs] for 33.8 nM HRV2 containing samples. Calculation of peak mobilities was carried 
out from duplicate measurements. From recorded mobilities we excluded the possibility 
that obtained peaks resulted from digested MBs (compare with mobility values presented 
above for DNase digested beacon). Peak sharpness may be related to large analyte size and 
charge; the molecular weight of viral RNA values around 2.2 MDa which leads to 
decreased longitudinal diffusion inside the capillary. Also interaction of nucleotides with 
Mg
2+
 might cause a local gradient in the MgCl2 concentration leading as well to peak 
sharpening. The unexpected high number of obtained FL peaks might be related to MB 
attachment to differently folded viral RNA molecules. Also several thermodynamically 
stable MB hybridization products with the roughly 7 100 nucleotides of the viral RNA are 
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reasonable (compare to [95]), however, because of high target length we skipped 
hybridization prediction with the full length target sequence. 
Apart from heat denaturation of viral samples in the presence of MBs also acidification of 
HRV2 samples was tested (data not shown). In contrast to heated samples concentration 
conditions during acidification were such that mainly 135S particles were created (refer to 
3.1). Thus, no signals for RNA attached MBs could be obtained after sample acidification. 
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Fig. 51: FL signals obtained after hybridization of HRV2 IRES targeting MB, Cy5 labeled with 
full length viral RNA (A). Magnification of middle and lower trace from (A) depicted in (B); 
A 
B C 
109 
 
magnification of upper trace from (B) depicted in (C). Magnified areas are highlighted, 
respectively. Viral RNA release was triggered via sample heating to 56.0°C for 10 min in the 
presence of MBs. CE and capillary as with figure 48, BGE and sample composition as with figure 
49. Samples also included indicated concentrations of HRV2.  
 
In a next step in developing a liposome based assay for elucidating viral RNA transfer 
through membranes we ported the CE analysis of MBs to the microchip scale, since we 
suggested higher sensitivity of the Agilent 2100 Bioanalyzer system. Indeed, upon 
comparision of limit-of-detection (LOD) values we found the LOD of the unquenched MB 
on the conventional CE instrument at 0.81 nM, whereas the LOD on the 2100 Bioanalyzer 
lay 2.25 fold lower at 0.36 nM. In good accordance with our findings upon application of 
conventional CE, we succeeded to close the MB hairpin structure in the chip format as well 
upon application of MgCl2 in electrophoresis buffers (figure 52). 
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Fig. 52: Chip electrophoresis of HRV2 IRES targeting MB, Cy5 labeled. Analysis was carried out 
on the Agilent 2100 Bioanalyzer system upon application of DNA chips. Script changes were as 
described (refer to 3.2 – 3.4). BGE was 100 mM sodium borate, pH 8.3 either including 0.5 mM 
MgCl2 or not (as indicated). Samples consisted of 20 nM MB, 3.0 µM Atto 495 (EOF marker for 
detection at λex 470 nm) and 2.5 nM Atto 647 (internal standard for detection at λex 630 nm) in 
BGE. Depicted are traces detected with the red laser (λex 630 nm) of the instrument. 
 
Interestingly, although only 20 nM MB were applied to chip electrophoresis compared to 
the fivefold higher concentration with conventional CE, we still recorded a broad peak at 
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approximately 40s migration time originating from the closed MB upon application of 
MgCl2 in electrophoresis buffers. However, FL of the closed MB was still significantly 
lower than for the beacon in the open conformation. Like on conventional CE we also 
experienced a decline in the EOF on chips of about 25%. We recorded EOF values of 
about 53.9 ± 0.5 [10
-9
m²/Vs] in the absence and 40.7 ± 1.2 [10
-9
m²/Vs] in the presence of 
0.5 mM MgCl2. Measurements for elucidating EOF values were carried out in duplicates. 
 
As a next step in developing a liposome based chip electrophoretic assay for viral RNA 
transfer through membranes, we encapsulated molecular beacons in liposomes. We chose 
the lipid composition of n-phl liposomes (refer to 3.2), that was also employed for chip 
electrophoretic leakage experiments. Again the MB targeting the IRES sequence of HRV2 
was Cy5 labeled. It was encapsulated at 50 nM in 50 mM sodium borate buffer, pH 8.3 
including 0.5 mM MgCl2. Initial experiments worked with conditions under MBP-V33333 
receptor mediation, which previously did not yield any liposome leakage (up to 
approximately 20 nM HRV2 in incubation solution, refer to figure 42). Liposomes were 
decorated with recombinant receptor fragments before virus attachment. Receptor 
mediated adducts were then acidified to pH 5.1 and incubated for 15 min to allow for RNA 
transfer. After reneutralization and additional incubation at ambient temperature, samples 
were analyzed via chip electrophoresis. Although experimental conditions were employed 
that previously yielded good results in adduct formation and liposome leakage, 
experiments failed to detect the viral RNA transfer itself through membranes. However, 
influence of either the lipid membrane or of the Ni
2+
 chelating DOGS-NTA lipid on the 
MB could be excluded. The obtained unquenched MB signal in the presence of DOGS-
NTA lipid containing liposomes did not change (data not shown). Instead, gel 
electrophoresis experiments revealed partial digest of recombinant receptor fragments that 
such no longer exhibited virus binding characteristics. Therefore, we are of high spirits to 
get our experiments operating upon application of freshly prepared recombinant receptor 
solution. Further future modifications of our experimental setup for enhancing the 
sensitivity of this model system may include: 
 
(i) Longer incubation times for attachment of MB to target RNA since preliminary 
experiments showed slow kinetics of duplex strand formation. 
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(ii) Adjustment of encapsulated MB concentration to obtain higher signals. 
(iii) Adjustment of MB nucleotide sequence to allow for faster RNA detection. 
Partial binding of the stem sequence to the target oligonucleotide [95] might 
increase the kinetics of duplex strand formation. 
 
(iv)  Change in fluorophore from Cy5 to Atto 647 to further lower the LOD of MBs. 
 
(v) Targeting the poly A 3’ end of the viral RNA. Although the exact length of the 
poly A tail is variable, more than one short MB might then be able to target the 
viral RNA leading to an approx. 2 - 3 fold increase in the obtained signal for a 
single target molecule. 
 
(vi) Application of TroloxTM as an additional component of electrophoresis buffers. 
Literature [103] reports an increase in dye photostability and decreased blinking 
of fluorophores thus yielding higher average photon counts per molecule. For 
Cy5 an approximately 200 fold increase in average photon counts to approx. 
200 000 counts per molecule were reported, for Atto 647 an approximately 45 
fold increase in average photon counts leads to even approx. 850 000 counts per 
molecule. 
 
(vii) Binding of His6-tagged recombinant receptor fragments to Ni2+ chelating lipids 
was shown not to be complete although Ni
2+
 was employed in molar excess 
over receptor fragments (refer to 3.4). Therefore, receptor fragments were able 
to stabilize virions in free solution or even virus particles already attached to 
liposomes against pH induced viral uncoating [7]. We therefore suggest to 
circumvent this additional virus stabilization via exchange of recombinant 
receptor fragments anchored via Ni
2+
 and His- tags to lipid membranes to either 
recombinant receptor molecules including a transmembrane domain or to native 
receptor molecules obtained from cell culture. We propose that thereby a higher 
number of HRV2 particles is able to transfer its RNA genome through the 
liposomal membrane increasing the number of target molecules for MB 
detection. 
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(viii) Application of a two step acidification process; In vivo bound virus particles 
dissociate from membrane receptors at mildly acidic pH values. However, 
under these conditions still no virus uncoating takes place. The pH threshold for 
virus uncoating was reported at lower pH values of 5.6 (refer to 2.1.1.), where 
already no virus / receptor complex was formed. Application of such 
acidification steps in vitro might increase virus infectivity, i.e. the number of 
viral RNA molecules that are shuttled through the liposomal membrane. 
 
Experimental Section 
Chemicals: Boric acid (99.99%) and MgCl2 hexahydrate (cell culture tested) were purchased from Sigma 
Aldrich (Steinheim, Germany). The FL dyes Atto 495 and Atto 647 (both in free acid form) were from Atto 
Tec (Siegen, Germany) and obtained as well from Sigma Aldrich. Cy5 was from Amersham Bioscience 
(Little Chalfont, England) and employed from a 25 mM stock solution in DMSO. DMSO (p.a.) was from 
Fluka (Buchs, Switzerland). A 1:200 dilution of DMSO in water was employed as intermediate DMSO stock 
for CE measurements. Sodium hydroxide (pellets pure) was from E. Merck (Darmstadt, Germany). DNase I 
(RNase free from bovine pancreas) was from Fermentas Life Science (St. Leon-Rot, Germany).  Molecular 
Beacons and other oligonucleotides were composed of single stranded, unmodified DNA and obtained from 
VBC genomics (Vienna, Austria). The MB sequence was 
agccgAAATATAAAGGAAAAAGTGAAACACcggct for targeting the HRV2 IRES sequence. MBs were 
FL labeled at the 5’ end via carboxyfluorescein (FAM) for in-batch and via Cy5 for CE and chip 
measurements. The 3’ ends were modified via a black hole quenchers (BHQ), respectively. The 
oligonucleotide sequence for the positive control was 
tgggaccaactactttgggtgtccGTGTTTCACTTTTTCCTTTATATTTgcttatggtgacaat and for the negative control 
tactctgttattacggtaactttgtacgccagttttatctcccttcccccatgtaacttagaag. MBs and oligonucleotides were solved in 
nuclease free water (Quiagen, Hilden, Germany) to obtain 100 µM stock solutions. All other water was of 
Millipore grade. Lipids were as described (refer to 3.2) and obtained from Avanti Lipids (Alabaster, AL, 
USA) via Instruchemie (Delfzyl, The Netherlands). Liposomes in non-physiologic composition (n-phl) were 
prepared in 50 mM sodium borate, pH 8.3 including 0.5 mM MgCl2 and 50 nM of HRV2 IRES targeting 
MB, Cy5 labeled as previously described (refer to 3.2). 
 
Biological Material: An HRV2 aliquot, produced as described [8, 46], in 50 mM sodium borate, pH 7.4 at a 
concentration of 5.4 mg/mL was employed for experiments. A recombinant receptor fragment of the VLDLR 
at 5.5 mg/mL in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 20 mM CaCl2 was used for formation of 
receptor mediated adducts between liposomes and virus particles. It consisted of five repeats of the VLDLR 
binding domain number 3 arranged in tandem, fused to a His6 tag at its C- and to MBP at its N-terminus 
[75]. 
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Instrumentation: FL in-batch measurements were carried out on 96-well plates on a 1420 Multilabel 
Counter Victor² from Perkin Ellmer (Fremont, CA, USA). CE was carried out on an Agilent 3D CE coupled 
to a Picometrics (Ramonville, France) ZETALIF FL detection system equipped with a HeNe laser with λex = 
633 nm (10mW from Melles Griot obtained via Merz Brothers, Haid, Austria). Electrophoresis was at 
+ 20 kV and 30.0°C for 28 min runtime. The capillary was preconditioned for 2 min with BGE prior each 
run, postconditioning included flushing for 2 min with 1 M sodium hydroxide and 2 min with water. Samples 
were injected via application of 50 mbar pressure for 9 sec. Analytes were detected at 200, 205, 260 and 
490 nm; the band width valued 10 nm for each UV detection wavelength, respectively. FL was recorded with 
the HeNe 594 nm setup of the Picometrics system. A fused silica capillary (50 µm inner diameter, 375 µm 
outer diameter) with Ltot = 72.2 cm and Leff (UV) = 23.5 cm and Leff (FL) = 57.2 cm from Polymicro 
(Phoenix, USA) obtained via Optronis (Kehl, Germany) was employed for electrophoresis. Sodium borate 
(100 mM, pH 8.3) including variable MgCl2 concentrations was employed as BGE and sample buffer, 
respectively. Electrophoresis buffers were filtered through 0.45 µm CA membrane syringe filters prior to 
application. Chip electrophoresis was carried out on the Agilent 2100 Bioanalyzer system (Agilent 
Technologies, Waldbronn, Germany) employing DNA chips. Modifications in chip handling and analysis 
were as described (refer to 3.2). BGE and sample buffer were as with conventional CE. 
 
Sample preparation: For elucidating the impact of the MgCl2 concentration of electrophoresis buffers on 
the MB conformation samples consisting of 100 nM MB targeting the HRV2 IRES sequence and labeled via 
Cy5 and including 25 nM Atto 647 as internal standard and DMSO 1 : 4 x 10
3
 as EOF marker in 50 mM 
sodium borate, pH 8.3 with variable MgCl2 concentrations corresponding to the respective BGE were 
prepared. Samples for digest included 100 nM Cy5 labeled MB, 50 nM Atto 647 and DMSO 1 : 4 x 10
3
 in 
50  mM sodium borate, pH 8.3 with 0.5 mM MgCl2. Digestion was via DNase I at 0.05 units for an 
intermediate MB concentration of 400 nM for 10 min at 30.0°C before sample dilution to final 
concentrations. Diluted sample was additionally incubated for 35 min at 4.0°C (ice bath) and 35 min at 
30.0°C (tray of CE instrument), respectively. For other conventional CE samples, an intermediate analyte 
solution of 111 nM MB including 55.5 nM Atto 647 and 1 : 3.6 x 10
3
 DMSO in 55.5 mM sodium borate, 
pH 8.3 with 0.55 mM MgCl2 was prepared. 9 µL of this intermediate solution were mixed with 1 µL of 
oligonucleotide solutions (500 nM in water, respectively) or 1 µL of virus stock solution. Alternatively, virus 
stock solution was diluted 1 : 2 in the corresponding preparation buffer before mixing with the beacon 
solution. Corresponding buffer without any virions was used for preparation of a blank sample.  Incubation 
was for 40 min at 30.0°C in the tray of the CE instrument for control oligonucleotides and for 10 min at 
56.0°C for hybridization of MBs to viral RNA. Chip electrophoretic samples consisted of 20 nM Cy5 labeled 
MB, 3.0 µM Atto 495 (EOF marker for detection at λex 470 nm) and 2.5 nM Atto 647 (internal standard for 
detection at λex 630 nm) in BGE. BGE was 100 mM sodium borate, pH 8.3; for indicated experiments it 
included additionally 0.5 mM MgCl2. 
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4 Method Development on the Agilent 2100 
Bioanalyzer System 
 
4.1 Application of a Fluorescent EOF Marker 
 
In order to assess the EOF upon chip electrophoresis with FL detection, it was aimed to 
include a fluorophore with a known electrophoretic mobility in all respective samples 
(comparable to DMSO as EOF marker for UV detection). The Agilent 2100 Bioanalyzer 
offers the possibility of simultaneous detection at two wavelenghts – λex at 470 and 
630 nm. Detection at λex = 630 nm showed higher sensitivity and was therefore employed 
for tracing FL labeled analytes. To circumvent possible separation problems between 
analyte peaks and a peak of a standard fluorophore, I opted for the second detection 
window offered by the instrument, with λex at 470 nm (blue LED) for detection of a FL 
EOF marker. Several fluorophores were investigated for their applicability as FL standard. 
 
4.1.1 Calcein 
Calcein (HPCE grade) was obtained from Sigma Aldrich (Steinheim, Germany); figure 53 
shows a respective molecule. Its absorption / emission characteristics (λex / em = 470 / 
509 nm) correspond well to the blue detection window of the Agilent 2100 Bioanalyzer 
system (λex / em = 470 / 525 nm). 
 
 
Fig. 53: Calcein (HPCE grade) from Sigma Aldrich, image taken from 
http://www.sigmaaldrich.com 
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Initial experiments showed detectability of Calcein with the Agilent 2100 Bioanalyzer 
system (figure 54). However, problems with the peak shape of the Calcein peak were 
experienced; heterogeneous and tailing peaks were obtained.  
Fig. 54: Detection of Calcein employing the blue LED (λex / em = 470 / 525 nm) of the Agilent 
2100 Bioanalyzer System. Script modifications as detailed (refer to 3.2 - 3.5); measurements were 
carried out on DNA chips, BGE: 100 mM sodium borate, pH 8.3; Samples included Calcein at 
indicated concentrations. 
 
Detection of heterogeneous Calcein peaks could be related to several possible reasons: 
 
(i) Contamination of obtained Calcein – An improbable assumption, since the 
supplying company guaranteed HPCE grade of the analyte substance. 
 
(ii) Wall adsorption to the chip separation channel – In order to exclude wall 
adsorption phenomena as reasons for obtained heterogeneous peaks, addition of 
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SDS at different concentrations to the BGE was tested (figure 55). At all 
investigated SDS concentrations the peak appearance did not change 
significantly. For higher SDS concentrations the observed effects seemed to be 
even more pronounced. Wall adsorption of Calcein as cause for tailing and 
heterogeneous peaks therefore could be excluded. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 55: Calcein peak shape depending on the SDS content of the BGE. Script 
modifications as detailed (refer to 3.2 - 3.5); measurements were carried out on DNA 
chips employing the blue LED of the instrument (λex / em = 470 / 525 nm) for 
detection; Sample: Calcein 1.0 µM in BGE; BGE: 100 mM sodium borate, pH 8.3 at 
indicated SDS concentrations. 
 
(iii) Additional sample uptake at the injection cross during respective chip 
electrophoretic runs – Cleaning currents between sample injection to the 
separation channel and the analytical run itself were introduced to minimize 
additional analyte uptake at the injection cross. However, this did not lead to a 
significant improvement of peak shapes as presented in figure 56. In fact, 
increasing cleaning currents even lead to partial separation between three 
constituents of Calcein. 
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Fig. 56: Calcein peak shape depending on the introduction of cleaning currents after 
electrophoretic sample injection to the separation channel and before chip electrophoretic analysis 
to minimize additional sample uptake at the injection cross. Script modifications as detailed (refer 
to 3.2 - 3.5). Additional cleaning currents of indicated length were introduce to the chip 
electrophoretic setup. Mmeasurements were carried out on DNA chips employing the blue LED 
of the instrument (λex / em = 470 / 525 nm) for detection; Sample: Calcein 1.0 µM in BGE; BGE: 
100 mM sodium borate, pH 8.3. 
 
In overall, although the exact reason of heterogeneous and tailing peaks could not be 
resolved, Calcein did not seem suitable as FL EOF marker for chip electrophoretic 
analysis on the Agilent 2100 Bioanalyzer system upon employment of the blue 
detection window of the instrument. Also, its reactivity to divalent cations precluded 
the application of Ni
2+
 loaded liposome surfaces for receptor attachment. Therefore, in 
a next step, Atto 495 was tested as FL marker substance. 
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4.1.2 Atto 495 
Atto 495 (HPCE grade) was obtained from Sigma Aldrich (Steinheim, Germany) in its free 
acid form. Figure 57 depicts a respective molecule. Its absorption / emission characteristics 
(λex / em = 495 / 527 nm) corresponds well with the blue detection window of the Agilent 
2100 Bioanalyzer system (λex / em = 470 / 525 nm).  
 
Fig. 57: Atto 495 (HPCE grade) from Sigma Aldrich, image taken from 
http://www.sigmaaldrich.com 
 
The pH value of the BGE for CE analysis of virions had to be chosen in the basic range 
(refer to 2.3.1); therefore, experiments had been carried out upon application of sodium 
borate buffer at pH 8.3. Chip electrophoretic analysis of liposomes and receptor mediated 
adducts between virions and liposomes also precludes the application of detergents in the 
BGE. From these considerations Atto 495 was electrophoresed in sodium borate buffer, pH 
8.3 in the absence of any surfactants. Figure 58 depicts the UV adsorption spectra of all 
neutral compounds recorded under these conditions, i.e. DMSO and the Atto dye. As could 
be learned from these spectra, Atto 495 migrated with the EOF under such electrophoresis 
conditions – the fluorophore was recorded in its zwitterionic form.  
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Fig. 58: UV absorption spectra for DMSO and Atto 495 containing samples – UV spectra of plain 
DMSO (A), of Atto 495 (B) and of a mix of these two components (C). From the UV absorption 
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spectra, comigration of Atto 495 with DMSO was concluded. Atto 495 was therefore recorded in 
its zwitterionic form. CE: fused silica capillary, 50 µm inner diameter, Ltot = 60.0 cm, Leff = 
51.6 cm; CE was at + 20 kV, 20.0°C and sample injection at 400 mbar x sec; Analytes were 
detected at 200 nm and 470 nm via their UV absorption characteristics and UV spectra of 
corresponding peaks were obtained via the Agilent HPCHEM software; BGE: 100 mM sodium 
borate, pH 8.3; Samples: 31.5 µM Atto 495 and / or DMSO 1 : 6.1 x 10
3
 in BGE. 
 
However, since CE of rhinoviruses had been carried out so far upon addition of surfactants 
to the BGE, I also tested the applicability of this marker in such an electrophoresis system. 
Upon SDS addition to the BGE, Atto 495 was found to interact with the detergent already 
below its respective CMC. Therefore, Atto 495 no longer migrated with the EOF but 
passed the detector at later time points (figure 59). It is of note that the EOF mobility of all 
three electropherograms presented below was comparable at approximately 62.6 ± 0.6 
x 10
-9
 m²/Vs. Electropherograms were recorded with FL detection (ZETALIF detector, 
Picometrics, Ramonville, France equipped with an Argon laser, model 163-M12 - 25 mW 
from Spectra-Physics, Mountain View, CA). 
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Fig. 59: Atto 495 signal in dependence of the SDS concentration of the BGE (100 mM sodium 
borate, pH 8.3) as indicated. Electrophoresis conditions: fused silica capillary, 75 µm inner 
diameter, Ltotal = 73.0 cm, LUV = 23.5 cm, LFL = 58.0 cm; sample injection at 200 mbar x sec; 
temperature of capillary at 20.0°C; electrophoresis at + 20 kV; detection at 200 nm (UV) and via 
ZETALIF system at λex = 488 nm (FL); The sample consisted of 30 nM Atto 495 and DMSO 
1:6.1 x 10
3
 in non SDS containing BGE. 
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Upon application of a theoretical approach we were able to predict shapes of the mobility 
dependence curves of Atto 495 on the SDS content of the BGE (above the CMC of SDS). 
For several assumed partition coefficients of Atto 495 between the bulk phase and SDS 
micelles we obtained (figure 60): 
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Fig. 60: Prediction of the electrophoretic mobility of Atto 495 in the presence of SDS in the BGE 
(100 mM sodium borate, pH 8.3) above the CMC. Depending on the partition coefficient of the 
FL dye between the bulk phase and SDS micelles different curves are fitted. 
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In following experiments we could demonstrate the mobility dependence of Atto 495 on 
the SDS content of the BGE according to our predictions for high partition coefficients. 
Measurements were carried out at least in duplicate on an Agilent 3D CE employing a 
ZETALIF FL detection system equipped with an Argon laser (λex = 488 nm). In good 
agreement with obtained data points a linear fit was chosen for the description of the Atto 
495 mobility behaviour below the CMC at approximately 2.4 mM SDS (figure 61). The 
migration of Atto 495 above the CMC of SDS in the BGE was similar as predicted for high 
partition coefficients. Slight variances in the curve shape (when compared to figure 60) are 
probably due to aggregating SDS monomers interacting with the dye. Such an effect had 
also been recorded previously [104]. 
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Fig. 61: Mobility of Atto 495 depending on the SDS content of the BGE (100 mM sodium borate, 
pH 8.3). For SDS concentrations below the CMC, a good correlation between obtained data 
points and an employed linear fit was found.  
 
Electropherograms recorded on the Agilent 2100 Bioanalyzer system with the blue LED 
(λex / em = 470 / 525 nm) of the instrument and employing DNA chips demonstrated as well 
interaction of the fluorophore with SDS. At higher detergent concentrations of the BGE the 
migration time of the FL dye was shifted to higher values as experienced already in the 
capillary format (figure 62). Atto 495 is nevertheless suitable as FL marker for chip 
electrophoresis. However, for SDS containing BGEs the interaction between the dye and 
the surfactant has to be considered. 
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Fig. 62: Atto 495 signals recorded on the Agilent 2100 Bioanalyzer system employing a BGE 
(100 mM sodium borate, pH 8.3) with different SDS concentrations. Interactions between the FL 
dye and the surfactant can be deduced from prolonged migration times of Atto 495 in the presence 
of the detergent. Script modifications as presented under3.2; measurements were carried out on 
DNA chips employing the blue LED of the instrument (λex / em = 470 / 525 nm) for detection; 
Sample: 3.0 µM Atto 495 in BGE; BGE: 100 mM sodium borate, pH 8.3 including SDS at 
indicated levels. 
 
In overall, Atto 495 performed well on the Agilent 2100 Bioanalyzer chip electrophoresis 
system. In the absence of SDS (as intended for analysis of liposomes) the dye even is 
suitable as FL EOF marker employing the blue detection window of the instrument. Atto 
495 therefore was included in all subsequent samples at approximately 3.0 µM 
concentration for EOF assessment. 
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4.2 Determination of Stable Electrophoresis 
Conditions for Chip Analysis 
 
Upon application of 100 mM sodium borate, pH 8.3 without addition of surfactants as 
BGE during chip electrophoresis two sets of possible EOF values on Agilent 2100 
Bioanalyzer DNA chips were experienced. The average EOF of one set was 38.21 ± 2.79 
[10
-9
 m²/Vs] (value obtained from 43 measurements), the other set yielded 55.05 ± 2.21 
[10
-9
 m²/Vs] (value obtained from 23 measurements) in average. EOF values were 
determined upon application of Atto 495 as FL EOF marker (refer to 4.1.2). Chip 
electrophoresis at high EOF values yields several advantages: 
 
(i) Short analysis times 
 
(ii) Sharper peaks for analytes with low electrophoretic mobility 
 
(iii) High reproducibility of peak migration times between electropherograms, 
especially upon sample analysis from different wells of the same chip  
 
(iv) Easier detection of peak mobility shifts in the course of bioaffinity reactions 
 
These advantages were the reason why it was tried to obtain high EOF values for all chip 
electrophoretic measurements. Upon investigation of reasons for low EOF values several 
possible causes were considered: 
 
(i) BGE pH value – Upon application of a BGE with pH 8.3, silanol groups on the 
surface of the chip channels are deprotonated. Nevertheless, we investigated the 
EOF dependence on BGE pH values between 8.20 and 8.45. As expected, no 
connection between EOF and pH in the investigated pH range was found. Small 
variations in pH resulting from different BGE batches could therefore be 
excluded as reason for low EOF values.  
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(ii) BGE ionic strength – Small differences in the pH value of various BGE batches 
led as well to variances in the respective buffer ionic strength values. However, 
like with pH variances, no connection between slightly varying ionic strength 
levels of the BGE and obtained EOF values could be drawn. 
 
(iii) Temperature of analysis – Agilent 2100 Bioanalyzer DNA chips are heated to 
30.0°C during analysis. However, especially since our instrument was not 
equipped with a thermostatization possibility, slight variances in temperature 
were expected to occur during analyses. Indeed, chip temperatures between 
30.0°C and 33.3°C (regarding a representative set of 15 analyzed DNA chips) 
were recorded. However, as with investigated pH and ionic strength 
dependencies, it was not possible to deduce a correlation between elevated chip 
temperature during analysis and the two sets of obtained EOF values. 
 
(iv) Carry-over of detergents between different DNA chips – Control of HRV2 
labeling via Cy5 was achieved in SDS containing BGE [1, 2]. However, since 
the analysis of liposome including samples precluded the application of 
surfactants in the BGE, SDS was omitted for other chip electrophoretic setups. 
The electrode cartridge of the instrument was, although thoroughly cleaned via 
the electrode cleaning chip between different analytical setups, the same for 
both applications. Therefore, SDS carry-over between DNA chips could not be 
completely excluded. Although upon addition of SDS to the BGE a stabilizing 
effect on the migration behavior of marker substances could be achieved, EOF 
values could not be stabilized on a high level via SDS addition to the BGE. 
Furthermore, surfactant addition to the BGE lead to tailing of liposome peaks 
upon electrophoresis and was thus omitted for further analyses.  
 
(v) Time depending alteration of the BGE – Buffer uptake of carbon dioxide as 
well as formation of polyborates with time was investigated as possible reason 
of shifting EOF values. However, low EOF values could not be related to either 
of these mechanisms, exclusively. 
 
(vi) Hydrodynamics – Another explanatory attempt considered hydrodynamics on 
chips as possible reason for different EOF values. In a series of experiments the 
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BGE content of the buffer outlet was varied by as much as 10 % in relation to 
the buffer inlet. Furthermore runtimes were reduced to minimize volume 
throughput to the outlet well. Again no correlation to different EOF sets was 
obtained.  
 
(vii) Finally, it was observed that preparation of BGE as well as of the Cy5 dilution 
in BGE for setup of the instrument optics had a significant impact on the EOF. 
Interestingly, only upon application of BGE and a Cy5 dilution in BGE 
prepared freshly on the day of analysis (i.e. not older than 7 hours at 
maximum), high EOF values were reproducibly obtained. The exact mechanism 
of this effect was not investigated in detail but the chip electrophoresis protocol 
was adapted according to these findings. 
 
In accordance to these findings concerning high EOF values during chip electrophoresis 
the BGE was prepared freshly on the day of analysis from boric acid and 3M sodium 
hydroxide, equally prepared on the day of analysis. Cy5 stock (25 mM in DMSO) was 
diluted in DMSO to yield a less concentrated stock solution (62.5 µM in DMSO). This less 
concentrated dye stock in DMSO was diluted 1 : 1 x 10
3
 in BGE as well freshly on the 
respective day of analysis. Such, reproducible EOF values of 54.17 ± 0.88  [10
-9
 m²/Vs] 
(n = 8 measurements from 8 chips measured on four consecutive days upon application of 
4 independently prepared BGE aliquots) for chip electrophoresis on the Agilent 2100 
Bioanalyzer system in the absence of any detergents were obtained. 
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4.3 Fluorescence Labeling of HRV2 
 
Labeling of primary amino-groups of the HRV2 viral capsid was carried out via Cy5 to 
allow for detection via the red laser (λex = 633 nm) of the Agilent 2100 Bioanalyzer 
system. According to literature [60 – 62], 50 mM sodium borate, pH 8.3 was employed as 
labeling buffer. The DMSO content of the labeling solution was limited to 5 % of the total 
volume, because of supposed virus instability in organic solvents. Such, 5 µL of virus 
solution in 50 mM sodium borate, pH 7.4 were incubated with 4.5 µL of 50 mM sodium 
borate, pH 8.3 and 0.5 µL of Cy5 in DMSO. Cy5 was obtained in solid form from 
Amersham Bioscience (Little Chalfont, England) and dissolved in DMSO (p.a. from 
Sigma Aldrich, Steinheim, Germany) to yield a 25 mM stock solution. To adjust the molar 
excess value of dye over virus, Cy5 stock was diluted in DMSO to yield stocks of less 
concentration prior to labeling. Staining was carried out under light protection for approx. 
12 - 20 hours at ambient temperature (approx. 20 - 25°C). 
 
Primary amines on the virus surface originate from surface exposed lysines located on VP1 
loops positioned on the starshaped dome of the capsid [61, 62]. This part of the virus 
capsid is also taking part in receptor recognition. Therefore, it was surprising that FL 
modification of virions still allowed for receptor binding. Cell infection, however, was 
significantly reduced upon labeling [61, 62].  
 
A fairly large molar excess of dye molecules over virions was necessary for FL 
modification of viral capsids [61, 62]. Upon application of high molar excess levels of dye 
over virus, high FL signals for modified virions were obtained. However, we were 
interested in obtaining FL detectable particels with high resemblance to unmodified virions 
for application in bioaffinity reactions. Therefore, we opted for a compromise in labeling 
conditions – application of an approximately 2.5 x 103 fold molar excess of dye over virus 
for capsid labeling modified approximately half of all lysines that were normally labeled 
upon application of higher molar excess levels of dye over virus (figure 63).  
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Fig. 63: The degree of virus surface modification during labeling (as expressed via the sum of 
normalized peak areas for SEC fractions containing labeled virions) is depending on the molar 
excess level of dye over virus molecules in the course of the labeling process. HRV2 was 
modified via the amine-reactive probe Cy5 at indicated molar excess levels. Low-molecular-mass 
material was removed from samples [1, 2] and SEC fractions were subjected to electrophoresis on 
the Agilent 2100 Bioanalyzer instrument. Obtained peak areas were normalized regarding the 
concentration of the virus starting material and the dilution in the course of sample preparation. 
Normalized peak areas from all SEC fractions of a respective HRV2 labeling experiment were 
summed up and plotted against the employed molar excess level of dye over virus particles. 
 
The protocol for removal of low-molecular-mass material from virus labeling solutions 
was modified compared to the one found in literature [1, 2, 61, 62]. Instead of SEC on 
columns we opted for spin SEC. Corning X spin filter inlets (0.45µm CA membrane, 
figure 64, A) were filled with Sephadex G50 swelled in 50 mM sodium borate, pH 8.3. To 
obtain a maximum amount of SEC material inside these filter inlets, excess buffer was 
removed via spinning (30 sec at 100 rcf) on an Eppendorf table centrifuge (model 5415D) 
between SEC material additions. Such, 900 µL of swelled material were applied to filter 
inlets in total. Consecutively, SEC material was dried via spinning (1 min at 400 rcf 
followed by 1 min at 800 rcf). This column was found to detach from the filter inlet wall 
and to sway upon touch of the filter inlet (figure 64, B). In such a way, sample dilution 
upon depletion of low molecular mass material was minimized. Application of other SEC 
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material was found not to be suitable for application in the spin SEC setup – Sephadex G15 
did not detach from the tube wall and Sephadex G100 could not be dried via spinning. 
 
  
 
Fig. 64: Spin SEC upon application of Corning X spin filters (A). Filter inlets were filled with 
Sephadex G50 (B) consecutively spun dry on an Eppendorf table centrifuge to minimize sample 
dilution in the course of free dye depletion. Image A taken from http://www.sigmaaldrich.com  
 
The virus labeling solution (10 µL in total) was applied to the SEC column and eluted via 
spinning (1 min at 800 rcf). Because of the high molecular weight of virus particles, 
elution of analytes was proposed already with this first elution step. Nevertheless, the 
column was rinsed thereafter with 20 µL of 50 mM sodium borate, pH 8.3. The obtained 
combined volume of 30 µL (termed fraction 1a) was subjected to spin SEC on a second 
column. This time the column was rinsed with 15 µL of 50 mM sodium borate, pH 8.3. 
The obtained combined volume of 45 µL (termed fraction 2a) contained the bulk of FL 
modified virions. Column rinsing with 20 µL of 50 mM sodium borate, pH 8.3 for both 
SEC columns after collection of the main fraction, respectively, yielded fractions 1b and 
2b. Collection of second fractions for both spin SEC passes was necessary to determine the 
content of FL labeled virions in the main SEC fraction.  
 
SEC fractions were subjected to chip electrophoresis after dilution. Typically (depending 
on the amount of virus starting material), a 1 : 10 dilution of the SEC main fraction still 
yielded a sufficiently high peak for chip electrophoresis. As demonstrated (figure 65), 
fraction 2a indeed contained the highest number of FL modified particles. Free dye was 
depleted with a minimum of analyte dilution in the course of the purification process. 
Upon consideration of FL virus peak areas of fractions 1b, 2a and 2b approximately 94% 
of all modified virus particles were found in the main SEC fraction 2a.  
A        B 
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Fig. 65: Comparison of spin SEC fractions after 1 : 10 sample dilution. HRV2 was labeled via the 
amine-reactive probe Cy5 at an approx. 2.5 x 10
3
 fold molar excess level of dye over virus 
particles. The labeling solution was subjected to spin SEC purification as detailed in the text to 
deplete an analyte containing solution from free dye molecules with a minimum of further analyte 
dilution. Spin SEC fractions were analyzed via chip electrophoresis. As expected, fraction 2a was 
found to include the majority of FL modified viral particles. Free dye molecules however were 
mostly detected in fraction 1b.   
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6 Conclusion 
 
Human Rhinoviruses belong to the picornavirus family and cause relative harmless 
infections of the upper respiratory tract. However, picornaviridae also include more 
hazardous viral species like polio-, hepatitis-A- and foot-and-mouth-disease virus. This 
fact accounts for the importance of carrying out experimental work with a relatively 
harmless member of this virus family for elucidating steps in the early infection pathway. 
Work in the course of my thesis concentrated on HRV2, the best studied serotype of HRVs 
binding to members of the LDLR family for cell entry.  
 
In my research I was able to expand the applicability of capillary electrophoresis from the 
analysis of native virions to species of the HRV2 uncoating process. Refinement of sample 
preparation conditions allowed for specific targeting of particles trapped at a stage of viral 
uncoating, where virions still include the RNA genome but had already emitted part of 
their proteinaceous capsid to the surrounding solution (subviral 135S particles). Such, the 
stage was set for further structural elucidation of intermediates of the viral uncoating 
process.  
 
Porting of CE conditions to a commercially available chip electrophoresis instrument – the 
Agilent 2100 Bioanalyzer system – allowed for virus analysis in the absence of detergents, 
which had not been possible with a conventional CE setup. Thus, electrophoresis of virions 
alongside lipid vesicles mimicking the cell surface environment under well defined 
conditions was achieved. Such, independent steps of early viral infection, ranging from 
virus attachment to receptor decorated particles to processes related to the viral genome 
transfer through membranes, could be discretely targeted. However, although it was 
possible to lay the basis for further elucidation of the viral genome transfer across 
membranes upon application of molecular beacons, this final step of viral infection could 
not be reached with the developed, liposome-based, chip electrophoretic setup. Therefore, 
future work will be directed to follow this last step of early viral infection. Nevertheless, in 
the course of the present work innovative applications of chip electrophoresis for targeting 
of questions related to infectious processes were worked out, even on a commercially 
available instrument.   
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Zusammenfassung der Dissertation (dt.) 
 
Bis heute konnten in etwa 100 Serotypen von Humanen Rhinoviren (HRVs), welche eine 
der häufigsten Erkältungsursachen darstellen, unterschieden werden. Diese Serotypen 
werden nach dem jeweiligen Rezeptor, an den sie im Laufe der Zellinfektion binden, in 
zwei Gruppen unterteilt. Viren der Hauptgruppe binden an intercellular adhesion molecule 
1 (ICAM – 1), Viren der Nebengruppe an Vertreter der low-density-lipoprotein Rezeptor 
(LDLR) Familie. Chip Elektrophorese ermöglichte in der Vergangenheit bereits erfolgreich 
die Analyse von fluoreszenzmarkierten Viren sowie die Verfolgung entsprechender 
Bioaffinitätsreaktionen. Zum Beispiel konnte die Bindung von HRV2, einem Rhinovirus 
der Nebengruppe, an Rezeptorfragmente verfolgt werden [Weiss et al. (2007): Virus 
analysis by electrophoresis on a microfluidic chip, J. Chromatogr. B 860, 173 – 179 sowie 
Kolivoška et al. (2007): Electrophoresis on a microfluidic chip for analysis of 
fluorescence-labeled human rhinovirus, Electrophoresis 28, 4734 – 4740]. 
 
In Weiterführung dieser grundlegenden Experimente, versuchte ich, im Laufe dieser 
Dissertation, die spezifische, rezeptorvermittelte Bindung von fluoreszenzmarkiertem 
HRV2 an Zellen mit Hilfe von Chip Elektrophorese zu zeigen. Anstelle von Zellen 
arbeitete ich jedoch mit unilamellaren, rezeptordekorierten Vesikeln (Liposomen). Dieses 
Modellsystem ermöglichte Experimente unter gut definierten Bedingungen, anders als es 
bei Verwendung von tatsächlichem zellulären Material möglich gewesen wäre. 
 
Zusätzlich zu reinen Bindungsexperimenten zwischen Viren und Membranen wurde auch 
der Transfer der viralen RNA in das Liposomeninnere untersucht. In vivo gelangen HRVs 
über rezeptorvermittelte Endocytose in das Zellinnere. Im Zuge dieser Transportroute 
werden Endosome angesäuert, was zur Konformationsänderung von aufgenommenen 
Viren führt. Bedingt durch diese Konformationsänderung gelingt es Viren, ihre RNA durch 
die Endosomenmembran in das Cytosol der infizierten Zelle zu transferieren. Daraus ergab 
sich mein Interesse an membrandestabilisierenden Fähigkeiten von viralen Proteinen sowie 
von ganzen Viren. Zusätzlich wurden auch grundlegende Experimente zum Transfer der 
viralen RNA selbst durch Membranen unter Zuhilfenahme von molcecular beacons 
durchgeführt. Molecular beacons sind fluoreszenzmarkierten Sonden, die nach erfolgter 
Bindung an eine korrespondierende Nukleotidsequenz ein Fluoreszenzsignal ergeben.  
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Gefreiten 
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